User login
Household Medicine Cabinet Source of Most Pediatric Poisonings
Approximately 95% of visits related to medication poisoning in children younger than 5 years are caused by self-ingestion, based on data from nearly 500,000 emergency visits during 2001-2008, according to a study published online Sept. 16 in the Journal of Pediatrics.
"If we are to make progress in reducing childhood injury from pharmaceutical poisoning, we need to better understand the epidemic," said Dr. G. Randall Bond of the University of Cincinnati and colleagues.
The researchers reviewed case information from 453,599 children aged 5 years and younger who visited emergency departments due to possible medication poisoning via ingestion of a single product. Data were taken from the American Association of Poison Control Centers’ National Poison Data System, an electronic database of all calls to the organization’s member centers (J. Pediatr. 2011 Sept. 16 [doi:10.1016/j.jpeds.2011.07.042]).
Of the self-ingested poisonings, prescription products accounted for the largest percentage of ED visits (55%), hospital admissions (76%), and significant injuries (71%).
Opioid analgesics had the greatest increase in impact on health care resources during the study period – ED visits increased by 101%, injury rates increased by 92%, and hospital admission rates increased by 86%.
The findings were limited by the self-reported nature of the cases, but they support data from previous studies on the increasing numbers of emergency department visits by young children due to medication poisoning, Dr. Bond and his coauthors said. "The most likely explanation for these observations is a rise in the number of medications in the environment of small children," they noted.
These medications may be more accessible to children in the home because the number of opioid analgesic prescriptions has increased, according to data from the U.S. Drug Enforcement Administration’s database, the researchers noted.
When it comes to preventing medication poisonings, "the results of this study suggest that focus should shift to self-ingestion and prescription products," the researchers said. "The largest potential benefits would come from a shift in attention to packaging design changes that reduce the quantity a child could quickly and easily access in a self-ingestion episode," they added.
Of 90 unintentional deaths recorded in the database, 66 were ingestion related. Of these, opioid analgesic and cough medicines accounted for the most deaths (20).
Another recent study by Dr. Gary M. Vilke of the University of California, San Diego and colleagues provided a breakdown of more than 40,000 paramedic transport calls related to poisonings in children younger than 5 years between 2000 and 2007 (J. Emerg. Med. 2011;41:265-9).
In this retrospective study, more than half of the poisonings were due to ingestion of prescription or over-the-counter medications (56%). In addition, medications made up a majority of the poisonings in each age group: less than 1 year (40%), 1 year (46%), 2 years (66%), 3 years (68%), and 4 years (60%). The researchers also noted that 10% of the poisonings were caused by cosmetics. This study was limited by the use of a preexisting database and the inclusion only of cases in which poisoning was the chief complaint.
However, the findings reinforce the need for better education about the poisoning potential of household medications, as shown in the study by Dr. Bond and colleagues.
None of the researchers in either study had any financial conflicts to disclose.
Approximately 95% of visits related to medication poisoning in children younger than 5 years are caused by self-ingestion, based on data from nearly 500,000 emergency visits during 2001-2008, according to a study published online Sept. 16 in the Journal of Pediatrics.
"If we are to make progress in reducing childhood injury from pharmaceutical poisoning, we need to better understand the epidemic," said Dr. G. Randall Bond of the University of Cincinnati and colleagues.
The researchers reviewed case information from 453,599 children aged 5 years and younger who visited emergency departments due to possible medication poisoning via ingestion of a single product. Data were taken from the American Association of Poison Control Centers’ National Poison Data System, an electronic database of all calls to the organization’s member centers (J. Pediatr. 2011 Sept. 16 [doi:10.1016/j.jpeds.2011.07.042]).
Of the self-ingested poisonings, prescription products accounted for the largest percentage of ED visits (55%), hospital admissions (76%), and significant injuries (71%).
Opioid analgesics had the greatest increase in impact on health care resources during the study period – ED visits increased by 101%, injury rates increased by 92%, and hospital admission rates increased by 86%.
The findings were limited by the self-reported nature of the cases, but they support data from previous studies on the increasing numbers of emergency department visits by young children due to medication poisoning, Dr. Bond and his coauthors said. "The most likely explanation for these observations is a rise in the number of medications in the environment of small children," they noted.
These medications may be more accessible to children in the home because the number of opioid analgesic prescriptions has increased, according to data from the U.S. Drug Enforcement Administration’s database, the researchers noted.
When it comes to preventing medication poisonings, "the results of this study suggest that focus should shift to self-ingestion and prescription products," the researchers said. "The largest potential benefits would come from a shift in attention to packaging design changes that reduce the quantity a child could quickly and easily access in a self-ingestion episode," they added.
Of 90 unintentional deaths recorded in the database, 66 were ingestion related. Of these, opioid analgesic and cough medicines accounted for the most deaths (20).
Another recent study by Dr. Gary M. Vilke of the University of California, San Diego and colleagues provided a breakdown of more than 40,000 paramedic transport calls related to poisonings in children younger than 5 years between 2000 and 2007 (J. Emerg. Med. 2011;41:265-9).
In this retrospective study, more than half of the poisonings were due to ingestion of prescription or over-the-counter medications (56%). In addition, medications made up a majority of the poisonings in each age group: less than 1 year (40%), 1 year (46%), 2 years (66%), 3 years (68%), and 4 years (60%). The researchers also noted that 10% of the poisonings were caused by cosmetics. This study was limited by the use of a preexisting database and the inclusion only of cases in which poisoning was the chief complaint.
However, the findings reinforce the need for better education about the poisoning potential of household medications, as shown in the study by Dr. Bond and colleagues.
None of the researchers in either study had any financial conflicts to disclose.
Approximately 95% of visits related to medication poisoning in children younger than 5 years are caused by self-ingestion, based on data from nearly 500,000 emergency visits during 2001-2008, according to a study published online Sept. 16 in the Journal of Pediatrics.
"If we are to make progress in reducing childhood injury from pharmaceutical poisoning, we need to better understand the epidemic," said Dr. G. Randall Bond of the University of Cincinnati and colleagues.
The researchers reviewed case information from 453,599 children aged 5 years and younger who visited emergency departments due to possible medication poisoning via ingestion of a single product. Data were taken from the American Association of Poison Control Centers’ National Poison Data System, an electronic database of all calls to the organization’s member centers (J. Pediatr. 2011 Sept. 16 [doi:10.1016/j.jpeds.2011.07.042]).
Of the self-ingested poisonings, prescription products accounted for the largest percentage of ED visits (55%), hospital admissions (76%), and significant injuries (71%).
Opioid analgesics had the greatest increase in impact on health care resources during the study period – ED visits increased by 101%, injury rates increased by 92%, and hospital admission rates increased by 86%.
The findings were limited by the self-reported nature of the cases, but they support data from previous studies on the increasing numbers of emergency department visits by young children due to medication poisoning, Dr. Bond and his coauthors said. "The most likely explanation for these observations is a rise in the number of medications in the environment of small children," they noted.
These medications may be more accessible to children in the home because the number of opioid analgesic prescriptions has increased, according to data from the U.S. Drug Enforcement Administration’s database, the researchers noted.
When it comes to preventing medication poisonings, "the results of this study suggest that focus should shift to self-ingestion and prescription products," the researchers said. "The largest potential benefits would come from a shift in attention to packaging design changes that reduce the quantity a child could quickly and easily access in a self-ingestion episode," they added.
Of 90 unintentional deaths recorded in the database, 66 were ingestion related. Of these, opioid analgesic and cough medicines accounted for the most deaths (20).
Another recent study by Dr. Gary M. Vilke of the University of California, San Diego and colleagues provided a breakdown of more than 40,000 paramedic transport calls related to poisonings in children younger than 5 years between 2000 and 2007 (J. Emerg. Med. 2011;41:265-9).
In this retrospective study, more than half of the poisonings were due to ingestion of prescription or over-the-counter medications (56%). In addition, medications made up a majority of the poisonings in each age group: less than 1 year (40%), 1 year (46%), 2 years (66%), 3 years (68%), and 4 years (60%). The researchers also noted that 10% of the poisonings were caused by cosmetics. This study was limited by the use of a preexisting database and the inclusion only of cases in which poisoning was the chief complaint.
However, the findings reinforce the need for better education about the poisoning potential of household medications, as shown in the study by Dr. Bond and colleagues.
None of the researchers in either study had any financial conflicts to disclose.
FROM THE JOURNAL OF PEDIATRICS
Major Finding: Prescription medications accounted for 55% of emergency department visits for poisoning in children aged 5 years and younger.
Data Source: Data on 453,599 cases from the American Association of Poison Control Centers’ National Poison Data System, 2001-2008.
Disclosures: None of the researchers in either study had any financial conflicts to disclose.
Court Upholds Doctors' Right to Discuss Firearms
A U.S. District Court judge has granted a preliminary injunction that stops Florida from enforcing a new law barring physicians from asking their patients about firearms ownership, saying that the law may be unconstitutional and has a good chance of being overturned.
The injunction, granted Sept. 14 by Judge Marcia Cooke, immediately prevents the state from pursuing disciplinary action against physicians who inquire about firearms in the home and counsel on firearms-injury prevention.
The decision won praise from the American Academy of Pediatrics, which has fought the law.
"The AAP is pleased the court recognized the confidential nature of the physician-patient relationship and the critical importance of this counseling, which is a cornerstone of pediatric care," Dr. O. Marion Burton, AAP president, said in a statement. "Today’s court victory ensures that important conversations about firearm safety can continue to take place between doctors and patients."
The Florida law, passed last spring and signed by Gov. Rick Scott (R) in June, forbids licensed health care practitioners from asking about gun ownership unless the practitioner believes "in good faith" that the information is relevant to patients’ and family members’ medical care or safety. Under the law, physicians and other health care practitioners also cannot record information on firearms in patients’ medical records.
Violators of the law could be subject to state medical board disciplinary action and sanctions.
The Florida chapters of the AAP, the American College of Physicians, and the American Academy of Family Physicians, along with six individual Florida physicians, filed suit in June against the law, saying it substantially curtails their First Amendment rights to exchange information with patients about gun safety. The judge agreed.
"Plaintiffs state that, as a result of the law, they are no longer (i) asking patients about firearm ownership, (ii) following up on routine questions regarding firearm ownership, (iii) providing patient intake questionnaires that include questions about firearms, or (iv) orally counseling patients about firearm safety," Judge Cooke wrote in her injunction.
Proponents of the Florida law have argued that it represents a Second Amendment issue involving the right to bear arms. However, Judge Cooke disagreed, calling it a First Amendment – or freedom of speech – issue instead.
"A practitioner who counsels a patient on firearm safety, even when entirely irrelevant to medical care or safety, does not affect nor interfere with the patient’s right to continue to own, possess, or use firearms," she wrote.
A U.S. District Court judge has granted a preliminary injunction that stops Florida from enforcing a new law barring physicians from asking their patients about firearms ownership, saying that the law may be unconstitutional and has a good chance of being overturned.
The injunction, granted Sept. 14 by Judge Marcia Cooke, immediately prevents the state from pursuing disciplinary action against physicians who inquire about firearms in the home and counsel on firearms-injury prevention.
The decision won praise from the American Academy of Pediatrics, which has fought the law.
"The AAP is pleased the court recognized the confidential nature of the physician-patient relationship and the critical importance of this counseling, which is a cornerstone of pediatric care," Dr. O. Marion Burton, AAP president, said in a statement. "Today’s court victory ensures that important conversations about firearm safety can continue to take place between doctors and patients."
The Florida law, passed last spring and signed by Gov. Rick Scott (R) in June, forbids licensed health care practitioners from asking about gun ownership unless the practitioner believes "in good faith" that the information is relevant to patients’ and family members’ medical care or safety. Under the law, physicians and other health care practitioners also cannot record information on firearms in patients’ medical records.
Violators of the law could be subject to state medical board disciplinary action and sanctions.
The Florida chapters of the AAP, the American College of Physicians, and the American Academy of Family Physicians, along with six individual Florida physicians, filed suit in June against the law, saying it substantially curtails their First Amendment rights to exchange information with patients about gun safety. The judge agreed.
"Plaintiffs state that, as a result of the law, they are no longer (i) asking patients about firearm ownership, (ii) following up on routine questions regarding firearm ownership, (iii) providing patient intake questionnaires that include questions about firearms, or (iv) orally counseling patients about firearm safety," Judge Cooke wrote in her injunction.
Proponents of the Florida law have argued that it represents a Second Amendment issue involving the right to bear arms. However, Judge Cooke disagreed, calling it a First Amendment – or freedom of speech – issue instead.
"A practitioner who counsels a patient on firearm safety, even when entirely irrelevant to medical care or safety, does not affect nor interfere with the patient’s right to continue to own, possess, or use firearms," she wrote.
A U.S. District Court judge has granted a preliminary injunction that stops Florida from enforcing a new law barring physicians from asking their patients about firearms ownership, saying that the law may be unconstitutional and has a good chance of being overturned.
The injunction, granted Sept. 14 by Judge Marcia Cooke, immediately prevents the state from pursuing disciplinary action against physicians who inquire about firearms in the home and counsel on firearms-injury prevention.
The decision won praise from the American Academy of Pediatrics, which has fought the law.
"The AAP is pleased the court recognized the confidential nature of the physician-patient relationship and the critical importance of this counseling, which is a cornerstone of pediatric care," Dr. O. Marion Burton, AAP president, said in a statement. "Today’s court victory ensures that important conversations about firearm safety can continue to take place between doctors and patients."
The Florida law, passed last spring and signed by Gov. Rick Scott (R) in June, forbids licensed health care practitioners from asking about gun ownership unless the practitioner believes "in good faith" that the information is relevant to patients’ and family members’ medical care or safety. Under the law, physicians and other health care practitioners also cannot record information on firearms in patients’ medical records.
Violators of the law could be subject to state medical board disciplinary action and sanctions.
The Florida chapters of the AAP, the American College of Physicians, and the American Academy of Family Physicians, along with six individual Florida physicians, filed suit in June against the law, saying it substantially curtails their First Amendment rights to exchange information with patients about gun safety. The judge agreed.
"Plaintiffs state that, as a result of the law, they are no longer (i) asking patients about firearm ownership, (ii) following up on routine questions regarding firearm ownership, (iii) providing patient intake questionnaires that include questions about firearms, or (iv) orally counseling patients about firearm safety," Judge Cooke wrote in her injunction.
Proponents of the Florida law have argued that it represents a Second Amendment issue involving the right to bear arms. However, Judge Cooke disagreed, calling it a First Amendment – or freedom of speech – issue instead.
"A practitioner who counsels a patient on firearm safety, even when entirely irrelevant to medical care or safety, does not affect nor interfere with the patient’s right to continue to own, possess, or use firearms," she wrote.
Mount Sinai Team Reduces LOS, Costs with Mobile ACE Approach
With our aging population, the challenges of meeting the unique needs of frail elderly patients will continue to mount. In the current issue of the Journal of Hospital Medicine, authors from Mount Sinai Medical Center in New York City report on their adaptation of the acute care for the elderly, or ACE, approach.1 They found that by bringing geriatrics-focused, team-based care to the patient (instead of locating the patient only in the ACE unit), they were able to reduce costs by an average of $4,943 per patient.
And, beginning in year two of the study, when the team incorporated hospitalists into their model, the ACE team decreased length of stay (LOS) by 1.6 days per patient.
From ACE to MACE
Since the mid-1990s, studies have shown that the ACE unit model can be effective in meeting the unique needs of frail, elderly patients. But even at institutions where these geriatric-focused units have been established, hospitals might not have enough dedicated beds for every elderly patient.
“A geographically based unit is difficult to accomplish when you have high occupancy rates in the hospital,” says lead author Jeffrey Farber, MD, assistant professor of geriatrics and palliative medicine and director of the Mobile ACE Service at Mount Sinai.
Dr. Farber and his colleagues began their mobile ACE (MACE) approach in 2007. Their retrospective cohort study compared outcomes of 8,094 hospitalized elderly patients cared for in the traditional ACE, the general medical service, or the MACE over a three-year period. To compare ACE and MACE patient outcomes, they limited their study sample to patients who already had been seen as part of their outpatient geriatrics service. Besides the shorter LOS, the MACE model also realized a net savings of $2,081 in direct hospital costs, $9,37 in nursing costs, and $223 in pharmacy costs in year two.
The MACE team, comprised of a geriatrician-hospitalist, geriatric medicine fellow, social worker, and nurse coordinator, met daily or twice a day. The nurse coordinator identified and resolved complex family and living situations, and daily check-ins with the patients’ caregivers or family members ensured that care plans and discharge plans were clearly understood before the patient left the hospital, Dr. Farber explains.
—Jeffrey Farber, MD, assistant professor of geriatrics and palliative medicine, director, Mobile ACE Service, Mount Sinai Medical Center, New York City
Gathering pre-hospitalization history is facilitated by the linkage of the hospital’s electronic health record with that of the Mount Sinai outpatient geriatrics practice and the hospital’s affiliated nursing home. Dr. Farber admits the integrated system confers an advantage to the geriatrics service. But community-based hospitalists can increase their odds of having accurate pre-hospitalization information by concerted outreach to referral sources in their community, he says.
Commenting on the study’s results, Heidi Wald, MD, MSPH, associate professor of medicine in the division of healthcare policy research at the University of Colorado Denver School of Medicine, notes that “hospitalists are great at providing efficient care, and geriatricians are good at preserving function and mitigating harm, so it was only logical that hybrids of the two models might achieve both sets of aims.”
One model that she and her UC Denver colleagues have studied utilizes “geriatricized” hospitalists (through focused geriatrics and CME programs), which allows the physicians to feel comfortable managing the unique needs of these patients. She says that functional outcomes warrant attention in the next generation of studies in this area.
Dr. Farber’s colleague, William Hung, MD, is analyzing the data of a prospective, longitudinal study focusing on functional status and post-hospitalization follow-up.
Gretchen Henkel is a freelance writer based in southern California.
Reference
1. Farber JI, Korc-Grodzicki B, Du Q, Leipzig, RM, Siu, AL. Operational and quality outcomes of a mobile acute care for the elderly service. J Hosp Med. 2011;6(6):358-363.
With our aging population, the challenges of meeting the unique needs of frail elderly patients will continue to mount. In the current issue of the Journal of Hospital Medicine, authors from Mount Sinai Medical Center in New York City report on their adaptation of the acute care for the elderly, or ACE, approach.1 They found that by bringing geriatrics-focused, team-based care to the patient (instead of locating the patient only in the ACE unit), they were able to reduce costs by an average of $4,943 per patient.
And, beginning in year two of the study, when the team incorporated hospitalists into their model, the ACE team decreased length of stay (LOS) by 1.6 days per patient.
From ACE to MACE
Since the mid-1990s, studies have shown that the ACE unit model can be effective in meeting the unique needs of frail, elderly patients. But even at institutions where these geriatric-focused units have been established, hospitals might not have enough dedicated beds for every elderly patient.
“A geographically based unit is difficult to accomplish when you have high occupancy rates in the hospital,” says lead author Jeffrey Farber, MD, assistant professor of geriatrics and palliative medicine and director of the Mobile ACE Service at Mount Sinai.
Dr. Farber and his colleagues began their mobile ACE (MACE) approach in 2007. Their retrospective cohort study compared outcomes of 8,094 hospitalized elderly patients cared for in the traditional ACE, the general medical service, or the MACE over a three-year period. To compare ACE and MACE patient outcomes, they limited their study sample to patients who already had been seen as part of their outpatient geriatrics service. Besides the shorter LOS, the MACE model also realized a net savings of $2,081 in direct hospital costs, $9,37 in nursing costs, and $223 in pharmacy costs in year two.
The MACE team, comprised of a geriatrician-hospitalist, geriatric medicine fellow, social worker, and nurse coordinator, met daily or twice a day. The nurse coordinator identified and resolved complex family and living situations, and daily check-ins with the patients’ caregivers or family members ensured that care plans and discharge plans were clearly understood before the patient left the hospital, Dr. Farber explains.
—Jeffrey Farber, MD, assistant professor of geriatrics and palliative medicine, director, Mobile ACE Service, Mount Sinai Medical Center, New York City
Gathering pre-hospitalization history is facilitated by the linkage of the hospital’s electronic health record with that of the Mount Sinai outpatient geriatrics practice and the hospital’s affiliated nursing home. Dr. Farber admits the integrated system confers an advantage to the geriatrics service. But community-based hospitalists can increase their odds of having accurate pre-hospitalization information by concerted outreach to referral sources in their community, he says.
Commenting on the study’s results, Heidi Wald, MD, MSPH, associate professor of medicine in the division of healthcare policy research at the University of Colorado Denver School of Medicine, notes that “hospitalists are great at providing efficient care, and geriatricians are good at preserving function and mitigating harm, so it was only logical that hybrids of the two models might achieve both sets of aims.”
One model that she and her UC Denver colleagues have studied utilizes “geriatricized” hospitalists (through focused geriatrics and CME programs), which allows the physicians to feel comfortable managing the unique needs of these patients. She says that functional outcomes warrant attention in the next generation of studies in this area.
Dr. Farber’s colleague, William Hung, MD, is analyzing the data of a prospective, longitudinal study focusing on functional status and post-hospitalization follow-up.
Gretchen Henkel is a freelance writer based in southern California.
Reference
1. Farber JI, Korc-Grodzicki B, Du Q, Leipzig, RM, Siu, AL. Operational and quality outcomes of a mobile acute care for the elderly service. J Hosp Med. 2011;6(6):358-363.
With our aging population, the challenges of meeting the unique needs of frail elderly patients will continue to mount. In the current issue of the Journal of Hospital Medicine, authors from Mount Sinai Medical Center in New York City report on their adaptation of the acute care for the elderly, or ACE, approach.1 They found that by bringing geriatrics-focused, team-based care to the patient (instead of locating the patient only in the ACE unit), they were able to reduce costs by an average of $4,943 per patient.
And, beginning in year two of the study, when the team incorporated hospitalists into their model, the ACE team decreased length of stay (LOS) by 1.6 days per patient.
From ACE to MACE
Since the mid-1990s, studies have shown that the ACE unit model can be effective in meeting the unique needs of frail, elderly patients. But even at institutions where these geriatric-focused units have been established, hospitals might not have enough dedicated beds for every elderly patient.
“A geographically based unit is difficult to accomplish when you have high occupancy rates in the hospital,” says lead author Jeffrey Farber, MD, assistant professor of geriatrics and palliative medicine and director of the Mobile ACE Service at Mount Sinai.
Dr. Farber and his colleagues began their mobile ACE (MACE) approach in 2007. Their retrospective cohort study compared outcomes of 8,094 hospitalized elderly patients cared for in the traditional ACE, the general medical service, or the MACE over a three-year period. To compare ACE and MACE patient outcomes, they limited their study sample to patients who already had been seen as part of their outpatient geriatrics service. Besides the shorter LOS, the MACE model also realized a net savings of $2,081 in direct hospital costs, $9,37 in nursing costs, and $223 in pharmacy costs in year two.
The MACE team, comprised of a geriatrician-hospitalist, geriatric medicine fellow, social worker, and nurse coordinator, met daily or twice a day. The nurse coordinator identified and resolved complex family and living situations, and daily check-ins with the patients’ caregivers or family members ensured that care plans and discharge plans were clearly understood before the patient left the hospital, Dr. Farber explains.
—Jeffrey Farber, MD, assistant professor of geriatrics and palliative medicine, director, Mobile ACE Service, Mount Sinai Medical Center, New York City
Gathering pre-hospitalization history is facilitated by the linkage of the hospital’s electronic health record with that of the Mount Sinai outpatient geriatrics practice and the hospital’s affiliated nursing home. Dr. Farber admits the integrated system confers an advantage to the geriatrics service. But community-based hospitalists can increase their odds of having accurate pre-hospitalization information by concerted outreach to referral sources in their community, he says.
Commenting on the study’s results, Heidi Wald, MD, MSPH, associate professor of medicine in the division of healthcare policy research at the University of Colorado Denver School of Medicine, notes that “hospitalists are great at providing efficient care, and geriatricians are good at preserving function and mitigating harm, so it was only logical that hybrids of the two models might achieve both sets of aims.”
One model that she and her UC Denver colleagues have studied utilizes “geriatricized” hospitalists (through focused geriatrics and CME programs), which allows the physicians to feel comfortable managing the unique needs of these patients. She says that functional outcomes warrant attention in the next generation of studies in this area.
Dr. Farber’s colleague, William Hung, MD, is analyzing the data of a prospective, longitudinal study focusing on functional status and post-hospitalization follow-up.
Gretchen Henkel is a freelance writer based in southern California.
Reference
1. Farber JI, Korc-Grodzicki B, Du Q, Leipzig, RM, Siu, AL. Operational and quality outcomes of a mobile acute care for the elderly service. J Hosp Med. 2011;6(6):358-363.
Showtime for Patient Education
Hospitalist Andrea Peterson, MD, of Norwalk Hospital in Norwalk, Conn., whose job involves educating hospitalized patients about their personal health, has found an additional channel for teaching health concepts: She cohosts "Health Talk," a half-hour local cable television show in Fairfield County.
Dr. Peterson, who started working at Norwalk in 2002 as the hospital's fourth hospitalist, cohosts "Health Talk" with the hospital's vice president and chief medical officer, Eric Mazur, MD. She first appeared on the show as a guest, discussing subjects of professional interest, such as end-of-life care, ethics, patient safety, and spirituality in medicine, then served later as fill-in host before becoming the permanent cohost.
"It's really fun. It's totally different than my day job," she says. "It can also be fatiguing—you have to be bright and energetic on a sustained basis."
Conversations on the air are different than interactions with patients, as the dead space of TV can be deadly, she says. "I had to learn, with the help of a media coach, to start asking the next question while the person is finishing the previous answer. But I've gotten to interact with colleagues in totally different ways and to meet patients with inspiring stories," she says.
The program tapes four shows one day a month. Each program is broadcast several times over the course of a week. Interview subjects are both doctors and patients, and most of the interactions are unscripted.
"Both Eric and I feel it is very important to have topics and discussions that are real and meaningful to people's health, bread-and-butter issues like diabetes, colon-cancer screening, strokes and MI, and medication safety," Dr. Peterson says. "We continually do smoking education. We're always telling people: Talk to your family about what's important to you. Appoint a healthcare surrogate. These are the same messages I give to my patients in the hospital," she says.
Think you may be interesting in hosting your own patient education program? Click here for a list of community and public access TV sites.
Hospitalist Andrea Peterson, MD, of Norwalk Hospital in Norwalk, Conn., whose job involves educating hospitalized patients about their personal health, has found an additional channel for teaching health concepts: She cohosts "Health Talk," a half-hour local cable television show in Fairfield County.
Dr. Peterson, who started working at Norwalk in 2002 as the hospital's fourth hospitalist, cohosts "Health Talk" with the hospital's vice president and chief medical officer, Eric Mazur, MD. She first appeared on the show as a guest, discussing subjects of professional interest, such as end-of-life care, ethics, patient safety, and spirituality in medicine, then served later as fill-in host before becoming the permanent cohost.
"It's really fun. It's totally different than my day job," she says. "It can also be fatiguing—you have to be bright and energetic on a sustained basis."
Conversations on the air are different than interactions with patients, as the dead space of TV can be deadly, she says. "I had to learn, with the help of a media coach, to start asking the next question while the person is finishing the previous answer. But I've gotten to interact with colleagues in totally different ways and to meet patients with inspiring stories," she says.
The program tapes four shows one day a month. Each program is broadcast several times over the course of a week. Interview subjects are both doctors and patients, and most of the interactions are unscripted.
"Both Eric and I feel it is very important to have topics and discussions that are real and meaningful to people's health, bread-and-butter issues like diabetes, colon-cancer screening, strokes and MI, and medication safety," Dr. Peterson says. "We continually do smoking education. We're always telling people: Talk to your family about what's important to you. Appoint a healthcare surrogate. These are the same messages I give to my patients in the hospital," she says.
Think you may be interesting in hosting your own patient education program? Click here for a list of community and public access TV sites.
Hospitalist Andrea Peterson, MD, of Norwalk Hospital in Norwalk, Conn., whose job involves educating hospitalized patients about their personal health, has found an additional channel for teaching health concepts: She cohosts "Health Talk," a half-hour local cable television show in Fairfield County.
Dr. Peterson, who started working at Norwalk in 2002 as the hospital's fourth hospitalist, cohosts "Health Talk" with the hospital's vice president and chief medical officer, Eric Mazur, MD. She first appeared on the show as a guest, discussing subjects of professional interest, such as end-of-life care, ethics, patient safety, and spirituality in medicine, then served later as fill-in host before becoming the permanent cohost.
"It's really fun. It's totally different than my day job," she says. "It can also be fatiguing—you have to be bright and energetic on a sustained basis."
Conversations on the air are different than interactions with patients, as the dead space of TV can be deadly, she says. "I had to learn, with the help of a media coach, to start asking the next question while the person is finishing the previous answer. But I've gotten to interact with colleagues in totally different ways and to meet patients with inspiring stories," she says.
The program tapes four shows one day a month. Each program is broadcast several times over the course of a week. Interview subjects are both doctors and patients, and most of the interactions are unscripted.
"Both Eric and I feel it is very important to have topics and discussions that are real and meaningful to people's health, bread-and-butter issues like diabetes, colon-cancer screening, strokes and MI, and medication safety," Dr. Peterson says. "We continually do smoking education. We're always telling people: Talk to your family about what's important to you. Appoint a healthcare surrogate. These are the same messages I give to my patients in the hospital," she says.
Think you may be interesting in hosting your own patient education program? Click here for a list of community and public access TV sites.
In the Literature: Research You Need to Know
Clinical question: Is transcatheter aortic-valve replacement comparable to surgical valve replacement in high-operative-risk patients?
Background: In the randomized Placement of Aortic Transcatheter Valves (PARTNER) trial, patients who were not surgical candidates underwent transcatheter aortic-valve replacement, resulting in reduced symptoms and 20% improvement in one-year survival rates. Transcatheter valve replacement has not been compared to surgical replacement in high-operative-risk patients who remain candidates for surgical replacement.
Study design: Randomized controlled trial powered for noninferiority.
Setting: Twenty-five centers in the U.S., Canada, and Germany.
Synopsis: Six-hundred ninety-nine high-operative-risk patients with severe aortic stenosis were randomized to undergo transcatheter aortic-valve replacement or surgical replacement. In the intention-to-treat analysis, all-cause mortality rates were 3.4% in the transcatheter group and 6.5% in the surgical group at 30 days (P=0.07) and 24.2% vs. 26.8% at one year (P=0.44). Rates of major stroke were 3.8% in the transcatheter group compared with 2.1% in the surgical group at 30 days (P=0.20) and 5.1% vs. 2.4% at one year (P=0.07).
The transcatheter group had a significantly higher rate of major vascular complications, but had lower rates of major bleeding and new onset-atrial fibrillation. At one year, improvement in cardiac symptoms and the six-minute-walk distance were not significantly different in the two groups.
Bottom line: In high-operative-risk patients with severe aortic stenosis, transcatheter and surgical aortic-valve replacement had similar mortality at 30 days and one year, but there were a few significant differences in periprocedural risks.
Citation: Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
For more physician reviews of HM-related literature, visit our website.
Clinical question: Is transcatheter aortic-valve replacement comparable to surgical valve replacement in high-operative-risk patients?
Background: In the randomized Placement of Aortic Transcatheter Valves (PARTNER) trial, patients who were not surgical candidates underwent transcatheter aortic-valve replacement, resulting in reduced symptoms and 20% improvement in one-year survival rates. Transcatheter valve replacement has not been compared to surgical replacement in high-operative-risk patients who remain candidates for surgical replacement.
Study design: Randomized controlled trial powered for noninferiority.
Setting: Twenty-five centers in the U.S., Canada, and Germany.
Synopsis: Six-hundred ninety-nine high-operative-risk patients with severe aortic stenosis were randomized to undergo transcatheter aortic-valve replacement or surgical replacement. In the intention-to-treat analysis, all-cause mortality rates were 3.4% in the transcatheter group and 6.5% in the surgical group at 30 days (P=0.07) and 24.2% vs. 26.8% at one year (P=0.44). Rates of major stroke were 3.8% in the transcatheter group compared with 2.1% in the surgical group at 30 days (P=0.20) and 5.1% vs. 2.4% at one year (P=0.07).
The transcatheter group had a significantly higher rate of major vascular complications, but had lower rates of major bleeding and new onset-atrial fibrillation. At one year, improvement in cardiac symptoms and the six-minute-walk distance were not significantly different in the two groups.
Bottom line: In high-operative-risk patients with severe aortic stenosis, transcatheter and surgical aortic-valve replacement had similar mortality at 30 days and one year, but there were a few significant differences in periprocedural risks.
Citation: Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
For more physician reviews of HM-related literature, visit our website.
Clinical question: Is transcatheter aortic-valve replacement comparable to surgical valve replacement in high-operative-risk patients?
Background: In the randomized Placement of Aortic Transcatheter Valves (PARTNER) trial, patients who were not surgical candidates underwent transcatheter aortic-valve replacement, resulting in reduced symptoms and 20% improvement in one-year survival rates. Transcatheter valve replacement has not been compared to surgical replacement in high-operative-risk patients who remain candidates for surgical replacement.
Study design: Randomized controlled trial powered for noninferiority.
Setting: Twenty-five centers in the U.S., Canada, and Germany.
Synopsis: Six-hundred ninety-nine high-operative-risk patients with severe aortic stenosis were randomized to undergo transcatheter aortic-valve replacement or surgical replacement. In the intention-to-treat analysis, all-cause mortality rates were 3.4% in the transcatheter group and 6.5% in the surgical group at 30 days (P=0.07) and 24.2% vs. 26.8% at one year (P=0.44). Rates of major stroke were 3.8% in the transcatheter group compared with 2.1% in the surgical group at 30 days (P=0.20) and 5.1% vs. 2.4% at one year (P=0.07).
The transcatheter group had a significantly higher rate of major vascular complications, but had lower rates of major bleeding and new onset-atrial fibrillation. At one year, improvement in cardiac symptoms and the six-minute-walk distance were not significantly different in the two groups.
Bottom line: In high-operative-risk patients with severe aortic stenosis, transcatheter and surgical aortic-valve replacement had similar mortality at 30 days and one year, but there were a few significant differences in periprocedural risks.
Citation: Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
For more physician reviews of HM-related literature, visit our website.
International Hospital Medicine Scene
In the 15 years since Wachter and Goldman coined the term hospitalists, the specialty of Hospital Medicine grew faster than any other in the history of American medicine.1 The early drivers for growth were largely economic: There were significant reductions in resource use, with a 13% decrease in hospital costs and a 16% decrease in hospital lengths of stay (LOS).2 Hospitalist clinician‐educators increased the satisfaction of residents and medical students in academic settings.2 Patient satisfaction and hospital mortality did not suffer.2
Recent growth of Hospital Medicine revolves around 3 drivers: 1) improving quality and safety of hospitalized patientsowing in large part to the Institute of Medicine's 2 compelling reports, To Err Is Human3 and Crossing the Quality Chasm4; 2) hospitalist and specialist (surgeon) comanagement; and 3) the effects of duty hours restrictions imposed by the Accreditation Council for Graduate Medical Education affecting United States (US) teaching hospitals.5
In this issue of the Journal of Hospital Medicine, Shu and colleagues6 report on the performance of a hospitalist program in Taiwan. To the best of our knowledge, this report from Asia is the first published report of a successful hospitalist model with measurable patient outcomes outside of North America. Specifically, over a year, the authors found that patients admitted by hospitalists had a shorter LOS and lower cost per case, with no difference in in‐hospital mortality and 30‐day readmission. These results were obtained despite the fact that the cohort of patients admitted to the hospitalist team was older, sicker, and had worse functional capacity. Additionally, the patients admitted to the hospitalist team, and who died during hospitalization, were more likely to have a do‐not‐resuscitate (DNR) order signed, when compared with those patients admitted to the general internal medicine teaching service. Comparing LOS with North America may be problematic. As Shu and colleagues6 point out, there are cultural and economic issues that affect the behavior of patients and physicians in Taiwan.
The healthcare system in Taiwan has similarities to the healthcare systems in the United Kingdom (UK) and the US. In 1995, Taiwan implemented a national health insurance system. The UK has had a National Health Service for many years that provides most services for free. The Taiwanese system requires modest copayments for services. The implementation of the national health insurance system in Taiwan increased healthcare access from 57% of the population to 98%.7 The increase in insurance across the population with modest copayments has made it possible for a larger percentage of the population to access the healthcare system.7 According to the authors, this has resulted in increased hospital admissions (35% in the decade since the introduction of national health insurance), resulting in a shortage of Hospital Medicine physicians and hospital beds.7 Compounding the stressors on this system is that the diagnosis related group (DRG) reimbursement model, similar to the American DRG reimbursement model, will soon take effect in Taiwan. As a result, our colleagues in Taiwan are experiencing issues commonly faced by mature hospitalist programs in the US: increased needs in efficiency to improve patient flow and decrease emergency room overcrowding and LOS; and concerns with safe discharges of high‐risk patients while ensuring outpatient follow‐up. This is a scenario with which US hospitalists are all too familiar.
The next step for Taiwan might be to implement a culturally specific patient education program regarding the discharge process. The first step would be a needs assessment survey of patients in Taiwan, inquiring about concerns regarding readiness for discharge. They might inquire about patient beliefs regarding understanding indications for inpatient hospitalization versus discharge to home, home with home services, or skilled nursing facilities. They might be able to drill down to the root cause of refusal to be discharged home. These data could help our colleagues in Taiwan create their own discharge program to drive down LOS closer to that of the US and other Western countries, in order to reap financial benefits and improve resource utilization.
What do we know about the growth of Hospital Medicine around the world? The Society of Hospital Medicine (SHM) reports international members from 26 countries around the world. In North America, SHM members are found in the US, Canada, and Bermuda. In Europe, SHM members are found in England, Ireland, Scotland, Spain, Belgium, Portugal, Italy, and Germany. In South America, SHM members are found in Brazil, Chile, Colombia, and Argentina. In Asia and the Middle East, SHM has members in Saudi Arabia, Israel, United Arab Emirates, Pakistan, Japan, China, the Philippines, and Singapore. In Oceania, SHM has members in Australia, and New Zealand. In Africa, 1 SHM member is from Nigeria (Society of Hospital Medicine Data, 2011). In fact, the International Hospitalists Section of SHM is 1 of only 2 sections that the Society recognizes.
Hospitalists are organizing themselves abroad as well. In Canada, the Canadian Society of Hospital Medicine was founded in 2001 and has had 8 national conferences to date.8 There are roughly 1,000 Canadian hospitalists (Wilton D, personal communication, 2011). Whereas most US hospitalists are internists or pediatricians, in Canada, most hospitalists are family physicians. In the US, hospitalists are more likely to perform the following services: consultation, intensive care unit patient care, rapid response team service, surgical comanagement, and evening on‐site coverage. Canadian hospitalists are more likely to provide pediatric care and psychiatry inpatient comanagement.9
In the UK, the professional organization of physicians most similar to US hospitalists, acute physicians, is called SAM (The Society for Acute Medicine). It was founded in 2000.10 In the UK, general practitioners (GPs) never care for inpatients; at the time, GPs referred all admissions to organ‐specific specialists (eg, cardiologists). Acute medicine was created due to the realization that medical inpatients were too complex to have specialists managing them. Training programs were set up circa 2003 to create this specialty and address this need. Acute physicians staff geographically localized acute medicine units near emergency departments. These patients stay 1 to 3 days in an effort to concentrate services and resources to these patients, to prevent longer stays once fully admitted (Smith R, personal communication, April 23, 2011). Acute medicine units in the UK, Ireland, and Australia have led to positive benefits on patient outcomes. A review article by Scott and colleagues revealed reductions in LOS, inpatient mortality, and emergency department LOS, without increased 30‐day readmission rates. They found increased staff and patient satisfaction, and more medical patients discharged directly to home from acute medical units.11 The development of acute medicine in Australia and New Zealand began around 2005 and derives from the geographic localization of the UK model. Whereas the UK model has a focus on the first 72 hours of hospitalization, the model in Australia and New Zealand is more similar to the US model of following patients through their entire admission.12 Unlike the UK, Australia does not have dedicated acute medicine training programs.
PASHA, the Pan‐American Society of Hospitalists, is a loose affiliation of hospitalists largely in South America, linking with their North American colleagues. PASHA grew out of SOBRAMH, Sociedade Brasileira de Medicina Hospitalarthe first Hospital Medicine Society in South America, tracing its roots to 2004. To date, PASHA has had 1 international conference, but there have been 2 national conferences each in Brazil and Chile, and 1 in Colombia. The concept and advantages of Hospital Medicine have been presented at a conference in Panama. Argentina has its first Hospital Medicine Congress scheduled for September 2011, in concert with PASHA.
Two Hospital Medicine programs abroad deserve special mention. Both started in 2005 and have instituted the full hospitalist package, including multiple evidence‐based order sets at both sites (eg, deep vein thrombosis [DVT] prophylaxis and hyperglycemia management). At the Pontificia Universidad Catlica in Santiago, Chile, they have been awarded national grants to study hyperglycemia in hospitalized patients, and they have sent their faculty to the US for additional training in patient safety, quality improvement, leadership, and medical informatics. They have succeeded in decreasing LOS and improved the exam grades of their learners. Their faculty has published in national journals and is now beginning to submit their work for publication in US‐based journals (Rojas L, personal communication, April 22, 2011). The Clnica Universidad de Navarra (CUN) in Pamplona, Spain is a Joint Commission certified facility with a full electronic medical record. Hospitalists there are looking at ways in which hospitalist‐staffed intermediate care units can benefit patient outcomes. Additionally, they have comanagement arrangements with nearly all surgical subspecialties. The Management of the Hospitalized Patient symposium was organized by CUN hospitalists in 2007the first Hospital Medicine Congress, to our knowledge, in continental Europe. At any one time, 30% of all residents in all specialties rotate with CUN hospitalists (Lucena F, personal communication, April 22, 2011).
The specialty of Hospital Medicine is truly global. Our colleagues around the world employing the hospitalist model of care are now producing outcomes similar to the published models in North America and to the acute medicine models in Europe and Australia. According to the Society of Hospital Medicine, there are over 30,000 hospitalists in the US. There could be well over 50,000 hospitalists around the world. In 5 years, the world may have 100,000 hospitalists. The same drivers are fueling the growth of Hospital Medicine around the world. The evidence is building that the hospitalist model of care has financial and quality benefits that transcend borders. We forecast that the hospitalist model of care will become an increasingly larger part of the solution around the world to fix these international healthcare systems.
- ,.The emerging role of “hospitalists” in the American health care system.N Engl J Med.1996;335(7):514–517.
- ,.The hospitalist movement 5 years later.JAMA.2002;287(4):487–494.
- ,,.To Err Is Human: Building a Safer Health System; Institute of Medicine Committee on Quality of Health Care in America.Washington, DC:National Academy Press;2000.
- ,,.Crossing the Quality Chasm: A New Health System for the 21st Century; Institute of Medicine Committee of Health Care in America.Washington, DC:National Academy Press;2001.
- .The state of hospital medicine in 2008.Med Clin North Am.2008;92:265–273.
- et al.J Hosp Med.2011;6:378–382.
- ,,.A 10‐year experience with universal health insurance in Taiwan: measuring changes in health and health disparity.Ann Intern Med.2008;148(4):258–267.
- Canadian Hospitalist: Canadian Society of Hospital Medicine Web site. Available at: http://canadianhospitalist.ca/. Accessed April 15,2011.
- ,,,,,.Characteristics of hospitalists and hospitalist programs in the United States and Canada.J Clin Outcomes Manage.2009;16(2):69–74.
- The Society for Acute Medicine Web site. Available at: www.acutemedicine.org.uk. Accessed April 14,2011.
- ,,.Effectiveness of acute medical units in hospitals: a systematic review.Int J Qual Health Care.2009;21(6):397–407.
- .Acute and general medicine on opposite sides of the world.Acute Med.2011;10(2):67–68.
In the 15 years since Wachter and Goldman coined the term hospitalists, the specialty of Hospital Medicine grew faster than any other in the history of American medicine.1 The early drivers for growth were largely economic: There were significant reductions in resource use, with a 13% decrease in hospital costs and a 16% decrease in hospital lengths of stay (LOS).2 Hospitalist clinician‐educators increased the satisfaction of residents and medical students in academic settings.2 Patient satisfaction and hospital mortality did not suffer.2
Recent growth of Hospital Medicine revolves around 3 drivers: 1) improving quality and safety of hospitalized patientsowing in large part to the Institute of Medicine's 2 compelling reports, To Err Is Human3 and Crossing the Quality Chasm4; 2) hospitalist and specialist (surgeon) comanagement; and 3) the effects of duty hours restrictions imposed by the Accreditation Council for Graduate Medical Education affecting United States (US) teaching hospitals.5
In this issue of the Journal of Hospital Medicine, Shu and colleagues6 report on the performance of a hospitalist program in Taiwan. To the best of our knowledge, this report from Asia is the first published report of a successful hospitalist model with measurable patient outcomes outside of North America. Specifically, over a year, the authors found that patients admitted by hospitalists had a shorter LOS and lower cost per case, with no difference in in‐hospital mortality and 30‐day readmission. These results were obtained despite the fact that the cohort of patients admitted to the hospitalist team was older, sicker, and had worse functional capacity. Additionally, the patients admitted to the hospitalist team, and who died during hospitalization, were more likely to have a do‐not‐resuscitate (DNR) order signed, when compared with those patients admitted to the general internal medicine teaching service. Comparing LOS with North America may be problematic. As Shu and colleagues6 point out, there are cultural and economic issues that affect the behavior of patients and physicians in Taiwan.
The healthcare system in Taiwan has similarities to the healthcare systems in the United Kingdom (UK) and the US. In 1995, Taiwan implemented a national health insurance system. The UK has had a National Health Service for many years that provides most services for free. The Taiwanese system requires modest copayments for services. The implementation of the national health insurance system in Taiwan increased healthcare access from 57% of the population to 98%.7 The increase in insurance across the population with modest copayments has made it possible for a larger percentage of the population to access the healthcare system.7 According to the authors, this has resulted in increased hospital admissions (35% in the decade since the introduction of national health insurance), resulting in a shortage of Hospital Medicine physicians and hospital beds.7 Compounding the stressors on this system is that the diagnosis related group (DRG) reimbursement model, similar to the American DRG reimbursement model, will soon take effect in Taiwan. As a result, our colleagues in Taiwan are experiencing issues commonly faced by mature hospitalist programs in the US: increased needs in efficiency to improve patient flow and decrease emergency room overcrowding and LOS; and concerns with safe discharges of high‐risk patients while ensuring outpatient follow‐up. This is a scenario with which US hospitalists are all too familiar.
The next step for Taiwan might be to implement a culturally specific patient education program regarding the discharge process. The first step would be a needs assessment survey of patients in Taiwan, inquiring about concerns regarding readiness for discharge. They might inquire about patient beliefs regarding understanding indications for inpatient hospitalization versus discharge to home, home with home services, or skilled nursing facilities. They might be able to drill down to the root cause of refusal to be discharged home. These data could help our colleagues in Taiwan create their own discharge program to drive down LOS closer to that of the US and other Western countries, in order to reap financial benefits and improve resource utilization.
What do we know about the growth of Hospital Medicine around the world? The Society of Hospital Medicine (SHM) reports international members from 26 countries around the world. In North America, SHM members are found in the US, Canada, and Bermuda. In Europe, SHM members are found in England, Ireland, Scotland, Spain, Belgium, Portugal, Italy, and Germany. In South America, SHM members are found in Brazil, Chile, Colombia, and Argentina. In Asia and the Middle East, SHM has members in Saudi Arabia, Israel, United Arab Emirates, Pakistan, Japan, China, the Philippines, and Singapore. In Oceania, SHM has members in Australia, and New Zealand. In Africa, 1 SHM member is from Nigeria (Society of Hospital Medicine Data, 2011). In fact, the International Hospitalists Section of SHM is 1 of only 2 sections that the Society recognizes.
Hospitalists are organizing themselves abroad as well. In Canada, the Canadian Society of Hospital Medicine was founded in 2001 and has had 8 national conferences to date.8 There are roughly 1,000 Canadian hospitalists (Wilton D, personal communication, 2011). Whereas most US hospitalists are internists or pediatricians, in Canada, most hospitalists are family physicians. In the US, hospitalists are more likely to perform the following services: consultation, intensive care unit patient care, rapid response team service, surgical comanagement, and evening on‐site coverage. Canadian hospitalists are more likely to provide pediatric care and psychiatry inpatient comanagement.9
In the UK, the professional organization of physicians most similar to US hospitalists, acute physicians, is called SAM (The Society for Acute Medicine). It was founded in 2000.10 In the UK, general practitioners (GPs) never care for inpatients; at the time, GPs referred all admissions to organ‐specific specialists (eg, cardiologists). Acute medicine was created due to the realization that medical inpatients were too complex to have specialists managing them. Training programs were set up circa 2003 to create this specialty and address this need. Acute physicians staff geographically localized acute medicine units near emergency departments. These patients stay 1 to 3 days in an effort to concentrate services and resources to these patients, to prevent longer stays once fully admitted (Smith R, personal communication, April 23, 2011). Acute medicine units in the UK, Ireland, and Australia have led to positive benefits on patient outcomes. A review article by Scott and colleagues revealed reductions in LOS, inpatient mortality, and emergency department LOS, without increased 30‐day readmission rates. They found increased staff and patient satisfaction, and more medical patients discharged directly to home from acute medical units.11 The development of acute medicine in Australia and New Zealand began around 2005 and derives from the geographic localization of the UK model. Whereas the UK model has a focus on the first 72 hours of hospitalization, the model in Australia and New Zealand is more similar to the US model of following patients through their entire admission.12 Unlike the UK, Australia does not have dedicated acute medicine training programs.
PASHA, the Pan‐American Society of Hospitalists, is a loose affiliation of hospitalists largely in South America, linking with their North American colleagues. PASHA grew out of SOBRAMH, Sociedade Brasileira de Medicina Hospitalarthe first Hospital Medicine Society in South America, tracing its roots to 2004. To date, PASHA has had 1 international conference, but there have been 2 national conferences each in Brazil and Chile, and 1 in Colombia. The concept and advantages of Hospital Medicine have been presented at a conference in Panama. Argentina has its first Hospital Medicine Congress scheduled for September 2011, in concert with PASHA.
Two Hospital Medicine programs abroad deserve special mention. Both started in 2005 and have instituted the full hospitalist package, including multiple evidence‐based order sets at both sites (eg, deep vein thrombosis [DVT] prophylaxis and hyperglycemia management). At the Pontificia Universidad Catlica in Santiago, Chile, they have been awarded national grants to study hyperglycemia in hospitalized patients, and they have sent their faculty to the US for additional training in patient safety, quality improvement, leadership, and medical informatics. They have succeeded in decreasing LOS and improved the exam grades of their learners. Their faculty has published in national journals and is now beginning to submit their work for publication in US‐based journals (Rojas L, personal communication, April 22, 2011). The Clnica Universidad de Navarra (CUN) in Pamplona, Spain is a Joint Commission certified facility with a full electronic medical record. Hospitalists there are looking at ways in which hospitalist‐staffed intermediate care units can benefit patient outcomes. Additionally, they have comanagement arrangements with nearly all surgical subspecialties. The Management of the Hospitalized Patient symposium was organized by CUN hospitalists in 2007the first Hospital Medicine Congress, to our knowledge, in continental Europe. At any one time, 30% of all residents in all specialties rotate with CUN hospitalists (Lucena F, personal communication, April 22, 2011).
The specialty of Hospital Medicine is truly global. Our colleagues around the world employing the hospitalist model of care are now producing outcomes similar to the published models in North America and to the acute medicine models in Europe and Australia. According to the Society of Hospital Medicine, there are over 30,000 hospitalists in the US. There could be well over 50,000 hospitalists around the world. In 5 years, the world may have 100,000 hospitalists. The same drivers are fueling the growth of Hospital Medicine around the world. The evidence is building that the hospitalist model of care has financial and quality benefits that transcend borders. We forecast that the hospitalist model of care will become an increasingly larger part of the solution around the world to fix these international healthcare systems.
In the 15 years since Wachter and Goldman coined the term hospitalists, the specialty of Hospital Medicine grew faster than any other in the history of American medicine.1 The early drivers for growth were largely economic: There were significant reductions in resource use, with a 13% decrease in hospital costs and a 16% decrease in hospital lengths of stay (LOS).2 Hospitalist clinician‐educators increased the satisfaction of residents and medical students in academic settings.2 Patient satisfaction and hospital mortality did not suffer.2
Recent growth of Hospital Medicine revolves around 3 drivers: 1) improving quality and safety of hospitalized patientsowing in large part to the Institute of Medicine's 2 compelling reports, To Err Is Human3 and Crossing the Quality Chasm4; 2) hospitalist and specialist (surgeon) comanagement; and 3) the effects of duty hours restrictions imposed by the Accreditation Council for Graduate Medical Education affecting United States (US) teaching hospitals.5
In this issue of the Journal of Hospital Medicine, Shu and colleagues6 report on the performance of a hospitalist program in Taiwan. To the best of our knowledge, this report from Asia is the first published report of a successful hospitalist model with measurable patient outcomes outside of North America. Specifically, over a year, the authors found that patients admitted by hospitalists had a shorter LOS and lower cost per case, with no difference in in‐hospital mortality and 30‐day readmission. These results were obtained despite the fact that the cohort of patients admitted to the hospitalist team was older, sicker, and had worse functional capacity. Additionally, the patients admitted to the hospitalist team, and who died during hospitalization, were more likely to have a do‐not‐resuscitate (DNR) order signed, when compared with those patients admitted to the general internal medicine teaching service. Comparing LOS with North America may be problematic. As Shu and colleagues6 point out, there are cultural and economic issues that affect the behavior of patients and physicians in Taiwan.
The healthcare system in Taiwan has similarities to the healthcare systems in the United Kingdom (UK) and the US. In 1995, Taiwan implemented a national health insurance system. The UK has had a National Health Service for many years that provides most services for free. The Taiwanese system requires modest copayments for services. The implementation of the national health insurance system in Taiwan increased healthcare access from 57% of the population to 98%.7 The increase in insurance across the population with modest copayments has made it possible for a larger percentage of the population to access the healthcare system.7 According to the authors, this has resulted in increased hospital admissions (35% in the decade since the introduction of national health insurance), resulting in a shortage of Hospital Medicine physicians and hospital beds.7 Compounding the stressors on this system is that the diagnosis related group (DRG) reimbursement model, similar to the American DRG reimbursement model, will soon take effect in Taiwan. As a result, our colleagues in Taiwan are experiencing issues commonly faced by mature hospitalist programs in the US: increased needs in efficiency to improve patient flow and decrease emergency room overcrowding and LOS; and concerns with safe discharges of high‐risk patients while ensuring outpatient follow‐up. This is a scenario with which US hospitalists are all too familiar.
The next step for Taiwan might be to implement a culturally specific patient education program regarding the discharge process. The first step would be a needs assessment survey of patients in Taiwan, inquiring about concerns regarding readiness for discharge. They might inquire about patient beliefs regarding understanding indications for inpatient hospitalization versus discharge to home, home with home services, or skilled nursing facilities. They might be able to drill down to the root cause of refusal to be discharged home. These data could help our colleagues in Taiwan create their own discharge program to drive down LOS closer to that of the US and other Western countries, in order to reap financial benefits and improve resource utilization.
What do we know about the growth of Hospital Medicine around the world? The Society of Hospital Medicine (SHM) reports international members from 26 countries around the world. In North America, SHM members are found in the US, Canada, and Bermuda. In Europe, SHM members are found in England, Ireland, Scotland, Spain, Belgium, Portugal, Italy, and Germany. In South America, SHM members are found in Brazil, Chile, Colombia, and Argentina. In Asia and the Middle East, SHM has members in Saudi Arabia, Israel, United Arab Emirates, Pakistan, Japan, China, the Philippines, and Singapore. In Oceania, SHM has members in Australia, and New Zealand. In Africa, 1 SHM member is from Nigeria (Society of Hospital Medicine Data, 2011). In fact, the International Hospitalists Section of SHM is 1 of only 2 sections that the Society recognizes.
Hospitalists are organizing themselves abroad as well. In Canada, the Canadian Society of Hospital Medicine was founded in 2001 and has had 8 national conferences to date.8 There are roughly 1,000 Canadian hospitalists (Wilton D, personal communication, 2011). Whereas most US hospitalists are internists or pediatricians, in Canada, most hospitalists are family physicians. In the US, hospitalists are more likely to perform the following services: consultation, intensive care unit patient care, rapid response team service, surgical comanagement, and evening on‐site coverage. Canadian hospitalists are more likely to provide pediatric care and psychiatry inpatient comanagement.9
In the UK, the professional organization of physicians most similar to US hospitalists, acute physicians, is called SAM (The Society for Acute Medicine). It was founded in 2000.10 In the UK, general practitioners (GPs) never care for inpatients; at the time, GPs referred all admissions to organ‐specific specialists (eg, cardiologists). Acute medicine was created due to the realization that medical inpatients were too complex to have specialists managing them. Training programs were set up circa 2003 to create this specialty and address this need. Acute physicians staff geographically localized acute medicine units near emergency departments. These patients stay 1 to 3 days in an effort to concentrate services and resources to these patients, to prevent longer stays once fully admitted (Smith R, personal communication, April 23, 2011). Acute medicine units in the UK, Ireland, and Australia have led to positive benefits on patient outcomes. A review article by Scott and colleagues revealed reductions in LOS, inpatient mortality, and emergency department LOS, without increased 30‐day readmission rates. They found increased staff and patient satisfaction, and more medical patients discharged directly to home from acute medical units.11 The development of acute medicine in Australia and New Zealand began around 2005 and derives from the geographic localization of the UK model. Whereas the UK model has a focus on the first 72 hours of hospitalization, the model in Australia and New Zealand is more similar to the US model of following patients through their entire admission.12 Unlike the UK, Australia does not have dedicated acute medicine training programs.
PASHA, the Pan‐American Society of Hospitalists, is a loose affiliation of hospitalists largely in South America, linking with their North American colleagues. PASHA grew out of SOBRAMH, Sociedade Brasileira de Medicina Hospitalarthe first Hospital Medicine Society in South America, tracing its roots to 2004. To date, PASHA has had 1 international conference, but there have been 2 national conferences each in Brazil and Chile, and 1 in Colombia. The concept and advantages of Hospital Medicine have been presented at a conference in Panama. Argentina has its first Hospital Medicine Congress scheduled for September 2011, in concert with PASHA.
Two Hospital Medicine programs abroad deserve special mention. Both started in 2005 and have instituted the full hospitalist package, including multiple evidence‐based order sets at both sites (eg, deep vein thrombosis [DVT] prophylaxis and hyperglycemia management). At the Pontificia Universidad Catlica in Santiago, Chile, they have been awarded national grants to study hyperglycemia in hospitalized patients, and they have sent their faculty to the US for additional training in patient safety, quality improvement, leadership, and medical informatics. They have succeeded in decreasing LOS and improved the exam grades of their learners. Their faculty has published in national journals and is now beginning to submit their work for publication in US‐based journals (Rojas L, personal communication, April 22, 2011). The Clnica Universidad de Navarra (CUN) in Pamplona, Spain is a Joint Commission certified facility with a full electronic medical record. Hospitalists there are looking at ways in which hospitalist‐staffed intermediate care units can benefit patient outcomes. Additionally, they have comanagement arrangements with nearly all surgical subspecialties. The Management of the Hospitalized Patient symposium was organized by CUN hospitalists in 2007the first Hospital Medicine Congress, to our knowledge, in continental Europe. At any one time, 30% of all residents in all specialties rotate with CUN hospitalists (Lucena F, personal communication, April 22, 2011).
The specialty of Hospital Medicine is truly global. Our colleagues around the world employing the hospitalist model of care are now producing outcomes similar to the published models in North America and to the acute medicine models in Europe and Australia. According to the Society of Hospital Medicine, there are over 30,000 hospitalists in the US. There could be well over 50,000 hospitalists around the world. In 5 years, the world may have 100,000 hospitalists. The same drivers are fueling the growth of Hospital Medicine around the world. The evidence is building that the hospitalist model of care has financial and quality benefits that transcend borders. We forecast that the hospitalist model of care will become an increasingly larger part of the solution around the world to fix these international healthcare systems.
- ,.The emerging role of “hospitalists” in the American health care system.N Engl J Med.1996;335(7):514–517.
- ,.The hospitalist movement 5 years later.JAMA.2002;287(4):487–494.
- ,,.To Err Is Human: Building a Safer Health System; Institute of Medicine Committee on Quality of Health Care in America.Washington, DC:National Academy Press;2000.
- ,,.Crossing the Quality Chasm: A New Health System for the 21st Century; Institute of Medicine Committee of Health Care in America.Washington, DC:National Academy Press;2001.
- .The state of hospital medicine in 2008.Med Clin North Am.2008;92:265–273.
- et al.J Hosp Med.2011;6:378–382.
- ,,.A 10‐year experience with universal health insurance in Taiwan: measuring changes in health and health disparity.Ann Intern Med.2008;148(4):258–267.
- Canadian Hospitalist: Canadian Society of Hospital Medicine Web site. Available at: http://canadianhospitalist.ca/. Accessed April 15,2011.
- ,,,,,.Characteristics of hospitalists and hospitalist programs in the United States and Canada.J Clin Outcomes Manage.2009;16(2):69–74.
- The Society for Acute Medicine Web site. Available at: www.acutemedicine.org.uk. Accessed April 14,2011.
- ,,.Effectiveness of acute medical units in hospitals: a systematic review.Int J Qual Health Care.2009;21(6):397–407.
- .Acute and general medicine on opposite sides of the world.Acute Med.2011;10(2):67–68.
- ,.The emerging role of “hospitalists” in the American health care system.N Engl J Med.1996;335(7):514–517.
- ,.The hospitalist movement 5 years later.JAMA.2002;287(4):487–494.
- ,,.To Err Is Human: Building a Safer Health System; Institute of Medicine Committee on Quality of Health Care in America.Washington, DC:National Academy Press;2000.
- ,,.Crossing the Quality Chasm: A New Health System for the 21st Century; Institute of Medicine Committee of Health Care in America.Washington, DC:National Academy Press;2001.
- .The state of hospital medicine in 2008.Med Clin North Am.2008;92:265–273.
- et al.J Hosp Med.2011;6:378–382.
- ,,.A 10‐year experience with universal health insurance in Taiwan: measuring changes in health and health disparity.Ann Intern Med.2008;148(4):258–267.
- Canadian Hospitalist: Canadian Society of Hospital Medicine Web site. Available at: http://canadianhospitalist.ca/. Accessed April 15,2011.
- ,,,,,.Characteristics of hospitalists and hospitalist programs in the United States and Canada.J Clin Outcomes Manage.2009;16(2):69–74.
- The Society for Acute Medicine Web site. Available at: www.acutemedicine.org.uk. Accessed April 14,2011.
- ,,.Effectiveness of acute medical units in hospitals: a systematic review.Int J Qual Health Care.2009;21(6):397–407.
- .Acute and general medicine on opposite sides of the world.Acute Med.2011;10(2):67–68.
Quantifying Resident Clinical Experience
Internal medicine residency training continues to evolve as competency‐based and with education organized around patient care.13 Making the patient the center of resident education provides an opportunity for experiential learning in which learning can be organized around the clinical conditions that residents encounter. Despite the renewed emphasis on using patient experience as the basis for residency education, little is known regarding what specific diagnostic conditions are seen by internal medicine residents throughout their training. Attempts have been made to quantify resident clinical experience in various fields, using approaches such as review of medical records, case logs, and prescription profiles, but to date, we lack systematic methods to obtain clinical experience data for internal medicine residents.47
While residency curricula in internal medicine typically outlines specific rotations in various clinical areas such as general medical wards, cardiology services, and intensive care units, time spent on such rotations does not necessarily provide quantitative data on the actual clinical conditions that residents encounter, nor does it ensure consistent clinical experience between residents. It is plausible that there may be substantial variability in clinical experience between residents within the same program, and that the overall spectrum of clinical disorders seen by residents in a program may or may not be consistent with a desired optimum, though this is yet to be defined.
If residency education in internal medicine is to progressively incorporate more experiential learning, detailed knowledge of the clinical conditions seen by residents should be useful, not only for overall curriculum design, but this might also allow for various educational interventions to be made when there are variations in clinical experience between residents. Our program has been interested in the application of electronic resources for the improvement of patient care, such as through the handoff process and the use of personal digital assistants.8 We previously did a small analysis of clinical conditions seen by residents through non‐International Classification of Diseases, Ninth Revision (ICD‐9)‐based data they entered onto personal digital assistants. This suggested to us that electronic resources used by residents might serve as a venue by which they could enter diagnostic information which we could use to generate a more detailed analysis of the clinical conditions that they see. Here we describe a method by which we have attempted to quantify resident clinical experience in internal medicine using a modification of an electronic handoff system.
METHODS
The study was conducted within the Internal Medicine Residency Program at the Long Island Jewish Medical Center in New Hyde Park, New York, part of the North ShoreLong Island Jewish Health System, and was approved by the Institutional Review Board. This work was carried out as part of our participation in the Educational Innovation Project of the Residency Review Committee for Internal Medicine. A central objective of our proposal was to develop a method to assess residents' clinical experience on an individual and an aggregate basis. A group of faculty and residents in our residency program developed an electronic handoff tool which residents use for rapid access to key clinical data for their patients and for the handoff of clinical information for on call coverage. This handoff tool was developed with the technical assistance of MedTech Notes LLC which owns Patient Data Transfer System (PDTS) HandOff Note. We modified the handoff tool to include a section in which residents were required to enter a primary diagnosis for each of their patients (a hard stop design). We chose to use the ICD‐9 system for standardization and created two methods to select the code: 1) an organ system‐based dropdown list containing frequently used codes and 2) a search box allowing for searching of the complete ICD‐9 database. For the organ‐based dropdown list, selection of that organ system would reveal a brief list of frequently used codes to make it easier for residents to find them. Prior to using the handoff tool with the ICD‐9based primary diagnosis coding system, training sessions with the residents were conducted by 3 of the investigators along with 3 chief medical residents. These sessions included training not only in technical aspects of how to find diagnosis codes, but also how to make decisions regarding what the primary diagnosis should be. We also instructed our postgraduate year (PGY)‐1s to update their diagnostic selections during the course of the hospital stay.
Each data point represents a resident caring for a patient with a specific diagnostic entity, and is counted once for that resident's period of taking care of that patient. Thirty‐three PGY‐1s were studied and, on the internal medicine service, they were supervised by either hospitalist faculty or voluntary faculty in comparable proportions. If the patient's care is taken over by another resident, that second resident was also recorded as having had a diagnostic encounter with that patient, hence 1 patient could provide experience with the same diagnostic entity for 1 or more residents. Using this method, the denominator is not patients seen, but residentpatient diagnostic encounters that have taken place. The ICD‐9 diagnostic conditions entered by the residents were grouped using the ICD‐9 system. Individual diagnostic profiles for each resident, as well as an aggregate profile for all residents to reflect the residency program as a whole, were generated. We also carried out an analysis of the ICD‐9 codes entered by 6 consecutive PGY‐1s to assess how the diagnostic spectrum might vary among a small sampling of PGY‐1s. In order to evaluate the accuracy of the residents' diagnostic selections, we carried out a validation assessment using a tool used by the residents' supervising hospitalists (who were the attendings of record for those patients). This was carried out on a subset of patients and could be done at any time during the hospital stay. The hospitalists were asked to review their residents' ICD‐9 codes and indicate whether they agreed or disagreed.
RESULTS
A total of 7562 residentpatient diagnostic encounters were studied from July 1, 2007 through June 1, 2008. Mean patient age was 66 19.4 years. The age distribution is given in Table 1 and reveals that 65% of diagnostic encounters were with patients age 60 years or greater. Twelve housestaff teams were studied, each consisting of 2 PGY‐1s and a supervising PGY‐2 or PGY‐3 resident. All ICD‐9 codes were selected by categorical and preliminary internal medicine PGY‐1s on medical ward and intensive care unit rotations. Residents from other departments doing rotations on the medical service were excluded. A validation assessment of 341 patients indicated 83.3% agreement by the supervising hospitalist with the primary ICD‐9 code selected. ICD‐9 codes were then grouped and categorized using ICD‐9 nomenclature with the distribution provided in Table 2. A wide spectrum of clinical conditions is apparent including symptoms and ill‐defined conditions, circulatory disorders, respiratory disorders, neoplasms, genitourinary disorders, digestive disorders, diseases of the blood/blood forming organs, endocrinologic/nutritional/metabolic/emmmune disorders, and disorders of the skin and subcutaneous tissue, overall accounting for about 86% of resident clinical experience.
| Age Category | No. | Percent of Total |
|---|---|---|
| 1829 | 441 | 5.83 |
| 3039 | 455 | 6.02 |
| 4049 | 705 | 9.32 |
| 5059 | 1,010 | 13.36 |
| 6069 | 1,218 | 16.11 |
| 7079 | 1,465 | 19.37 |
| 8089 | 1,673 | 22.12 |
| 90110 | 595 | 7.87 |
| ICD‐9 Category Description | Frequency | Percent |
|---|---|---|
| ||
| Symptoms/Ill‐Defined Conditions | 1,475 | 19.51 |
| Circulatory System | 1,381 | 18.26 |
| Respiratory System | 939 | 12.42 |
| Neoplasms | 572 | 7.56 |
| Genitourinary System | 502 | 6.64 |
| Digestive System | 464 | 6.14 |
| Blood/Blood‐Forming Organs | 444 | 5.87 |
| Endo/Nutritional/Metabolic/Immunity | 393 | 5.20 |
| Skin and Subcutaneous Tissue | 380 | 5.03 |
| Injury and Poisoning | 222 | 2.94 |
| Musculoskeletal/Connective Tissue | 199 | 2.63 |
| Infectious/Parasitic | 194 | 2.57 |
| Mental Disorders | 166 | 2.20 |
| Nervous System/Sense Organs | 125 | 1.65 |
| Health Status/Contact with Health Services | 81 | 1.07 |
| Pregnancy/Childbirth/Puerperium | 14 | 0.19 |
We also examined the most common diagnostic conditions within each of these categories. The 3 most common ICD‐9 codes entered by residents within each category are provided in Table 3. Symptoms and ill‐defined conditions represent a sizable portion of resident clinical experience (19.51%). Within this category, the most common conditions were fever; abdominal pain (unspecified site); and chest pain, unspecified. Disorders of the circulatory and respiratory systems were the next most common categories of conditions seen by residents, comprising 18.26% and 12.42%, respectively, of resident clinical experience. Within the category of circulatory disorders, congestive heart failure and acute myocardial infarction were the most common conditions seen; for respiratory disorders, pneumonia, chronic airway obstruction, and asthma were most commonly encountered. In aggregate, symptoms and ill‐defined conditions, and disorders of the circulatory and respiratory systems accounted for 50% of resident clinical experience.
| ICD‐9 Category Description | ICD‐9 Code | Code Description | Frequency | Percent |
|---|---|---|---|---|
| ||||
| Symptoms/Ill‐Defined Conditions | 780.6 | Fever | 190 | 2.51 |
| 789 | Abdominal pain; unspecified site | 149 | 1.97 | |
| 786.5 | Chest pain, unspecified | 140 | 1.85 | |
| Circulatory System | 428 | Congestive heart failure, unspecified | 346 | 4.58 |
| 410.9 | Acute myocardial infarction; unspecified site; unspecified episode of care | 135 | 1.79 | |
| 410.1 | Acute myocardial infarction; other anterior wall; unspecified episode of care | 106 | 1.40 | |
| Respiratory System | 486 | Pneumonia, organism unspecified | 363 | 4.80 |
| 496 | Chronic airway obstruction, not elsewhere classified | 162 | 2.14 | |
| 493.9 | Asthma, unspecified; unspecified | 96 | 1.27 | |
| Neoplasms | 199.1 | Malignant neoplasm without specification of site; other | 86 | 1.14 |
| 162.9 | Malignant neoplasm; bronchus lung; unspecified | 73 | 0.97 | |
| 202.8 | Other lymphomas; unspecified site, extranodal and solid organ sites | 71 | 0.94 | |
| Genitourinary System | 599 | Urinary tract infection, site not specified | 247 | 3.27 |
| 584.9 | Acute renal failure, unspecified | 91 | 1.20 | |
| 585.6 | End stage renal disease | 40 | 0.53 | |
| Digestive System | 578.9 | Hemorrhage of gastrointestinal tract, unspecified | 119 | 1.57 |
| 558.9 | Other and unspecified noninfectious gastroenteritis and colitis | 69 | 0.91 | |
| 577 | Acute pancreatitis | 36 | 0.48 | |
| Blood/Blood‐Forming Organs | 285.9 | Anemia, unspecified | 127 | 1.68 |
| 282.64 | Sickle‐cell/Hb‐C disease with crisis | 80 | 1.06 | |
| 282.6 | Sickle‐cell disease, unspecified | 73 | 0.97 | |
| Endo/Nutritional/Metabolic/Immunity | 276.1 | Hypoosmolality and/or hyponatremia | 57 | 0.75 |
| 251.2 | Hypoglycemia, unspecified | 56 | 0.74 | |
| 250.1 | Diabetes with ketoacidosis; type II, not stated as uncontrolled | 50 | 0.66 | |
| Skin and Subcutaneous Tissue | 682.9 | Other cellulitis and abscess; unspecified site | 256 | 3.39 |
| 682.5 | Other cellulitis and abscess; buttock | 37 | 0.49 | |
| 686.9 | Unspecified local infection of skin and subcutaneous tissue | 23 | 0.30 | |
| Injury and Poisoning | 848.9 | Unspecified site of sprain and strain | 32 | 0.42 |
| 977.9 | Poisoning by unspecified drug or medicinal substance | 32 | 0.42 | |
| 829 | Fracture; unspecified bone, closed | 22 | 0.29 | |
| Musculoskeletal/Connective Tissue | 730.2 | Unspecified osteomyelitis; site unspecified | 33 | 0.44 |
| 710 | Systemic lupus erythematosus | 25 | 0.33 | |
| 728.87 | Muscle weakness (generalized) | 19 | 0.25 | |
| Infectious/Parasitic | 38.9 | Unspecified septicemia | 58 | 0.77 |
| 8.45 | Intestinal infection/clostridium difficile | 54 | 0.71 | |
| 9.1 | Colitis, enteritis, and gastroenteritis of presumed infectious organ | 15 | 0.20 | |
| Mental Disorders | 291.81 | Alcohol withdrawal | 43 | 0.57 |
| 307.9 | Other and unspecified special symptoms or syndromes, not elsewhere classified | 35 | 0.46 | |
| 294.8 | Other persistent mental disorders due to conditions classified elsewhere | 20 | 0.26 | |
| Nervous System/Sense Organs | 322.9 | Meningitis, unspecified | 30 | 0.40 |
| 331 | Alzheimer's disease | 14 | 0.19 | |
| 340 | Multiple sclerosis | 6 | 0.08 | |
| Health Status/Contact with Health Services | 885.9 | Accidental fall from other slipping tripping or stumbling | 18 | 0.24 |
| 884.4 | Accidental fall from bed | 7 | 0.09 | |
| V13.02 | Personal history of urinary (tract) infection | 4 | 0.05 | |
| Pregnancy/Childbirth/Puerperium | 673.8 | Other pulmonary embolism; unspecified episode of care | 9 | 0.12 |
| 665 | Rupture of uterus before onset of labor; unspecified episode of care | 1 | 0.01 | |
| 665.7 | Pelvic hematoma, unspecified episode of care | 1 | 0.01 | |
Individual resident clinical experience varied as well. As shown in Table 4, for a group of 6 PGY‐1s, there was substantial variability in the ICD‐9 diagnostic categories. For example, the percentages of codes falling into the cardiovascular disease category ranged from 15.27% to 27.91%, and for respiratory disease ranged from 8.22% to 18.55%. These data suggest that there may be sizable differences in the proportions of various clinical conditions seen by residents over a year of training.
| ICD‐9 Category Description | Mean | SD | Min | Max |
|---|---|---|---|---|
| ||||
| Symptoms/Ill‐Defined Conditions | 21.43 | 5.07 | 15.50 | 29.90 |
| Circulatory System | 21.84 | 4.38 | 15.27 | 27.91 |
| Respiratory System | 12.43 | 3.83 | 8.22 | 18.55 |
| Neoplasms | 8.47 | 2.64 | 4.12 | 11.80 |
| Genitourinary System | 5.26 | 1.09 | 4.03 | 6.98 |
| Digestive System | 4.53 | 0.96 | 3.09 | 5.65 |
| Blood/Blood‐Forming Organs | 4.64 | 2.73 | 3.05 | 10.05 |
| Endo/Nutritional/Metabolic/Immunity | 5.64 | 1.68 | 3.11 | 7.22 |
| Skin and Subcutaneous Tissue | 4.28 | 1.63 | 2.42 | 6.19 |
| Injury and Poisoning | 3.90 | 1.01 | 3.09 | 5.43 |
| Musculoskeletal/Connective Tissue | 2.86 | 1.36 | 1.55 | 4.58 |
| Infectious/Parasitic | 3.86 | 2.62 | 2.42 | 8.53 |
| Mental Disorders | 1.47 | 0.62 | 0.81 | 2.28 |
| Nervous System/Sense Organs | 1.49 | 0.87 | 0.62 | 3.09 |
DISCUSSION
Years ago, residency training transitioned from a predominantly bedside experience to a curriculum with a large didactic, non‐bedside component, following parameters defined by organizations such as the Accreditation Council for Graduate Medical Education. Residency training is undergoing substantial change to become competency‐based and to organize learning around patient care experiences.2, 3, 9 The Educational Innovation Project of the Residency Review Committee for Internal Medicine is one such endeavor to help develop new methods by which to accomplish this.1 Effective incorporation of innovative experiential learning methods, based on the core competencies, will require a detailed knowledge of resident clinical experience during the course of their training, yet such data have been sparse in internal medicine. Sequist et al. analyzed data from an electronic medical record to assess resident clinical experience in the outpatient setting.4 Bachur and Nagler have used an electronic patient tracking system to assess the clinical experience of pediatric emergency medicine fellows.5, 6 Most attempts to describe resident clinical experience have relied upon extracting diagnostic information from medical records, case logs, etc, though in another approach, Rohrbaugh et al. reviewed psychiatric resident prescription profiles,7 which might provide some indirect data on clinical experience if applied to internal medicine.
In this study, we attempted to quantify resident clinical experience using resident‐selected ICD‐9 codes, in contrast to other methods that have relied upon medical record review and other resident‐independent approaches. There are various strengths and limitations to this approach. Using the ICD‐9 system provides a number of strengths, a major one being standardization, allowing comparisons between different programs and perhaps even facilitating the development of guidelines for resident clinical experience. In addition, this approach using the ICD‐9 system could be readily implemented at any institution and does not require any specific technology. While we chose to do this through our handoff system, an institution could use any of a variety of other systems to accomplish this. For example, resident‐entered ICD‐9 coding systems could be incorporated into electronic discharge summaries, history and physicals, or progress notes. There may also be some practical benefits to having residents learn how to use the ICD‐9 system at this stage of their careers.
There are limitations to this approach as well. The ICD‐9 system was not intended to be used for medical education purposes. There are features of it that can make finding the best diagnosis difficult, and routes to it may at times seem counterintuitive. While we did not carry out resident surveys, a number of residents anecdotally mentioned that it took time to become comfortable using the system, and it could be challenging at times to find a diagnosis description that best fit what they were looking for. To make diagnosis selection easier, we created an organ system‐based dropdown list in the handoff tool so that when residents select an organ system, another list opens up containing commonly used ICD‐9 codes. This grouping is based on organ system alone and does not necessarily follow the ICD‐9 grouping (in contrast, our reported data in this article are all based on ICD‐9 grouping). A search tool to allow searching the entire ICD‐9 database was also made available on the handoff tool. Other factors that could limit diagnosis code accuracy could be lack of clinical knowledge, and error as a result of pressure to come up with a diagnosis because of the hard stop design of our system, in which residents were required to enter a primary diagnosis, potentially causing alert fatigue. A validation assessment that we carried out revealed fairly good agreement with the specific ICD‐9 codes chosen by the resident, but greater accuracy would be desirable. Further education on diagnosis selection and refinements to the handoff tool should help facilitate this. We are currently addressing this by ongoing education on diagnosis selection and by having the hospitalists share the handoff tool with the residents, allowing them to provide direct feedback on diagnostic selections.
More than 19% of the diagnoses selected by residents fell into the category of symptoms and ill‐defined conditions. This raises a number of potential educational issues. One of those is that if residents do, in fact, encounter such entities at such a high frequency, then the internal medicine curriculum must be structured in such a way as to complement this clinical experience with a comprehensive learning program. However, we must also consider the possibility that, in many such instances, a more definitive diagnosis became evident by the time of discharge and this may not have been reflected in the ICD‐9 code that the resident chose. Hence, the category of symptoms and ill‐defined conditions may actually be somewhat smaller than our findings would suggest.
Many issues will need to be addressed as programs obtain more data on their residents' clinical experience. While there may be many reasons to use the ICD‐9 system for selecting diagnoses including those listed above, the system by which ICD‐9 groups diagnoses might not provide ideal educational information, again as the ICD‐9 system was not designed for this purpose. While in this article we have reported the residents' diagnostic encounters grouped according to the ICD‐9 grouping system to provide an initial standardized description, grouping according to another diagnostic system that is felt to be more educationally meaningful may be preferred.
While one might assume that a higher frequency of exposure to certain clinical conditions should enhance competency, that relationship may not be straightforward in internal medicine. For surgical procedures, there are, in fact, data to show improved outcomes for surgeons with higher operative volumes for those procedures,10 but in internal medicine, we do not have data to demonstrate that competence of a resident caring for a particular condition is enhanced by experience alone. Therefore, as programs obtain more data on clinical experience, it will be important that the focus be kept on quality as opposed to quantity.
Obtaining data on resident clinical experience might greatly facilitate experiential learning approaches. For example, as residents go through training and encounter specific diagnostic conditions, those experiences could be supplemented by various learning innovations to make those experiences more meaningful and, hopefully, more likely to result in the development of competence, though that will require measurement. In our program, for example, we have incorporated an approach using illness scenarios, in that when residents have had a certain level of clinical experience with a given clinical condition, they are assembled in small groups and competency‐based case discussions are carried out with a preceptor. In addition, for those instances in which an individual resident may lack direct clinical experience in a certain area, this might be addressed by interventions to increase their contact with those conditions and/or targeted learning interventions to help develop competence. A resident found to be lacking in clinical experience in a certain area could be assigned to the care of more patients with that condition, or to spending more time in a venue in which that condition is more likely to be encountered. Various learning activities including didactics, case discussions, simulation, self‐directed learning, and others could also be used to compensate for such variability. Furthermore, if a residency program's aggregate clinical experience is divergent from some desirable standard yet to be determined, a detailed knowledge of this could help guide that program's curriculum revision. For example, for residents in a program in which there is relatively low exposure to patients with oncological issues, this could be compensated for by external rotations to achieve more clinical experience in oncology, as well as supplementation of the curriculum with additional learning activities in oncology, which could include small group discussions, self‐directed learning activities, case discussions, and others. While at present there are no defined standards for clinical experience and it remains to be seen if there would be a correlation with development of competence, no such standard would serve a purpose if programs did not have reliable and practical means of clinical experience assessment.
In summary, resident‐selected ICD‐9 codes may be a useful means to obtain data regarding resident clinical experience in internal medicine. Such data may be useful to residency training programs in developing new curricula based on experiential learning.
- ,,.Internal medicine's Educational Innovations Project: improving health care and learning.Am J Med.2009;122:398–404.
- ,,,,.Redesigning residency education in internal medicine: a position paper from the Association of Program Directors in Internal Medicine.Ann Intern Med.2006;144:920–926.
- ,,for the Education Committee of the American College of Physicians.Redesigning training for internal medicine.Ann Intern Med.2006;144:927–932.
- ,,,,.Use of an electronic medical record to profile the continuity clinic experiences of primary care residents.Acad Med.2005;80:390–394.
- ,,.An automated electronic case log: using electronic information systems to assess training in emergency medicine.Acad Emerg Med.2006;13:733–739.
- ,.Use of an automated electronic case log to assess fellowship training: tracking the pediatric emergency medicine experience.Pediatr Emerg Care.2008;24:75–82.
- ,,,.Utilizing VA information technology to develop psychiatric resident prescription profiles.Acad Psychiatry.2009;33:27–30.
- ,,, et al.Personal digital assistants (PDAs): a review of their application in graduate medical education.Am J Med Qual.2005;20:262–267.
- ,,, et al.Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force.Acad Med.2007;82:1211–1219.
- ,,,,,.Surgeon volume and operative mortality in the United States.N Engl J Med.2003;349:2117–2127.
Internal medicine residency training continues to evolve as competency‐based and with education organized around patient care.13 Making the patient the center of resident education provides an opportunity for experiential learning in which learning can be organized around the clinical conditions that residents encounter. Despite the renewed emphasis on using patient experience as the basis for residency education, little is known regarding what specific diagnostic conditions are seen by internal medicine residents throughout their training. Attempts have been made to quantify resident clinical experience in various fields, using approaches such as review of medical records, case logs, and prescription profiles, but to date, we lack systematic methods to obtain clinical experience data for internal medicine residents.47
While residency curricula in internal medicine typically outlines specific rotations in various clinical areas such as general medical wards, cardiology services, and intensive care units, time spent on such rotations does not necessarily provide quantitative data on the actual clinical conditions that residents encounter, nor does it ensure consistent clinical experience between residents. It is plausible that there may be substantial variability in clinical experience between residents within the same program, and that the overall spectrum of clinical disorders seen by residents in a program may or may not be consistent with a desired optimum, though this is yet to be defined.
If residency education in internal medicine is to progressively incorporate more experiential learning, detailed knowledge of the clinical conditions seen by residents should be useful, not only for overall curriculum design, but this might also allow for various educational interventions to be made when there are variations in clinical experience between residents. Our program has been interested in the application of electronic resources for the improvement of patient care, such as through the handoff process and the use of personal digital assistants.8 We previously did a small analysis of clinical conditions seen by residents through non‐International Classification of Diseases, Ninth Revision (ICD‐9)‐based data they entered onto personal digital assistants. This suggested to us that electronic resources used by residents might serve as a venue by which they could enter diagnostic information which we could use to generate a more detailed analysis of the clinical conditions that they see. Here we describe a method by which we have attempted to quantify resident clinical experience in internal medicine using a modification of an electronic handoff system.
METHODS
The study was conducted within the Internal Medicine Residency Program at the Long Island Jewish Medical Center in New Hyde Park, New York, part of the North ShoreLong Island Jewish Health System, and was approved by the Institutional Review Board. This work was carried out as part of our participation in the Educational Innovation Project of the Residency Review Committee for Internal Medicine. A central objective of our proposal was to develop a method to assess residents' clinical experience on an individual and an aggregate basis. A group of faculty and residents in our residency program developed an electronic handoff tool which residents use for rapid access to key clinical data for their patients and for the handoff of clinical information for on call coverage. This handoff tool was developed with the technical assistance of MedTech Notes LLC which owns Patient Data Transfer System (PDTS) HandOff Note. We modified the handoff tool to include a section in which residents were required to enter a primary diagnosis for each of their patients (a hard stop design). We chose to use the ICD‐9 system for standardization and created two methods to select the code: 1) an organ system‐based dropdown list containing frequently used codes and 2) a search box allowing for searching of the complete ICD‐9 database. For the organ‐based dropdown list, selection of that organ system would reveal a brief list of frequently used codes to make it easier for residents to find them. Prior to using the handoff tool with the ICD‐9based primary diagnosis coding system, training sessions with the residents were conducted by 3 of the investigators along with 3 chief medical residents. These sessions included training not only in technical aspects of how to find diagnosis codes, but also how to make decisions regarding what the primary diagnosis should be. We also instructed our postgraduate year (PGY)‐1s to update their diagnostic selections during the course of the hospital stay.
Each data point represents a resident caring for a patient with a specific diagnostic entity, and is counted once for that resident's period of taking care of that patient. Thirty‐three PGY‐1s were studied and, on the internal medicine service, they were supervised by either hospitalist faculty or voluntary faculty in comparable proportions. If the patient's care is taken over by another resident, that second resident was also recorded as having had a diagnostic encounter with that patient, hence 1 patient could provide experience with the same diagnostic entity for 1 or more residents. Using this method, the denominator is not patients seen, but residentpatient diagnostic encounters that have taken place. The ICD‐9 diagnostic conditions entered by the residents were grouped using the ICD‐9 system. Individual diagnostic profiles for each resident, as well as an aggregate profile for all residents to reflect the residency program as a whole, were generated. We also carried out an analysis of the ICD‐9 codes entered by 6 consecutive PGY‐1s to assess how the diagnostic spectrum might vary among a small sampling of PGY‐1s. In order to evaluate the accuracy of the residents' diagnostic selections, we carried out a validation assessment using a tool used by the residents' supervising hospitalists (who were the attendings of record for those patients). This was carried out on a subset of patients and could be done at any time during the hospital stay. The hospitalists were asked to review their residents' ICD‐9 codes and indicate whether they agreed or disagreed.
RESULTS
A total of 7562 residentpatient diagnostic encounters were studied from July 1, 2007 through June 1, 2008. Mean patient age was 66 19.4 years. The age distribution is given in Table 1 and reveals that 65% of diagnostic encounters were with patients age 60 years or greater. Twelve housestaff teams were studied, each consisting of 2 PGY‐1s and a supervising PGY‐2 or PGY‐3 resident. All ICD‐9 codes were selected by categorical and preliminary internal medicine PGY‐1s on medical ward and intensive care unit rotations. Residents from other departments doing rotations on the medical service were excluded. A validation assessment of 341 patients indicated 83.3% agreement by the supervising hospitalist with the primary ICD‐9 code selected. ICD‐9 codes were then grouped and categorized using ICD‐9 nomenclature with the distribution provided in Table 2. A wide spectrum of clinical conditions is apparent including symptoms and ill‐defined conditions, circulatory disorders, respiratory disorders, neoplasms, genitourinary disorders, digestive disorders, diseases of the blood/blood forming organs, endocrinologic/nutritional/metabolic/emmmune disorders, and disorders of the skin and subcutaneous tissue, overall accounting for about 86% of resident clinical experience.
| Age Category | No. | Percent of Total |
|---|---|---|
| 1829 | 441 | 5.83 |
| 3039 | 455 | 6.02 |
| 4049 | 705 | 9.32 |
| 5059 | 1,010 | 13.36 |
| 6069 | 1,218 | 16.11 |
| 7079 | 1,465 | 19.37 |
| 8089 | 1,673 | 22.12 |
| 90110 | 595 | 7.87 |
| ICD‐9 Category Description | Frequency | Percent |
|---|---|---|
| ||
| Symptoms/Ill‐Defined Conditions | 1,475 | 19.51 |
| Circulatory System | 1,381 | 18.26 |
| Respiratory System | 939 | 12.42 |
| Neoplasms | 572 | 7.56 |
| Genitourinary System | 502 | 6.64 |
| Digestive System | 464 | 6.14 |
| Blood/Blood‐Forming Organs | 444 | 5.87 |
| Endo/Nutritional/Metabolic/Immunity | 393 | 5.20 |
| Skin and Subcutaneous Tissue | 380 | 5.03 |
| Injury and Poisoning | 222 | 2.94 |
| Musculoskeletal/Connective Tissue | 199 | 2.63 |
| Infectious/Parasitic | 194 | 2.57 |
| Mental Disorders | 166 | 2.20 |
| Nervous System/Sense Organs | 125 | 1.65 |
| Health Status/Contact with Health Services | 81 | 1.07 |
| Pregnancy/Childbirth/Puerperium | 14 | 0.19 |
We also examined the most common diagnostic conditions within each of these categories. The 3 most common ICD‐9 codes entered by residents within each category are provided in Table 3. Symptoms and ill‐defined conditions represent a sizable portion of resident clinical experience (19.51%). Within this category, the most common conditions were fever; abdominal pain (unspecified site); and chest pain, unspecified. Disorders of the circulatory and respiratory systems were the next most common categories of conditions seen by residents, comprising 18.26% and 12.42%, respectively, of resident clinical experience. Within the category of circulatory disorders, congestive heart failure and acute myocardial infarction were the most common conditions seen; for respiratory disorders, pneumonia, chronic airway obstruction, and asthma were most commonly encountered. In aggregate, symptoms and ill‐defined conditions, and disorders of the circulatory and respiratory systems accounted for 50% of resident clinical experience.
| ICD‐9 Category Description | ICD‐9 Code | Code Description | Frequency | Percent |
|---|---|---|---|---|
| ||||
| Symptoms/Ill‐Defined Conditions | 780.6 | Fever | 190 | 2.51 |
| 789 | Abdominal pain; unspecified site | 149 | 1.97 | |
| 786.5 | Chest pain, unspecified | 140 | 1.85 | |
| Circulatory System | 428 | Congestive heart failure, unspecified | 346 | 4.58 |
| 410.9 | Acute myocardial infarction; unspecified site; unspecified episode of care | 135 | 1.79 | |
| 410.1 | Acute myocardial infarction; other anterior wall; unspecified episode of care | 106 | 1.40 | |
| Respiratory System | 486 | Pneumonia, organism unspecified | 363 | 4.80 |
| 496 | Chronic airway obstruction, not elsewhere classified | 162 | 2.14 | |
| 493.9 | Asthma, unspecified; unspecified | 96 | 1.27 | |
| Neoplasms | 199.1 | Malignant neoplasm without specification of site; other | 86 | 1.14 |
| 162.9 | Malignant neoplasm; bronchus lung; unspecified | 73 | 0.97 | |
| 202.8 | Other lymphomas; unspecified site, extranodal and solid organ sites | 71 | 0.94 | |
| Genitourinary System | 599 | Urinary tract infection, site not specified | 247 | 3.27 |
| 584.9 | Acute renal failure, unspecified | 91 | 1.20 | |
| 585.6 | End stage renal disease | 40 | 0.53 | |
| Digestive System | 578.9 | Hemorrhage of gastrointestinal tract, unspecified | 119 | 1.57 |
| 558.9 | Other and unspecified noninfectious gastroenteritis and colitis | 69 | 0.91 | |
| 577 | Acute pancreatitis | 36 | 0.48 | |
| Blood/Blood‐Forming Organs | 285.9 | Anemia, unspecified | 127 | 1.68 |
| 282.64 | Sickle‐cell/Hb‐C disease with crisis | 80 | 1.06 | |
| 282.6 | Sickle‐cell disease, unspecified | 73 | 0.97 | |
| Endo/Nutritional/Metabolic/Immunity | 276.1 | Hypoosmolality and/or hyponatremia | 57 | 0.75 |
| 251.2 | Hypoglycemia, unspecified | 56 | 0.74 | |
| 250.1 | Diabetes with ketoacidosis; type II, not stated as uncontrolled | 50 | 0.66 | |
| Skin and Subcutaneous Tissue | 682.9 | Other cellulitis and abscess; unspecified site | 256 | 3.39 |
| 682.5 | Other cellulitis and abscess; buttock | 37 | 0.49 | |
| 686.9 | Unspecified local infection of skin and subcutaneous tissue | 23 | 0.30 | |
| Injury and Poisoning | 848.9 | Unspecified site of sprain and strain | 32 | 0.42 |
| 977.9 | Poisoning by unspecified drug or medicinal substance | 32 | 0.42 | |
| 829 | Fracture; unspecified bone, closed | 22 | 0.29 | |
| Musculoskeletal/Connective Tissue | 730.2 | Unspecified osteomyelitis; site unspecified | 33 | 0.44 |
| 710 | Systemic lupus erythematosus | 25 | 0.33 | |
| 728.87 | Muscle weakness (generalized) | 19 | 0.25 | |
| Infectious/Parasitic | 38.9 | Unspecified septicemia | 58 | 0.77 |
| 8.45 | Intestinal infection/clostridium difficile | 54 | 0.71 | |
| 9.1 | Colitis, enteritis, and gastroenteritis of presumed infectious organ | 15 | 0.20 | |
| Mental Disorders | 291.81 | Alcohol withdrawal | 43 | 0.57 |
| 307.9 | Other and unspecified special symptoms or syndromes, not elsewhere classified | 35 | 0.46 | |
| 294.8 | Other persistent mental disorders due to conditions classified elsewhere | 20 | 0.26 | |
| Nervous System/Sense Organs | 322.9 | Meningitis, unspecified | 30 | 0.40 |
| 331 | Alzheimer's disease | 14 | 0.19 | |
| 340 | Multiple sclerosis | 6 | 0.08 | |
| Health Status/Contact with Health Services | 885.9 | Accidental fall from other slipping tripping or stumbling | 18 | 0.24 |
| 884.4 | Accidental fall from bed | 7 | 0.09 | |
| V13.02 | Personal history of urinary (tract) infection | 4 | 0.05 | |
| Pregnancy/Childbirth/Puerperium | 673.8 | Other pulmonary embolism; unspecified episode of care | 9 | 0.12 |
| 665 | Rupture of uterus before onset of labor; unspecified episode of care | 1 | 0.01 | |
| 665.7 | Pelvic hematoma, unspecified episode of care | 1 | 0.01 | |
Individual resident clinical experience varied as well. As shown in Table 4, for a group of 6 PGY‐1s, there was substantial variability in the ICD‐9 diagnostic categories. For example, the percentages of codes falling into the cardiovascular disease category ranged from 15.27% to 27.91%, and for respiratory disease ranged from 8.22% to 18.55%. These data suggest that there may be sizable differences in the proportions of various clinical conditions seen by residents over a year of training.
| ICD‐9 Category Description | Mean | SD | Min | Max |
|---|---|---|---|---|
| ||||
| Symptoms/Ill‐Defined Conditions | 21.43 | 5.07 | 15.50 | 29.90 |
| Circulatory System | 21.84 | 4.38 | 15.27 | 27.91 |
| Respiratory System | 12.43 | 3.83 | 8.22 | 18.55 |
| Neoplasms | 8.47 | 2.64 | 4.12 | 11.80 |
| Genitourinary System | 5.26 | 1.09 | 4.03 | 6.98 |
| Digestive System | 4.53 | 0.96 | 3.09 | 5.65 |
| Blood/Blood‐Forming Organs | 4.64 | 2.73 | 3.05 | 10.05 |
| Endo/Nutritional/Metabolic/Immunity | 5.64 | 1.68 | 3.11 | 7.22 |
| Skin and Subcutaneous Tissue | 4.28 | 1.63 | 2.42 | 6.19 |
| Injury and Poisoning | 3.90 | 1.01 | 3.09 | 5.43 |
| Musculoskeletal/Connective Tissue | 2.86 | 1.36 | 1.55 | 4.58 |
| Infectious/Parasitic | 3.86 | 2.62 | 2.42 | 8.53 |
| Mental Disorders | 1.47 | 0.62 | 0.81 | 2.28 |
| Nervous System/Sense Organs | 1.49 | 0.87 | 0.62 | 3.09 |
DISCUSSION
Years ago, residency training transitioned from a predominantly bedside experience to a curriculum with a large didactic, non‐bedside component, following parameters defined by organizations such as the Accreditation Council for Graduate Medical Education. Residency training is undergoing substantial change to become competency‐based and to organize learning around patient care experiences.2, 3, 9 The Educational Innovation Project of the Residency Review Committee for Internal Medicine is one such endeavor to help develop new methods by which to accomplish this.1 Effective incorporation of innovative experiential learning methods, based on the core competencies, will require a detailed knowledge of resident clinical experience during the course of their training, yet such data have been sparse in internal medicine. Sequist et al. analyzed data from an electronic medical record to assess resident clinical experience in the outpatient setting.4 Bachur and Nagler have used an electronic patient tracking system to assess the clinical experience of pediatric emergency medicine fellows.5, 6 Most attempts to describe resident clinical experience have relied upon extracting diagnostic information from medical records, case logs, etc, though in another approach, Rohrbaugh et al. reviewed psychiatric resident prescription profiles,7 which might provide some indirect data on clinical experience if applied to internal medicine.
In this study, we attempted to quantify resident clinical experience using resident‐selected ICD‐9 codes, in contrast to other methods that have relied upon medical record review and other resident‐independent approaches. There are various strengths and limitations to this approach. Using the ICD‐9 system provides a number of strengths, a major one being standardization, allowing comparisons between different programs and perhaps even facilitating the development of guidelines for resident clinical experience. In addition, this approach using the ICD‐9 system could be readily implemented at any institution and does not require any specific technology. While we chose to do this through our handoff system, an institution could use any of a variety of other systems to accomplish this. For example, resident‐entered ICD‐9 coding systems could be incorporated into electronic discharge summaries, history and physicals, or progress notes. There may also be some practical benefits to having residents learn how to use the ICD‐9 system at this stage of their careers.
There are limitations to this approach as well. The ICD‐9 system was not intended to be used for medical education purposes. There are features of it that can make finding the best diagnosis difficult, and routes to it may at times seem counterintuitive. While we did not carry out resident surveys, a number of residents anecdotally mentioned that it took time to become comfortable using the system, and it could be challenging at times to find a diagnosis description that best fit what they were looking for. To make diagnosis selection easier, we created an organ system‐based dropdown list in the handoff tool so that when residents select an organ system, another list opens up containing commonly used ICD‐9 codes. This grouping is based on organ system alone and does not necessarily follow the ICD‐9 grouping (in contrast, our reported data in this article are all based on ICD‐9 grouping). A search tool to allow searching the entire ICD‐9 database was also made available on the handoff tool. Other factors that could limit diagnosis code accuracy could be lack of clinical knowledge, and error as a result of pressure to come up with a diagnosis because of the hard stop design of our system, in which residents were required to enter a primary diagnosis, potentially causing alert fatigue. A validation assessment that we carried out revealed fairly good agreement with the specific ICD‐9 codes chosen by the resident, but greater accuracy would be desirable. Further education on diagnosis selection and refinements to the handoff tool should help facilitate this. We are currently addressing this by ongoing education on diagnosis selection and by having the hospitalists share the handoff tool with the residents, allowing them to provide direct feedback on diagnostic selections.
More than 19% of the diagnoses selected by residents fell into the category of symptoms and ill‐defined conditions. This raises a number of potential educational issues. One of those is that if residents do, in fact, encounter such entities at such a high frequency, then the internal medicine curriculum must be structured in such a way as to complement this clinical experience with a comprehensive learning program. However, we must also consider the possibility that, in many such instances, a more definitive diagnosis became evident by the time of discharge and this may not have been reflected in the ICD‐9 code that the resident chose. Hence, the category of symptoms and ill‐defined conditions may actually be somewhat smaller than our findings would suggest.
Many issues will need to be addressed as programs obtain more data on their residents' clinical experience. While there may be many reasons to use the ICD‐9 system for selecting diagnoses including those listed above, the system by which ICD‐9 groups diagnoses might not provide ideal educational information, again as the ICD‐9 system was not designed for this purpose. While in this article we have reported the residents' diagnostic encounters grouped according to the ICD‐9 grouping system to provide an initial standardized description, grouping according to another diagnostic system that is felt to be more educationally meaningful may be preferred.
While one might assume that a higher frequency of exposure to certain clinical conditions should enhance competency, that relationship may not be straightforward in internal medicine. For surgical procedures, there are, in fact, data to show improved outcomes for surgeons with higher operative volumes for those procedures,10 but in internal medicine, we do not have data to demonstrate that competence of a resident caring for a particular condition is enhanced by experience alone. Therefore, as programs obtain more data on clinical experience, it will be important that the focus be kept on quality as opposed to quantity.
Obtaining data on resident clinical experience might greatly facilitate experiential learning approaches. For example, as residents go through training and encounter specific diagnostic conditions, those experiences could be supplemented by various learning innovations to make those experiences more meaningful and, hopefully, more likely to result in the development of competence, though that will require measurement. In our program, for example, we have incorporated an approach using illness scenarios, in that when residents have had a certain level of clinical experience with a given clinical condition, they are assembled in small groups and competency‐based case discussions are carried out with a preceptor. In addition, for those instances in which an individual resident may lack direct clinical experience in a certain area, this might be addressed by interventions to increase their contact with those conditions and/or targeted learning interventions to help develop competence. A resident found to be lacking in clinical experience in a certain area could be assigned to the care of more patients with that condition, or to spending more time in a venue in which that condition is more likely to be encountered. Various learning activities including didactics, case discussions, simulation, self‐directed learning, and others could also be used to compensate for such variability. Furthermore, if a residency program's aggregate clinical experience is divergent from some desirable standard yet to be determined, a detailed knowledge of this could help guide that program's curriculum revision. For example, for residents in a program in which there is relatively low exposure to patients with oncological issues, this could be compensated for by external rotations to achieve more clinical experience in oncology, as well as supplementation of the curriculum with additional learning activities in oncology, which could include small group discussions, self‐directed learning activities, case discussions, and others. While at present there are no defined standards for clinical experience and it remains to be seen if there would be a correlation with development of competence, no such standard would serve a purpose if programs did not have reliable and practical means of clinical experience assessment.
In summary, resident‐selected ICD‐9 codes may be a useful means to obtain data regarding resident clinical experience in internal medicine. Such data may be useful to residency training programs in developing new curricula based on experiential learning.
Internal medicine residency training continues to evolve as competency‐based and with education organized around patient care.13 Making the patient the center of resident education provides an opportunity for experiential learning in which learning can be organized around the clinical conditions that residents encounter. Despite the renewed emphasis on using patient experience as the basis for residency education, little is known regarding what specific diagnostic conditions are seen by internal medicine residents throughout their training. Attempts have been made to quantify resident clinical experience in various fields, using approaches such as review of medical records, case logs, and prescription profiles, but to date, we lack systematic methods to obtain clinical experience data for internal medicine residents.47
While residency curricula in internal medicine typically outlines specific rotations in various clinical areas such as general medical wards, cardiology services, and intensive care units, time spent on such rotations does not necessarily provide quantitative data on the actual clinical conditions that residents encounter, nor does it ensure consistent clinical experience between residents. It is plausible that there may be substantial variability in clinical experience between residents within the same program, and that the overall spectrum of clinical disorders seen by residents in a program may or may not be consistent with a desired optimum, though this is yet to be defined.
If residency education in internal medicine is to progressively incorporate more experiential learning, detailed knowledge of the clinical conditions seen by residents should be useful, not only for overall curriculum design, but this might also allow for various educational interventions to be made when there are variations in clinical experience between residents. Our program has been interested in the application of electronic resources for the improvement of patient care, such as through the handoff process and the use of personal digital assistants.8 We previously did a small analysis of clinical conditions seen by residents through non‐International Classification of Diseases, Ninth Revision (ICD‐9)‐based data they entered onto personal digital assistants. This suggested to us that electronic resources used by residents might serve as a venue by which they could enter diagnostic information which we could use to generate a more detailed analysis of the clinical conditions that they see. Here we describe a method by which we have attempted to quantify resident clinical experience in internal medicine using a modification of an electronic handoff system.
METHODS
The study was conducted within the Internal Medicine Residency Program at the Long Island Jewish Medical Center in New Hyde Park, New York, part of the North ShoreLong Island Jewish Health System, and was approved by the Institutional Review Board. This work was carried out as part of our participation in the Educational Innovation Project of the Residency Review Committee for Internal Medicine. A central objective of our proposal was to develop a method to assess residents' clinical experience on an individual and an aggregate basis. A group of faculty and residents in our residency program developed an electronic handoff tool which residents use for rapid access to key clinical data for their patients and for the handoff of clinical information for on call coverage. This handoff tool was developed with the technical assistance of MedTech Notes LLC which owns Patient Data Transfer System (PDTS) HandOff Note. We modified the handoff tool to include a section in which residents were required to enter a primary diagnosis for each of their patients (a hard stop design). We chose to use the ICD‐9 system for standardization and created two methods to select the code: 1) an organ system‐based dropdown list containing frequently used codes and 2) a search box allowing for searching of the complete ICD‐9 database. For the organ‐based dropdown list, selection of that organ system would reveal a brief list of frequently used codes to make it easier for residents to find them. Prior to using the handoff tool with the ICD‐9based primary diagnosis coding system, training sessions with the residents were conducted by 3 of the investigators along with 3 chief medical residents. These sessions included training not only in technical aspects of how to find diagnosis codes, but also how to make decisions regarding what the primary diagnosis should be. We also instructed our postgraduate year (PGY)‐1s to update their diagnostic selections during the course of the hospital stay.
Each data point represents a resident caring for a patient with a specific diagnostic entity, and is counted once for that resident's period of taking care of that patient. Thirty‐three PGY‐1s were studied and, on the internal medicine service, they were supervised by either hospitalist faculty or voluntary faculty in comparable proportions. If the patient's care is taken over by another resident, that second resident was also recorded as having had a diagnostic encounter with that patient, hence 1 patient could provide experience with the same diagnostic entity for 1 or more residents. Using this method, the denominator is not patients seen, but residentpatient diagnostic encounters that have taken place. The ICD‐9 diagnostic conditions entered by the residents were grouped using the ICD‐9 system. Individual diagnostic profiles for each resident, as well as an aggregate profile for all residents to reflect the residency program as a whole, were generated. We also carried out an analysis of the ICD‐9 codes entered by 6 consecutive PGY‐1s to assess how the diagnostic spectrum might vary among a small sampling of PGY‐1s. In order to evaluate the accuracy of the residents' diagnostic selections, we carried out a validation assessment using a tool used by the residents' supervising hospitalists (who were the attendings of record for those patients). This was carried out on a subset of patients and could be done at any time during the hospital stay. The hospitalists were asked to review their residents' ICD‐9 codes and indicate whether they agreed or disagreed.
RESULTS
A total of 7562 residentpatient diagnostic encounters were studied from July 1, 2007 through June 1, 2008. Mean patient age was 66 19.4 years. The age distribution is given in Table 1 and reveals that 65% of diagnostic encounters were with patients age 60 years or greater. Twelve housestaff teams were studied, each consisting of 2 PGY‐1s and a supervising PGY‐2 or PGY‐3 resident. All ICD‐9 codes were selected by categorical and preliminary internal medicine PGY‐1s on medical ward and intensive care unit rotations. Residents from other departments doing rotations on the medical service were excluded. A validation assessment of 341 patients indicated 83.3% agreement by the supervising hospitalist with the primary ICD‐9 code selected. ICD‐9 codes were then grouped and categorized using ICD‐9 nomenclature with the distribution provided in Table 2. A wide spectrum of clinical conditions is apparent including symptoms and ill‐defined conditions, circulatory disorders, respiratory disorders, neoplasms, genitourinary disorders, digestive disorders, diseases of the blood/blood forming organs, endocrinologic/nutritional/metabolic/emmmune disorders, and disorders of the skin and subcutaneous tissue, overall accounting for about 86% of resident clinical experience.
| Age Category | No. | Percent of Total |
|---|---|---|
| 1829 | 441 | 5.83 |
| 3039 | 455 | 6.02 |
| 4049 | 705 | 9.32 |
| 5059 | 1,010 | 13.36 |
| 6069 | 1,218 | 16.11 |
| 7079 | 1,465 | 19.37 |
| 8089 | 1,673 | 22.12 |
| 90110 | 595 | 7.87 |
| ICD‐9 Category Description | Frequency | Percent |
|---|---|---|
| ||
| Symptoms/Ill‐Defined Conditions | 1,475 | 19.51 |
| Circulatory System | 1,381 | 18.26 |
| Respiratory System | 939 | 12.42 |
| Neoplasms | 572 | 7.56 |
| Genitourinary System | 502 | 6.64 |
| Digestive System | 464 | 6.14 |
| Blood/Blood‐Forming Organs | 444 | 5.87 |
| Endo/Nutritional/Metabolic/Immunity | 393 | 5.20 |
| Skin and Subcutaneous Tissue | 380 | 5.03 |
| Injury and Poisoning | 222 | 2.94 |
| Musculoskeletal/Connective Tissue | 199 | 2.63 |
| Infectious/Parasitic | 194 | 2.57 |
| Mental Disorders | 166 | 2.20 |
| Nervous System/Sense Organs | 125 | 1.65 |
| Health Status/Contact with Health Services | 81 | 1.07 |
| Pregnancy/Childbirth/Puerperium | 14 | 0.19 |
We also examined the most common diagnostic conditions within each of these categories. The 3 most common ICD‐9 codes entered by residents within each category are provided in Table 3. Symptoms and ill‐defined conditions represent a sizable portion of resident clinical experience (19.51%). Within this category, the most common conditions were fever; abdominal pain (unspecified site); and chest pain, unspecified. Disorders of the circulatory and respiratory systems were the next most common categories of conditions seen by residents, comprising 18.26% and 12.42%, respectively, of resident clinical experience. Within the category of circulatory disorders, congestive heart failure and acute myocardial infarction were the most common conditions seen; for respiratory disorders, pneumonia, chronic airway obstruction, and asthma were most commonly encountered. In aggregate, symptoms and ill‐defined conditions, and disorders of the circulatory and respiratory systems accounted for 50% of resident clinical experience.
| ICD‐9 Category Description | ICD‐9 Code | Code Description | Frequency | Percent |
|---|---|---|---|---|
| ||||
| Symptoms/Ill‐Defined Conditions | 780.6 | Fever | 190 | 2.51 |
| 789 | Abdominal pain; unspecified site | 149 | 1.97 | |
| 786.5 | Chest pain, unspecified | 140 | 1.85 | |
| Circulatory System | 428 | Congestive heart failure, unspecified | 346 | 4.58 |
| 410.9 | Acute myocardial infarction; unspecified site; unspecified episode of care | 135 | 1.79 | |
| 410.1 | Acute myocardial infarction; other anterior wall; unspecified episode of care | 106 | 1.40 | |
| Respiratory System | 486 | Pneumonia, organism unspecified | 363 | 4.80 |
| 496 | Chronic airway obstruction, not elsewhere classified | 162 | 2.14 | |
| 493.9 | Asthma, unspecified; unspecified | 96 | 1.27 | |
| Neoplasms | 199.1 | Malignant neoplasm without specification of site; other | 86 | 1.14 |
| 162.9 | Malignant neoplasm; bronchus lung; unspecified | 73 | 0.97 | |
| 202.8 | Other lymphomas; unspecified site, extranodal and solid organ sites | 71 | 0.94 | |
| Genitourinary System | 599 | Urinary tract infection, site not specified | 247 | 3.27 |
| 584.9 | Acute renal failure, unspecified | 91 | 1.20 | |
| 585.6 | End stage renal disease | 40 | 0.53 | |
| Digestive System | 578.9 | Hemorrhage of gastrointestinal tract, unspecified | 119 | 1.57 |
| 558.9 | Other and unspecified noninfectious gastroenteritis and colitis | 69 | 0.91 | |
| 577 | Acute pancreatitis | 36 | 0.48 | |
| Blood/Blood‐Forming Organs | 285.9 | Anemia, unspecified | 127 | 1.68 |
| 282.64 | Sickle‐cell/Hb‐C disease with crisis | 80 | 1.06 | |
| 282.6 | Sickle‐cell disease, unspecified | 73 | 0.97 | |
| Endo/Nutritional/Metabolic/Immunity | 276.1 | Hypoosmolality and/or hyponatremia | 57 | 0.75 |
| 251.2 | Hypoglycemia, unspecified | 56 | 0.74 | |
| 250.1 | Diabetes with ketoacidosis; type II, not stated as uncontrolled | 50 | 0.66 | |
| Skin and Subcutaneous Tissue | 682.9 | Other cellulitis and abscess; unspecified site | 256 | 3.39 |
| 682.5 | Other cellulitis and abscess; buttock | 37 | 0.49 | |
| 686.9 | Unspecified local infection of skin and subcutaneous tissue | 23 | 0.30 | |
| Injury and Poisoning | 848.9 | Unspecified site of sprain and strain | 32 | 0.42 |
| 977.9 | Poisoning by unspecified drug or medicinal substance | 32 | 0.42 | |
| 829 | Fracture; unspecified bone, closed | 22 | 0.29 | |
| Musculoskeletal/Connective Tissue | 730.2 | Unspecified osteomyelitis; site unspecified | 33 | 0.44 |
| 710 | Systemic lupus erythematosus | 25 | 0.33 | |
| 728.87 | Muscle weakness (generalized) | 19 | 0.25 | |
| Infectious/Parasitic | 38.9 | Unspecified septicemia | 58 | 0.77 |
| 8.45 | Intestinal infection/clostridium difficile | 54 | 0.71 | |
| 9.1 | Colitis, enteritis, and gastroenteritis of presumed infectious organ | 15 | 0.20 | |
| Mental Disorders | 291.81 | Alcohol withdrawal | 43 | 0.57 |
| 307.9 | Other and unspecified special symptoms or syndromes, not elsewhere classified | 35 | 0.46 | |
| 294.8 | Other persistent mental disorders due to conditions classified elsewhere | 20 | 0.26 | |
| Nervous System/Sense Organs | 322.9 | Meningitis, unspecified | 30 | 0.40 |
| 331 | Alzheimer's disease | 14 | 0.19 | |
| 340 | Multiple sclerosis | 6 | 0.08 | |
| Health Status/Contact with Health Services | 885.9 | Accidental fall from other slipping tripping or stumbling | 18 | 0.24 |
| 884.4 | Accidental fall from bed | 7 | 0.09 | |
| V13.02 | Personal history of urinary (tract) infection | 4 | 0.05 | |
| Pregnancy/Childbirth/Puerperium | 673.8 | Other pulmonary embolism; unspecified episode of care | 9 | 0.12 |
| 665 | Rupture of uterus before onset of labor; unspecified episode of care | 1 | 0.01 | |
| 665.7 | Pelvic hematoma, unspecified episode of care | 1 | 0.01 | |
Individual resident clinical experience varied as well. As shown in Table 4, for a group of 6 PGY‐1s, there was substantial variability in the ICD‐9 diagnostic categories. For example, the percentages of codes falling into the cardiovascular disease category ranged from 15.27% to 27.91%, and for respiratory disease ranged from 8.22% to 18.55%. These data suggest that there may be sizable differences in the proportions of various clinical conditions seen by residents over a year of training.
| ICD‐9 Category Description | Mean | SD | Min | Max |
|---|---|---|---|---|
| ||||
| Symptoms/Ill‐Defined Conditions | 21.43 | 5.07 | 15.50 | 29.90 |
| Circulatory System | 21.84 | 4.38 | 15.27 | 27.91 |
| Respiratory System | 12.43 | 3.83 | 8.22 | 18.55 |
| Neoplasms | 8.47 | 2.64 | 4.12 | 11.80 |
| Genitourinary System | 5.26 | 1.09 | 4.03 | 6.98 |
| Digestive System | 4.53 | 0.96 | 3.09 | 5.65 |
| Blood/Blood‐Forming Organs | 4.64 | 2.73 | 3.05 | 10.05 |
| Endo/Nutritional/Metabolic/Immunity | 5.64 | 1.68 | 3.11 | 7.22 |
| Skin and Subcutaneous Tissue | 4.28 | 1.63 | 2.42 | 6.19 |
| Injury and Poisoning | 3.90 | 1.01 | 3.09 | 5.43 |
| Musculoskeletal/Connective Tissue | 2.86 | 1.36 | 1.55 | 4.58 |
| Infectious/Parasitic | 3.86 | 2.62 | 2.42 | 8.53 |
| Mental Disorders | 1.47 | 0.62 | 0.81 | 2.28 |
| Nervous System/Sense Organs | 1.49 | 0.87 | 0.62 | 3.09 |
DISCUSSION
Years ago, residency training transitioned from a predominantly bedside experience to a curriculum with a large didactic, non‐bedside component, following parameters defined by organizations such as the Accreditation Council for Graduate Medical Education. Residency training is undergoing substantial change to become competency‐based and to organize learning around patient care experiences.2, 3, 9 The Educational Innovation Project of the Residency Review Committee for Internal Medicine is one such endeavor to help develop new methods by which to accomplish this.1 Effective incorporation of innovative experiential learning methods, based on the core competencies, will require a detailed knowledge of resident clinical experience during the course of their training, yet such data have been sparse in internal medicine. Sequist et al. analyzed data from an electronic medical record to assess resident clinical experience in the outpatient setting.4 Bachur and Nagler have used an electronic patient tracking system to assess the clinical experience of pediatric emergency medicine fellows.5, 6 Most attempts to describe resident clinical experience have relied upon extracting diagnostic information from medical records, case logs, etc, though in another approach, Rohrbaugh et al. reviewed psychiatric resident prescription profiles,7 which might provide some indirect data on clinical experience if applied to internal medicine.
In this study, we attempted to quantify resident clinical experience using resident‐selected ICD‐9 codes, in contrast to other methods that have relied upon medical record review and other resident‐independent approaches. There are various strengths and limitations to this approach. Using the ICD‐9 system provides a number of strengths, a major one being standardization, allowing comparisons between different programs and perhaps even facilitating the development of guidelines for resident clinical experience. In addition, this approach using the ICD‐9 system could be readily implemented at any institution and does not require any specific technology. While we chose to do this through our handoff system, an institution could use any of a variety of other systems to accomplish this. For example, resident‐entered ICD‐9 coding systems could be incorporated into electronic discharge summaries, history and physicals, or progress notes. There may also be some practical benefits to having residents learn how to use the ICD‐9 system at this stage of their careers.
There are limitations to this approach as well. The ICD‐9 system was not intended to be used for medical education purposes. There are features of it that can make finding the best diagnosis difficult, and routes to it may at times seem counterintuitive. While we did not carry out resident surveys, a number of residents anecdotally mentioned that it took time to become comfortable using the system, and it could be challenging at times to find a diagnosis description that best fit what they were looking for. To make diagnosis selection easier, we created an organ system‐based dropdown list in the handoff tool so that when residents select an organ system, another list opens up containing commonly used ICD‐9 codes. This grouping is based on organ system alone and does not necessarily follow the ICD‐9 grouping (in contrast, our reported data in this article are all based on ICD‐9 grouping). A search tool to allow searching the entire ICD‐9 database was also made available on the handoff tool. Other factors that could limit diagnosis code accuracy could be lack of clinical knowledge, and error as a result of pressure to come up with a diagnosis because of the hard stop design of our system, in which residents were required to enter a primary diagnosis, potentially causing alert fatigue. A validation assessment that we carried out revealed fairly good agreement with the specific ICD‐9 codes chosen by the resident, but greater accuracy would be desirable. Further education on diagnosis selection and refinements to the handoff tool should help facilitate this. We are currently addressing this by ongoing education on diagnosis selection and by having the hospitalists share the handoff tool with the residents, allowing them to provide direct feedback on diagnostic selections.
More than 19% of the diagnoses selected by residents fell into the category of symptoms and ill‐defined conditions. This raises a number of potential educational issues. One of those is that if residents do, in fact, encounter such entities at such a high frequency, then the internal medicine curriculum must be structured in such a way as to complement this clinical experience with a comprehensive learning program. However, we must also consider the possibility that, in many such instances, a more definitive diagnosis became evident by the time of discharge and this may not have been reflected in the ICD‐9 code that the resident chose. Hence, the category of symptoms and ill‐defined conditions may actually be somewhat smaller than our findings would suggest.
Many issues will need to be addressed as programs obtain more data on their residents' clinical experience. While there may be many reasons to use the ICD‐9 system for selecting diagnoses including those listed above, the system by which ICD‐9 groups diagnoses might not provide ideal educational information, again as the ICD‐9 system was not designed for this purpose. While in this article we have reported the residents' diagnostic encounters grouped according to the ICD‐9 grouping system to provide an initial standardized description, grouping according to another diagnostic system that is felt to be more educationally meaningful may be preferred.
While one might assume that a higher frequency of exposure to certain clinical conditions should enhance competency, that relationship may not be straightforward in internal medicine. For surgical procedures, there are, in fact, data to show improved outcomes for surgeons with higher operative volumes for those procedures,10 but in internal medicine, we do not have data to demonstrate that competence of a resident caring for a particular condition is enhanced by experience alone. Therefore, as programs obtain more data on clinical experience, it will be important that the focus be kept on quality as opposed to quantity.
Obtaining data on resident clinical experience might greatly facilitate experiential learning approaches. For example, as residents go through training and encounter specific diagnostic conditions, those experiences could be supplemented by various learning innovations to make those experiences more meaningful and, hopefully, more likely to result in the development of competence, though that will require measurement. In our program, for example, we have incorporated an approach using illness scenarios, in that when residents have had a certain level of clinical experience with a given clinical condition, they are assembled in small groups and competency‐based case discussions are carried out with a preceptor. In addition, for those instances in which an individual resident may lack direct clinical experience in a certain area, this might be addressed by interventions to increase their contact with those conditions and/or targeted learning interventions to help develop competence. A resident found to be lacking in clinical experience in a certain area could be assigned to the care of more patients with that condition, or to spending more time in a venue in which that condition is more likely to be encountered. Various learning activities including didactics, case discussions, simulation, self‐directed learning, and others could also be used to compensate for such variability. Furthermore, if a residency program's aggregate clinical experience is divergent from some desirable standard yet to be determined, a detailed knowledge of this could help guide that program's curriculum revision. For example, for residents in a program in which there is relatively low exposure to patients with oncological issues, this could be compensated for by external rotations to achieve more clinical experience in oncology, as well as supplementation of the curriculum with additional learning activities in oncology, which could include small group discussions, self‐directed learning activities, case discussions, and others. While at present there are no defined standards for clinical experience and it remains to be seen if there would be a correlation with development of competence, no such standard would serve a purpose if programs did not have reliable and practical means of clinical experience assessment.
In summary, resident‐selected ICD‐9 codes may be a useful means to obtain data regarding resident clinical experience in internal medicine. Such data may be useful to residency training programs in developing new curricula based on experiential learning.
- ,,.Internal medicine's Educational Innovations Project: improving health care and learning.Am J Med.2009;122:398–404.
- ,,,,.Redesigning residency education in internal medicine: a position paper from the Association of Program Directors in Internal Medicine.Ann Intern Med.2006;144:920–926.
- ,,for the Education Committee of the American College of Physicians.Redesigning training for internal medicine.Ann Intern Med.2006;144:927–932.
- ,,,,.Use of an electronic medical record to profile the continuity clinic experiences of primary care residents.Acad Med.2005;80:390–394.
- ,,.An automated electronic case log: using electronic information systems to assess training in emergency medicine.Acad Emerg Med.2006;13:733–739.
- ,.Use of an automated electronic case log to assess fellowship training: tracking the pediatric emergency medicine experience.Pediatr Emerg Care.2008;24:75–82.
- ,,,.Utilizing VA information technology to develop psychiatric resident prescription profiles.Acad Psychiatry.2009;33:27–30.
- ,,, et al.Personal digital assistants (PDAs): a review of their application in graduate medical education.Am J Med Qual.2005;20:262–267.
- ,,, et al.Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force.Acad Med.2007;82:1211–1219.
- ,,,,,.Surgeon volume and operative mortality in the United States.N Engl J Med.2003;349:2117–2127.
- ,,.Internal medicine's Educational Innovations Project: improving health care and learning.Am J Med.2009;122:398–404.
- ,,,,.Redesigning residency education in internal medicine: a position paper from the Association of Program Directors in Internal Medicine.Ann Intern Med.2006;144:920–926.
- ,,for the Education Committee of the American College of Physicians.Redesigning training for internal medicine.Ann Intern Med.2006;144:927–932.
- ,,,,.Use of an electronic medical record to profile the continuity clinic experiences of primary care residents.Acad Med.2005;80:390–394.
- ,,.An automated electronic case log: using electronic information systems to assess training in emergency medicine.Acad Emerg Med.2006;13:733–739.
- ,.Use of an automated electronic case log to assess fellowship training: tracking the pediatric emergency medicine experience.Pediatr Emerg Care.2008;24:75–82.
- ,,,.Utilizing VA information technology to develop psychiatric resident prescription profiles.Acad Psychiatry.2009;33:27–30.
- ,,, et al.Personal digital assistants (PDAs): a review of their application in graduate medical education.Am J Med Qual.2005;20:262–267.
- ,,, et al.Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force.Acad Med.2007;82:1211–1219.
- ,,,,,.Surgeon volume and operative mortality in the United States.N Engl J Med.2003;349:2117–2127.
Copyright © 2011 Society of Hospital Medicine
Severe Sepsis
Severe sepsis and septic shock are associated with excess mortality when inappropriate initial antimicrobial therapy, defined as an antimicrobial regimen that lacks in vitro activity against the isolated organism(s) responsible for the infection, is administered.14 Unfortunately, bacterial resistance to antibiotics is increasing and creates a therapeutic challenge for clinicians when treating patients with serious infections, such as severe sepsis. Increasing rates of bacterial resistance leads many clinicians to empirically treat critically ill patients with broad‐spectrum antibiotics, which can perpetuate the cycle of increasing resistance.5, 6 Conversely, inappropriate initial antimicrobial therapy can lead to treatment failures and adverse patient outcomes.7 Individuals with severe sepsis appear to be at particularly high risk of excess mortality when inappropriate initial antimicrobial therapy is administered.8, 9
The most recent Surviving Sepsis Guidelines recommend empiric combination therapy targeting Gram‐negative bacteria, particularly for patients with known or suspected Pseudomonas infections, as a means to decrease the likelihood of administering inappropriate initial antimicrobial therapy.10 However, the selection of an antimicrobial regimen that is active against the causative pathogen(s) is problematic, as the treating physician usually does not know the susceptibilities of the pathogen(s) for the selected empiric antibiotics. Therefore, we performed a study with the main goal of determining whether resistance to the initially prescribed antimicrobial regimen was associated with clinical outcome in patients with severe sepsis attributed to Gram‐negative bacteremia.
Materials and Methods
Study Location and Patients
This study was conducted at a university‐affiliated, urban teaching hospital: Barnes‐Jewish Hospital (1200 beds). During a 6‐year period (January 2002 to December 2007), all hospitalized patients with a positive blood culture for Gram‐negative bacteria, with antimicrobial susceptibility testing performed for the blood isolate(s), were eligible for this investigation. This study was approved by the Washington University School of Medicine Human Studies Committee.
Study Design and Data Collection
A retrospective cohort study design was employed. Two investigators (J.A.D., R.M.R.) identified potential study patients by the presence of a positive blood culture for Pseudomonas aeruginosa, Acinetobacter species, or Enterobacteriaceae (Escherichia coli, Klebsiella species, Enterobacter species) combined with primary or secondary International Classification of Diseases (ICD‐9‐CM) codes indicative of acute organ dysfunction, at least two criteria from the systemic inflammatory response syndrome (SIRS),10 and initial antibiotic treatment with either cefepime, piperacillin‐tazobactam, or a carbapenem (imipenem or meropenem). These antimicrobials represent the primary agents employed for the treatment of Gram‐negative infections at Barnes‐Jewish Hospital during the study period, and had to be administered within 12 hours of having the subsequently positive blood cultures drawn. Based on the initial study database construction, 3 investigators (E.C.W., J.K., M.P.) merged patient‐specific data from the automated hospital medical records, microbiology database, and pharmacy database of Barnes‐Jewish Hospital to complete the clinical database under the auspices of the definitions described below.
The baseline characteristics collected by the study investigators included: age, gender, race, the presence of congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, chronic liver disease, underlying malignancy, and end‐stage renal disease requiring renal replacement therapy. All cause hospital mortality was evaluated as the primary outcome variable. Secondary outcomes included acquired organ dysfunction and hospital length of stay. The Acute Physiology and Chronic Health Evaluation (APACHE) II11 and Charlson co‐morbidity scores were also calculated during the 24 hours after the positive blood cultures were drawn. This was done because we included patients with community‐acquired infections who only had clinical data available after blood cultures were drawn.
Definitions
All definitions were selected prospectively as part of the original study design. Cases of Gram‐negative bacteremia were classified into mutually exclusive groups comprised of either community‐acquired or healthcare‐associated infection. Patients with healthcare‐associated bacteremia were categorized as community‐onset or hospital‐onset, as previously described.12 In brief, patients with healthcare‐associated community‐onset bacteremia had the positive culture obtained within the first 48 hours of hospital admission in combination with one or more of the following risk factors: (1) residence in a nursing home, rehabilitation hospital, or other long‐term nursing facility; (2) previous hospitalization within the immediately preceding 12 months; (3) receiving outpatient hemodialysis, peritoneal dialysis, wound care, or infusion therapy necessitating regular visits to a hospital‐based clinic; and (4) having an immune‐compromised state. Patients were classified as having healthcare‐associated hospital‐onset bacteremia when the culture was obtained 48 hours or more after admission. Community‐acquired bacteremia occurred in patients without healthcare risk factors and a positive blood culture within the first 48 hours of admission. Prior antibiotic exposure was defined as having occurred within the previous 30 days from the onset of severe sepsis.
To be included in the analysis, patients had to meet criteria for severe sepsis based on discharge ICD‐9‐CM codes for acute organ dysfunction, as previously described.13 The organs of interest included the heart, lungs, kidneys, bone marrow (hematologic), brain, and liver. Patients were classified as having septic shock if vasopressors (norepinephrine, dopamine, epinephrine, phenylephrine, or vasopressin) were initiated within 24 hours of the blood culture collection date and time. Empiric antimicrobial treatment was classified as being appropriate if the initially prescribed antibiotic regimen was active against the identified pathogen(s) based on in vitro susceptibility testing and administered within 12 hours following blood culture collection. Appropriate antimicrobial treatment also had to be prescribed for at least 24 hours. However, the total duration of antimicrobial therapy was at the discretion of the treating physicians. The Charlson co‐morbidity score was calculated using ICD‐9‐CM codes abstracted from the index hospitalization employing MS‐DRG Grouper version 26.
Antimicrobial Monitoring
From January 2002 through the present, Barnes‐Jewish Hospital utilized an antibiotic control program to help guide antimicrobial therapy. During this time, the use of cefepime and gentamicin was unrestricted. However, initiation of intravenous ciprofloxacin, imipenem/cilastatin, meropenem, or piperacillin/tazobactam was restricted and required preauthorization from either a clinical pharmacist or infectious diseases physician. Each intensive care unit (ICU) had a clinical pharmacist who reviewed all antibiotic orders to insure that dosing and interval of antibiotic administration was adequate for individual patients based on body size, renal function, and the resuscitation status of the patient. After daytime hours, the on‐call clinical pharmacist reviewed and approved the antibiotic orders. The initial antibiotic dosages for the antibiotics employed for the treatment of Gram‐negative infections at Barnes‐Jewish Hospital were as follows: cefepime, 1 to 2 grams every eight hours; pipercillin‐tazobactam, 4.5 grams every six hours; imipenem, 0.5 grams every six hours; meropenem, 1 gram every eight hours; ciprofloxacin, 400 mg every eight hours; gentamicin, 5 mg/kg once daily.
Starting in June 2005, a sepsis order set was implemented in the emergency department, general medical wards, and the intensive care units with the intent of standardizing empiric antibiotic selection for patients with sepsis based on the infection type (ie, community‐acquired pneumonia, healthcare‐associated pneumonia, intra‐abdominal infection, etc) and the hospital's antibiogram.14, 15 However, antimicrobial selection, dosing, and de‐escalation of therapy were still optimized by clinical pharmacists in these clinical areas.
Antimicrobial Susceptibility Testing
The microbiology laboratory performed antimicrobial susceptibility testing of the Gram‐negative blood isolates using the disk diffusion method according to guidelines and breakpoints established by the Clinical Laboratory and Standards Institute (CLSI) and published during the inclusive years of the study.16, 17 Zone diameters obtained by disk diffusion testing were converted to minimum inhibitory concentrations (MICs in mg/L) by linear regression analysis for each antimicrobial agent using the BIOMIC V3 antimicrobial susceptibility system (Giles Scientific, Inc., Santa Barbara, CA). Linear regression algorithms contained in the software of this system were determined by comparative studies correlating microbroth dilution‐determined MIC values with zone sizes obtained by disk diffusion testing.18
Data Analysis
Continuous variables were reported as mean the standard deviation, or median and quartiles. The Student's t test was used when comparing normally distributed data, and the MannWhitney U test was employed to analyze nonnormally distributed data. Categorical data were expressed as frequency distributions and the Chi‐squared test was used to determine if differences existed between groups. We performed multiple logistic regression analysis to identify clinical risk factors that were associated with hospital mortality (SPSS, Inc., Chicago, IL). All risk factors from Table 1, as well as the individual pathogens examined, were included in the corresponding multivariable analysis with the exception of acquired organ dysfunction (considered a secondary outcome). All tests were two‐tailed, and a P value <0.05 was determined to represent statistical significance.
| Variable | Hospital Survivors (n = 302) | Hospital Nonsurvivors (n = 233) | P value |
|---|---|---|---|
| |||
| Age, years | 57.9 16.2 | 60.3 15.8 | 0.091 |
| Male | 156 (51.7) | 132 (56.7) | 0.250 |
| Infection onset source | |||
| Community‐acquired | 31 (10.3) | 15 (6.4) | 0.005 |
| Healthcare‐associated community‐onset | 119 (39.4) | 68 (29.2) | |
| Healthcare‐associated hospital‐onset | 152 (50.3) | 150 (64.4) | |
| Underlying co‐morbidities | |||
| CHF | 43 (14.2) | 53 (22.7) | 0.011 |
| COPD | 42 (13.9) | 56 (24.0) | 0.003 |
| Chronic kidney disease | 31 (10.3) | 41 (17.6) | 0.014 |
| Liver disease | 34 (11.3) | 31 (13.3) | 0.473 |
| Active malignancy | 100 (33.1) | 83 (35.6) | 0.544 |
| Diabetes | 68 (22.5) | 50 (21.5) | 0.770 |
| Charlson co‐morbidity score | 4.5 3.5 | 5.2 3.9 | 0.041 |
| APACHE II score | 21.8 6.1 | 27.1 6.2 | <0.001 |
| ICU admission | 221 (73.2) | 216 (92.7) | <0.001 |
| Vasopressors | 137 (45.4) | 197 (84.5) | <0.001 |
| Mechanical ventilation | 124 (41.1) | 183 (78.5) | <0.001 |
| Drotrecogin alfa (activated) | 6 (2.0) | 21 (9.0) | <0.001 |
| Dysfunctional acquired organ systems | |||
| Cardiovascular | 149 (49.3) | 204 (87.6) | <0.001 |
| Respiratory | 141 (46.7) | 202 (86.7) | <0.001 |
| Renal | 145 (48.0) | 136 (58.4) | 0.017 |
| Hepatic | 13 (4.3) | 27 (11.6) | 0.001 |
| Hematologic | 103 (34.1) | 63 (27.0) | 0.080 |
| Neurologic | 11 (3.6) | 19 (8.2) | 0.024 |
| 2 Dysfunctional acquired organ systems | 164 (54.3) | 213 (91.4) | <0.001 |
| Source of bloodstream infection | |||
| Lungs | 95 (31.5) | 127 (54.5) | <0.001 |
| Urinary tract | 92 (30.5) | 45 (19.3) | |
| Central venous catheter | 30 (9.9) | 16 (6.9) | |
| Intra‐abdominal | 63 (20.9) | 33 (14.2) | |
| Unknown | 22 (7.3) | 12 (5.2) | |
| Prior antibiotics* | 103 (34.1) | 110 (47.2) | 0.002 |
Results
Patient Characteristics
Included in the study were 535 consecutive patients with severe sepsis attributed to Pseudomonas aeruginosa, Acinetobacter species, or Enterobacteriaceae bacteremia, of whom 233 (43.6%) died during their hospitalization. The mean age was 58.9 16.0 years (range, 18 to 96 years) with 288 (53.8%) males and 247 (46.2%) females. The infection sources included community‐acquired (n = 46, 8.6%), healthcare‐associated community‐onset (n = 187, 35.0%), and healthcare‐associated hospital‐onset (n = 302, 56.4%). Hospital nonsurvivors were statistically more likely to have a healthcare‐associated hospital‐onset infection, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, ICU admission, need for mechanical ventilation and/or vasopressors, administration of drotrecogin alfa (activated), prior antibiotic administration, the lungs as the source of infection, acquired dysfunction of the cardiovascular, respiratory, renal, hepatic, and neurologic organ systems, and greater APACHE II and Charlson co‐morbidity scores compared to hospital survivors (Table 1). Hospital nonsurvivors were also statistically less likely to have a healthcare‐associated community‐onset infection and a urinary source of infection compared to hospital survivors (Table 1).
Microbiology
Among the 547 Gram‐negative bacteria isolated from blood, the most common were Enterobacteriaceae (Escherichia coli, Klebsiella species, Enterobacter species) (70.2%) followed by Pseudomonas aeruginosa (20.8%) and Acinetobacter species (9.0%) (Table 2). Nine patients had two different Enterobacteriaceae species isolated from their blood cultures, and three patients had an Enterobacteriaceae species and Pseudomonas aeruginosa isolated from their blood cultures. Hospital nonsurvivors were statistically more likely to be infected with Pseudomonas aeruginosa and less likely to be infected with Enterobacteriaceae. The pathogen‐specific hospital mortality rate was significantly greater for Pseudomonas aeruginosa and Acinetobacter species compared to Enterobacteriaceae (P < 0.001 and P = 0.008, respectively).
| Bacteria | Hospital Survivors (n = 302) | Hospital Nonsurvivors (n = 233) | P value* | Percent Resistant | Pathogen‐ Specific Mortality Rate |
|---|---|---|---|---|---|
| |||||
| Enterobacteriaceae | 241 (79.8) | 143 (61.4) | <0.001 | 9.1 | 37.2 |
| Pseudomonas aeruginosa | 47 (15.6) | 67 (28.8) | <0.001 | 16.7 | 58.8 |
| Acinetobacter species | 22 (7.3) | 27 (11.6) | 0.087 | 71.4 | 55.1 |
Antimicrobial Treatment and Resistance
Among the study patients, 358 (66.9%) received cefepime, 102 (19.1%) received piperacillin‐tazobactam, and 75 (14.0%) received a carbapenem (meropenem or imipenem) as their initial antibiotic treatment. There were 169 (31.6%) patients who received initial combination therapy with either an aminoglycoside (n = 99, 58.6%) or ciprofloxacin (n = 70, 41.4%). Eighty‐two (15.3%) patients were infected with a pathogen that was resistant to the initial antibiotic treatment regimen [cefepime (n = 41; 50.0%), piperacillin‐tazobactam (n = 25; 30.5%), or imipenem/meropenem (n = 16; 19.5%), plus either an aminoglycoside or ciprofloxacin (n = 28; 34.1%)], and were classified as receiving inappropriate initial antibiotic therapy. Among the 453 (84.7%) patients infected with a pathogen that was susceptible to the initial antibiotic regimen, there was no relationship identified between minimum inhibitory concentration values and hospital mortality.
Patients infected with a pathogen resistant to the initial antibiotic regimen had significantly greater risk of hospital mortality (63.4% vs 40.0%; P < 0.001) (Figure 1). For the 82 individuals infected with a pathogen that was resistant to the initial antibiotic regimen, no difference in hospital mortality was observed among those prescribed initial combination treatment with an aminoglycoside (n = 17) (64.7% vs 61.1%; P = 0.790) or ciprofloxacin (n = 11) (72.7% vs 61.1%; P = 0.733) compared to monotherapy (n = 54). Similarly, among the patients infected with a pathogen that was susceptible to the initial antibiotic regimen, there was no difference in hospital mortality among those whose bloodstream isolate was only susceptible to the prescribed aminoglycoside (n = 12) compared to patients with isolates that were susceptible to the prescribed beta‐lactam antibiotic (n = 441) (41.7% vs 39.9%; P = 0.902).
Logistic regression analysis identified infection with a pathogen resistant to the initial antibiotic regimen [adjusted odds ratio (AOR), 2.28; 95% confidence interval (CI), 1.69‐3.08; P = 0.006], increasing APACHE II scores (1‐point increments) (AOR, 1.13; 95% CI, 1.10‐1.15; P < 0.001), the need for vasopressors (AOR, 2.57; 95% CI, 2.15‐3.53; P < 0.001), the need for mechanical ventilation (AOR, 2.54; 95% CI, 2.19‐3.47; P < 0.001), healthcare‐associated hospital‐onset infection (AOR, 1.67; 95% CI, 1.32‐2.10; P =0.027), and infection with Pseudomonas aeruginosa (AOR, 2.21; 95% CI, 1.74‐2.86; P =0.002) as independent risk factors for hospital mortality (Hosmer‐Lemeshow goodness‐of‐fit test = 0.305). The model explained between 29.7% (Cox and Snell R square) and 39.8% (Nagelkerke R squared) of the variance in hospital mortality, and correctly classified 75.3% of cases.
Secondary Outcomes
Two or more acquired organ system derangements occurred significantly more often among patients with a pathogen resistant to the initial antibiotic regimen compared to those infected with susceptible isolates (84.1% vs 68.0%; P = 0.003). Hospital length of stay was significantly longer for patients infected with a pathogen resistant to the initial antibiotic regimen compared to those infected with susceptible isolates [39.9 50.6 days (median 27 days; quartiles 12 days and 45.5 days) vs 21.6 22.0 days (median 15 days; quartiles 7 days and 30 days); P < 0.001].
Discussion
Our study demonstrated that hospital nonsurvivors with severe sepsis attributed to Gram‐negative bacteremia had significantly greater rates of resistance to their initially prescribed antibiotic regimen compared to hospital survivors. This observation was confirmed in a multivariate analysis controlling for severity of illness and other potential confounding variables. Additionally, acquired organ system derangements and hospital length of stay were greater for patients infected with Gram‐negative pathogens resistant to the empiric antibiotic regimen. We also observed no survival advantage with the use of combination antimicrobial therapy for the subgroup of patients whose pathogens were resistant to the initially prescribed antibiotic regimen. Lastly, no difference in mortality was observed for patients with bacterial isolates that were susceptible only to the prescribed aminoglycoside compared to those with isolates susceptible to the prescribed beta‐lactam antibiotic.
Several previous investigators have linked antibiotic resistance and outcome in patients with serious infections attributed to Gram‐negative bacteria. Tam et al. examined 34 patients with Pseudomonas aeruginosa bacteremia having elevated MICs to piperacillin‐tazobactam (32 g/mL) that were reported as susceptible.19 In seven of these cases, piperacillin‐tazobactam was prescribed empirically, whereas other agents directed against Gram‐negative bacteria were employed in the other patients (carbapenems, aminoglycosides). Thirty‐day mortality was significantly greater for the patients treated with piperacillin‐tazobactam (85.7% vs 22.2%; P = 0.004), and a multivariate analysis found treatment with piperacillin‐tazobactam to be independently associated with 30‐day mortality. Similarly, Bhat et al. examined 204 episodes of bacteremia caused by Gram‐negative bacteria for which patients received cefepime.20 Patients infected with a Gram‐negative bacteria having an MIC to cefepime greater than, or equal to, 8 g/mL had a significantly greater 28‐day mortality compared to patients infected with isolates having an MIC to cefepime that was less than 8 g/mL (54.8% vs 24.1%; P = 0.001).
Our findings are consistent with earlier studies of patients with serious Gram‐negative infections including bacteremia and nosocomial pneumonia. Micek et al. showed that patients with Pseudomonas aeruginosa bacteremia who received inappropriate initial antimicrobial therapy had a greater risk of hospital mortality compared to patients initially treated with an antimicrobial regimen having activity for the Pseudomonas isolate based on in vitro susceptibility testing.21 Similarly, Trouillet et al.,22 Beardsley et al.,23 and Heyland et al.24 found that combination antimicrobial regimens directed against Gram‐negative bacteria in patients with nosocomial pneumonia were more likely to be appropriate based on the antimicrobial susceptibility patterns of the organisms compared to monotherapy. In a more recent study, Micek et al. demonstrated that combination antimicrobial therapy directed against severe sepsis attributed to Gram‐negative bacteria was associated with improved outcomes compared to monotherapy, especially when the combination agent was an aminoglycoside.25 However, empiric combination therapy that included an aminoglycoside was also associated with increased nephrotoxicity which makes the empiric use of aminoglycosides in all patients with suspected Gram‐negative severe sepsis problematic.25, 26 Nevertheless, the use of combination therapy represents a potential strategy to maximize the administration of appropriate treatment for serious Gram‐negative bacterial infections.
Rapid assessment of antimicrobial susceptibility is another strategy that offers the possibility of identifying the resistance pattern of Gram‐negative pathogens quickly in order to provide more appropriate treatment. Bouza et al. found that use of a rapid E‐test on the respiratory specimens of patients with ventilator‐associated pneumonia was associated with fewer days of fever, fewer days of antibiotic administration until resolution of the episode of ventilator‐associated pneumonia, decreased antibiotic consumption, less Clostridium difficile‐associated diarrhea, lower costs of antimicrobial agents, and fewer days receiving mechanical ventilation.27 Other methods for the rapid identification of resistant bacteria include real‐time polymerase chain reaction assays based on hybridization probes to identify specific resistance mechanisms in bacteria.28 Application of such methods for identification of broad categories of resistance mechanisms in Gram‐negative bacteria offer the possibility of tailoring initial antimicrobial regimens in order to provide appropriate therapy in a more timely manner.
Our study has several important limitations that should be noted. First, the study was performed at a single center and the results may not be generalizable to other institutions. However, the findings from other investigators corroborate the importance of antimicrobial resistance as a predictor of outcome for patients with serious Gram‐negative infections.19, 20 Additionally, a similar association has been observed in patients with methicillin‐resistant Staphylococcus aureus bacteremia, supporting the more general importance of antimicrobial resistance as an outcome predictor.29 Second, the method employed for determining MICs was a literature‐based linear regression method correlating disk diffusion diameters with broth dilution MIC determinations. Therefore, the lack of correlation we observed between MIC values and outcome for susceptible Gram‐negative isolates associated with severe sepsis requires further confirmation. Third, we only examined 3 antibiotics, or antibiotic classes, so our results may not be applicable to other agents. This also applies to doripenem, as we did not have that specific carbapenem available at the time this investigation took place.
Another important limitation of our study is the relatively small number of individuals infected with a pathogen that was resistant to the initial treatment regimen, or only susceptible to the aminoglycoside when combination therapy was prescribed. This limited our ability to detect meaningful associations in these subgroups of patients, to include whether or not combination therapy influenced their clinical outcome. Finally, we did not examine the exact timing of antibiotic therapy relative to the onset of severe sepsis. Instead we used a 12‐hour window from when subsequently positive blood cultures were drawn to the administration of initial antibiotic therapy. Other investigators have shown that delays in initial appropriate therapy of more than one hour for patients with septic shock increases the risk of death.9, 30 Failure to include the exact timing of therapy could have resulted in a final multivariate model that includes prediction variables that would not otherwise have been incorporated.
In summary, we demonstrated that resistance to the initial antibiotic treatment regimen was associated with a greater risk of hospital mortality in patients with severe sepsis attributed to Gram‐negative bacteremia. These findings imply that more rapid assessment of antimicrobial susceptibility could result in improved prescription of antibiotics in order to maximize initial administration of appropriate therapy. Future studies are required to address whether rapid determination of antimicrobial susceptibility can result in more effective administration of appropriate therapy, and if this can result in improved patient outcomes.
- ,,,.Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.Chest.1999;115:462–474.
- ,,, et al.The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results.Crit Care Med.2003;31:2291–2301.
- ,,,,,.Impact of adequate empical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.Crit Care Med.2003;31:2742–2751.
- ,,,,,.Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.Am J Med.2003;115:529–535.
- ,.Antibiotic‐resistant bugs in the 21st century—a clinical super‐challenge.N Engl J Med.2009;360:439–443.
- ,,, et al.Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.Clin Infect Dis.2009;48:1–12.
- .Broad‐spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front.Clin Infect Dis.2008;47:S3–S13.
- ,,, et al.Bundled care for septic shock: an analysis of clinical trials.Crit Care Med.2010;38:668–678.
- ,,, et al.Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study.Am J Respir Crit Care Med.2009;180:861–866.
- ,,, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Crit Care Med.2008;36:296–327.
- ,,,.APACHE II: a severity of disease classification system.Crit Care Med.1985;13:818–829.
- ,,, et al.Invasive methicillin‐resistant Staphylococcus aureus infections in the United States.JAMA.2007;298:1763–1771.
- ,,,,,.Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.Crit Care Med.2001;29:1303–1310.
- ,,,,,.Hospital‐wide impact of a standardized order set for the management of bacteremic severe sepsis.Crit Care Med.2009;37:819–824.
- ,,, et al.Before‐after study of a standardized hospital order set for the management of septic shock.Crit Care Med.2007;34:2707–2713.
- National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. M100‐S12.Wayne, PA:National Committee for Clinical Laboratory Standards;2002.
- Clinical Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. M100‐S17.Wayne, PA:Clinical Laboratory Standards Institute;2007.
- ,,, et al.Evaluation of the BIOGRAM antimicrobial susceptibility test system.J Clin Microbiol.1985;22:793–798.
- ,,, et al.Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin‐tazobactam: implications on the appropriateness of the resistance breakpoint.Clin Infect Dis.2008;46:862–867.
- ,,, et al.Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by Gram‐negative organisms.Antimicrob Agents Chemother.2007;51:4390–4395.
- ,,,,,.Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.Antimicrob Agents Chemother.2005;49:1306–1311.
- ,,.Ventilator‐associated pneumonia caused by potentially drug‐resistant bacteria.Am J Respir Crit Care Med.1998;157:531–539.
- ,,,,,.Using local microbiologic data to develop institution‐specific guidelines for the treatment of hospital‐acquired pneumonia.Chest.2006;130:787–793.
- ,,, et al.Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator‐associated pneumonia.Crit Care Med.2008;36:737–744.
- ,,, et al.Empiric combination antibiotic therapy is associated with improved outcome in Gram‐negative sepsis: a retrospective analysis.Antimicrob Agents Chemother.2010;54:1742–1748.
- ,,, et al.Monotherapy versus beta‐lactam‐aminoglycoside combination treatment for Gram‐negative bacteremia: a prospective, observational study.Antimicrob Agents Chemother.1997;41:1127–1133.
- ,,, et al.Direct E‐test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator‐associated pneumonia.Clin Infect Dis.2007;44:382–387.
- ,,, et al.Rapid detection of CTX‐M‐producing Enterobacteriaceae in urine samples.J Antimicrob Chemother.2009;64:986–989.
- ,,, et al.Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin‐resistant Staphylococcus aureus bacteremia.Clin Infect Dis.2008;46:193–200.
- ,,, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.Crit Care Med.2006;34:1589–1596.
Severe sepsis and septic shock are associated with excess mortality when inappropriate initial antimicrobial therapy, defined as an antimicrobial regimen that lacks in vitro activity against the isolated organism(s) responsible for the infection, is administered.14 Unfortunately, bacterial resistance to antibiotics is increasing and creates a therapeutic challenge for clinicians when treating patients with serious infections, such as severe sepsis. Increasing rates of bacterial resistance leads many clinicians to empirically treat critically ill patients with broad‐spectrum antibiotics, which can perpetuate the cycle of increasing resistance.5, 6 Conversely, inappropriate initial antimicrobial therapy can lead to treatment failures and adverse patient outcomes.7 Individuals with severe sepsis appear to be at particularly high risk of excess mortality when inappropriate initial antimicrobial therapy is administered.8, 9
The most recent Surviving Sepsis Guidelines recommend empiric combination therapy targeting Gram‐negative bacteria, particularly for patients with known or suspected Pseudomonas infections, as a means to decrease the likelihood of administering inappropriate initial antimicrobial therapy.10 However, the selection of an antimicrobial regimen that is active against the causative pathogen(s) is problematic, as the treating physician usually does not know the susceptibilities of the pathogen(s) for the selected empiric antibiotics. Therefore, we performed a study with the main goal of determining whether resistance to the initially prescribed antimicrobial regimen was associated with clinical outcome in patients with severe sepsis attributed to Gram‐negative bacteremia.
Materials and Methods
Study Location and Patients
This study was conducted at a university‐affiliated, urban teaching hospital: Barnes‐Jewish Hospital (1200 beds). During a 6‐year period (January 2002 to December 2007), all hospitalized patients with a positive blood culture for Gram‐negative bacteria, with antimicrobial susceptibility testing performed for the blood isolate(s), were eligible for this investigation. This study was approved by the Washington University School of Medicine Human Studies Committee.
Study Design and Data Collection
A retrospective cohort study design was employed. Two investigators (J.A.D., R.M.R.) identified potential study patients by the presence of a positive blood culture for Pseudomonas aeruginosa, Acinetobacter species, or Enterobacteriaceae (Escherichia coli, Klebsiella species, Enterobacter species) combined with primary or secondary International Classification of Diseases (ICD‐9‐CM) codes indicative of acute organ dysfunction, at least two criteria from the systemic inflammatory response syndrome (SIRS),10 and initial antibiotic treatment with either cefepime, piperacillin‐tazobactam, or a carbapenem (imipenem or meropenem). These antimicrobials represent the primary agents employed for the treatment of Gram‐negative infections at Barnes‐Jewish Hospital during the study period, and had to be administered within 12 hours of having the subsequently positive blood cultures drawn. Based on the initial study database construction, 3 investigators (E.C.W., J.K., M.P.) merged patient‐specific data from the automated hospital medical records, microbiology database, and pharmacy database of Barnes‐Jewish Hospital to complete the clinical database under the auspices of the definitions described below.
The baseline characteristics collected by the study investigators included: age, gender, race, the presence of congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, chronic liver disease, underlying malignancy, and end‐stage renal disease requiring renal replacement therapy. All cause hospital mortality was evaluated as the primary outcome variable. Secondary outcomes included acquired organ dysfunction and hospital length of stay. The Acute Physiology and Chronic Health Evaluation (APACHE) II11 and Charlson co‐morbidity scores were also calculated during the 24 hours after the positive blood cultures were drawn. This was done because we included patients with community‐acquired infections who only had clinical data available after blood cultures were drawn.
Definitions
All definitions were selected prospectively as part of the original study design. Cases of Gram‐negative bacteremia were classified into mutually exclusive groups comprised of either community‐acquired or healthcare‐associated infection. Patients with healthcare‐associated bacteremia were categorized as community‐onset or hospital‐onset, as previously described.12 In brief, patients with healthcare‐associated community‐onset bacteremia had the positive culture obtained within the first 48 hours of hospital admission in combination with one or more of the following risk factors: (1) residence in a nursing home, rehabilitation hospital, or other long‐term nursing facility; (2) previous hospitalization within the immediately preceding 12 months; (3) receiving outpatient hemodialysis, peritoneal dialysis, wound care, or infusion therapy necessitating regular visits to a hospital‐based clinic; and (4) having an immune‐compromised state. Patients were classified as having healthcare‐associated hospital‐onset bacteremia when the culture was obtained 48 hours or more after admission. Community‐acquired bacteremia occurred in patients without healthcare risk factors and a positive blood culture within the first 48 hours of admission. Prior antibiotic exposure was defined as having occurred within the previous 30 days from the onset of severe sepsis.
To be included in the analysis, patients had to meet criteria for severe sepsis based on discharge ICD‐9‐CM codes for acute organ dysfunction, as previously described.13 The organs of interest included the heart, lungs, kidneys, bone marrow (hematologic), brain, and liver. Patients were classified as having septic shock if vasopressors (norepinephrine, dopamine, epinephrine, phenylephrine, or vasopressin) were initiated within 24 hours of the blood culture collection date and time. Empiric antimicrobial treatment was classified as being appropriate if the initially prescribed antibiotic regimen was active against the identified pathogen(s) based on in vitro susceptibility testing and administered within 12 hours following blood culture collection. Appropriate antimicrobial treatment also had to be prescribed for at least 24 hours. However, the total duration of antimicrobial therapy was at the discretion of the treating physicians. The Charlson co‐morbidity score was calculated using ICD‐9‐CM codes abstracted from the index hospitalization employing MS‐DRG Grouper version 26.
Antimicrobial Monitoring
From January 2002 through the present, Barnes‐Jewish Hospital utilized an antibiotic control program to help guide antimicrobial therapy. During this time, the use of cefepime and gentamicin was unrestricted. However, initiation of intravenous ciprofloxacin, imipenem/cilastatin, meropenem, or piperacillin/tazobactam was restricted and required preauthorization from either a clinical pharmacist or infectious diseases physician. Each intensive care unit (ICU) had a clinical pharmacist who reviewed all antibiotic orders to insure that dosing and interval of antibiotic administration was adequate for individual patients based on body size, renal function, and the resuscitation status of the patient. After daytime hours, the on‐call clinical pharmacist reviewed and approved the antibiotic orders. The initial antibiotic dosages for the antibiotics employed for the treatment of Gram‐negative infections at Barnes‐Jewish Hospital were as follows: cefepime, 1 to 2 grams every eight hours; pipercillin‐tazobactam, 4.5 grams every six hours; imipenem, 0.5 grams every six hours; meropenem, 1 gram every eight hours; ciprofloxacin, 400 mg every eight hours; gentamicin, 5 mg/kg once daily.
Starting in June 2005, a sepsis order set was implemented in the emergency department, general medical wards, and the intensive care units with the intent of standardizing empiric antibiotic selection for patients with sepsis based on the infection type (ie, community‐acquired pneumonia, healthcare‐associated pneumonia, intra‐abdominal infection, etc) and the hospital's antibiogram.14, 15 However, antimicrobial selection, dosing, and de‐escalation of therapy were still optimized by clinical pharmacists in these clinical areas.
Antimicrobial Susceptibility Testing
The microbiology laboratory performed antimicrobial susceptibility testing of the Gram‐negative blood isolates using the disk diffusion method according to guidelines and breakpoints established by the Clinical Laboratory and Standards Institute (CLSI) and published during the inclusive years of the study.16, 17 Zone diameters obtained by disk diffusion testing were converted to minimum inhibitory concentrations (MICs in mg/L) by linear regression analysis for each antimicrobial agent using the BIOMIC V3 antimicrobial susceptibility system (Giles Scientific, Inc., Santa Barbara, CA). Linear regression algorithms contained in the software of this system were determined by comparative studies correlating microbroth dilution‐determined MIC values with zone sizes obtained by disk diffusion testing.18
Data Analysis
Continuous variables were reported as mean the standard deviation, or median and quartiles. The Student's t test was used when comparing normally distributed data, and the MannWhitney U test was employed to analyze nonnormally distributed data. Categorical data were expressed as frequency distributions and the Chi‐squared test was used to determine if differences existed between groups. We performed multiple logistic regression analysis to identify clinical risk factors that were associated with hospital mortality (SPSS, Inc., Chicago, IL). All risk factors from Table 1, as well as the individual pathogens examined, were included in the corresponding multivariable analysis with the exception of acquired organ dysfunction (considered a secondary outcome). All tests were two‐tailed, and a P value <0.05 was determined to represent statistical significance.
| Variable | Hospital Survivors (n = 302) | Hospital Nonsurvivors (n = 233) | P value |
|---|---|---|---|
| |||
| Age, years | 57.9 16.2 | 60.3 15.8 | 0.091 |
| Male | 156 (51.7) | 132 (56.7) | 0.250 |
| Infection onset source | |||
| Community‐acquired | 31 (10.3) | 15 (6.4) | 0.005 |
| Healthcare‐associated community‐onset | 119 (39.4) | 68 (29.2) | |
| Healthcare‐associated hospital‐onset | 152 (50.3) | 150 (64.4) | |
| Underlying co‐morbidities | |||
| CHF | 43 (14.2) | 53 (22.7) | 0.011 |
| COPD | 42 (13.9) | 56 (24.0) | 0.003 |
| Chronic kidney disease | 31 (10.3) | 41 (17.6) | 0.014 |
| Liver disease | 34 (11.3) | 31 (13.3) | 0.473 |
| Active malignancy | 100 (33.1) | 83 (35.6) | 0.544 |
| Diabetes | 68 (22.5) | 50 (21.5) | 0.770 |
| Charlson co‐morbidity score | 4.5 3.5 | 5.2 3.9 | 0.041 |
| APACHE II score | 21.8 6.1 | 27.1 6.2 | <0.001 |
| ICU admission | 221 (73.2) | 216 (92.7) | <0.001 |
| Vasopressors | 137 (45.4) | 197 (84.5) | <0.001 |
| Mechanical ventilation | 124 (41.1) | 183 (78.5) | <0.001 |
| Drotrecogin alfa (activated) | 6 (2.0) | 21 (9.0) | <0.001 |
| Dysfunctional acquired organ systems | |||
| Cardiovascular | 149 (49.3) | 204 (87.6) | <0.001 |
| Respiratory | 141 (46.7) | 202 (86.7) | <0.001 |
| Renal | 145 (48.0) | 136 (58.4) | 0.017 |
| Hepatic | 13 (4.3) | 27 (11.6) | 0.001 |
| Hematologic | 103 (34.1) | 63 (27.0) | 0.080 |
| Neurologic | 11 (3.6) | 19 (8.2) | 0.024 |
| 2 Dysfunctional acquired organ systems | 164 (54.3) | 213 (91.4) | <0.001 |
| Source of bloodstream infection | |||
| Lungs | 95 (31.5) | 127 (54.5) | <0.001 |
| Urinary tract | 92 (30.5) | 45 (19.3) | |
| Central venous catheter | 30 (9.9) | 16 (6.9) | |
| Intra‐abdominal | 63 (20.9) | 33 (14.2) | |
| Unknown | 22 (7.3) | 12 (5.2) | |
| Prior antibiotics* | 103 (34.1) | 110 (47.2) | 0.002 |
Results
Patient Characteristics
Included in the study were 535 consecutive patients with severe sepsis attributed to Pseudomonas aeruginosa, Acinetobacter species, or Enterobacteriaceae bacteremia, of whom 233 (43.6%) died during their hospitalization. The mean age was 58.9 16.0 years (range, 18 to 96 years) with 288 (53.8%) males and 247 (46.2%) females. The infection sources included community‐acquired (n = 46, 8.6%), healthcare‐associated community‐onset (n = 187, 35.0%), and healthcare‐associated hospital‐onset (n = 302, 56.4%). Hospital nonsurvivors were statistically more likely to have a healthcare‐associated hospital‐onset infection, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, ICU admission, need for mechanical ventilation and/or vasopressors, administration of drotrecogin alfa (activated), prior antibiotic administration, the lungs as the source of infection, acquired dysfunction of the cardiovascular, respiratory, renal, hepatic, and neurologic organ systems, and greater APACHE II and Charlson co‐morbidity scores compared to hospital survivors (Table 1). Hospital nonsurvivors were also statistically less likely to have a healthcare‐associated community‐onset infection and a urinary source of infection compared to hospital survivors (Table 1).
Microbiology
Among the 547 Gram‐negative bacteria isolated from blood, the most common were Enterobacteriaceae (Escherichia coli, Klebsiella species, Enterobacter species) (70.2%) followed by Pseudomonas aeruginosa (20.8%) and Acinetobacter species (9.0%) (Table 2). Nine patients had two different Enterobacteriaceae species isolated from their blood cultures, and three patients had an Enterobacteriaceae species and Pseudomonas aeruginosa isolated from their blood cultures. Hospital nonsurvivors were statistically more likely to be infected with Pseudomonas aeruginosa and less likely to be infected with Enterobacteriaceae. The pathogen‐specific hospital mortality rate was significantly greater for Pseudomonas aeruginosa and Acinetobacter species compared to Enterobacteriaceae (P < 0.001 and P = 0.008, respectively).
| Bacteria | Hospital Survivors (n = 302) | Hospital Nonsurvivors (n = 233) | P value* | Percent Resistant | Pathogen‐ Specific Mortality Rate |
|---|---|---|---|---|---|
| |||||
| Enterobacteriaceae | 241 (79.8) | 143 (61.4) | <0.001 | 9.1 | 37.2 |
| Pseudomonas aeruginosa | 47 (15.6) | 67 (28.8) | <0.001 | 16.7 | 58.8 |
| Acinetobacter species | 22 (7.3) | 27 (11.6) | 0.087 | 71.4 | 55.1 |
Antimicrobial Treatment and Resistance
Among the study patients, 358 (66.9%) received cefepime, 102 (19.1%) received piperacillin‐tazobactam, and 75 (14.0%) received a carbapenem (meropenem or imipenem) as their initial antibiotic treatment. There were 169 (31.6%) patients who received initial combination therapy with either an aminoglycoside (n = 99, 58.6%) or ciprofloxacin (n = 70, 41.4%). Eighty‐two (15.3%) patients were infected with a pathogen that was resistant to the initial antibiotic treatment regimen [cefepime (n = 41; 50.0%), piperacillin‐tazobactam (n = 25; 30.5%), or imipenem/meropenem (n = 16; 19.5%), plus either an aminoglycoside or ciprofloxacin (n = 28; 34.1%)], and were classified as receiving inappropriate initial antibiotic therapy. Among the 453 (84.7%) patients infected with a pathogen that was susceptible to the initial antibiotic regimen, there was no relationship identified between minimum inhibitory concentration values and hospital mortality.
Patients infected with a pathogen resistant to the initial antibiotic regimen had significantly greater risk of hospital mortality (63.4% vs 40.0%; P < 0.001) (Figure 1). For the 82 individuals infected with a pathogen that was resistant to the initial antibiotic regimen, no difference in hospital mortality was observed among those prescribed initial combination treatment with an aminoglycoside (n = 17) (64.7% vs 61.1%; P = 0.790) or ciprofloxacin (n = 11) (72.7% vs 61.1%; P = 0.733) compared to monotherapy (n = 54). Similarly, among the patients infected with a pathogen that was susceptible to the initial antibiotic regimen, there was no difference in hospital mortality among those whose bloodstream isolate was only susceptible to the prescribed aminoglycoside (n = 12) compared to patients with isolates that were susceptible to the prescribed beta‐lactam antibiotic (n = 441) (41.7% vs 39.9%; P = 0.902).
Logistic regression analysis identified infection with a pathogen resistant to the initial antibiotic regimen [adjusted odds ratio (AOR), 2.28; 95% confidence interval (CI), 1.69‐3.08; P = 0.006], increasing APACHE II scores (1‐point increments) (AOR, 1.13; 95% CI, 1.10‐1.15; P < 0.001), the need for vasopressors (AOR, 2.57; 95% CI, 2.15‐3.53; P < 0.001), the need for mechanical ventilation (AOR, 2.54; 95% CI, 2.19‐3.47; P < 0.001), healthcare‐associated hospital‐onset infection (AOR, 1.67; 95% CI, 1.32‐2.10; P =0.027), and infection with Pseudomonas aeruginosa (AOR, 2.21; 95% CI, 1.74‐2.86; P =0.002) as independent risk factors for hospital mortality (Hosmer‐Lemeshow goodness‐of‐fit test = 0.305). The model explained between 29.7% (Cox and Snell R square) and 39.8% (Nagelkerke R squared) of the variance in hospital mortality, and correctly classified 75.3% of cases.
Secondary Outcomes
Two or more acquired organ system derangements occurred significantly more often among patients with a pathogen resistant to the initial antibiotic regimen compared to those infected with susceptible isolates (84.1% vs 68.0%; P = 0.003). Hospital length of stay was significantly longer for patients infected with a pathogen resistant to the initial antibiotic regimen compared to those infected with susceptible isolates [39.9 50.6 days (median 27 days; quartiles 12 days and 45.5 days) vs 21.6 22.0 days (median 15 days; quartiles 7 days and 30 days); P < 0.001].
Discussion
Our study demonstrated that hospital nonsurvivors with severe sepsis attributed to Gram‐negative bacteremia had significantly greater rates of resistance to their initially prescribed antibiotic regimen compared to hospital survivors. This observation was confirmed in a multivariate analysis controlling for severity of illness and other potential confounding variables. Additionally, acquired organ system derangements and hospital length of stay were greater for patients infected with Gram‐negative pathogens resistant to the empiric antibiotic regimen. We also observed no survival advantage with the use of combination antimicrobial therapy for the subgroup of patients whose pathogens were resistant to the initially prescribed antibiotic regimen. Lastly, no difference in mortality was observed for patients with bacterial isolates that were susceptible only to the prescribed aminoglycoside compared to those with isolates susceptible to the prescribed beta‐lactam antibiotic.
Several previous investigators have linked antibiotic resistance and outcome in patients with serious infections attributed to Gram‐negative bacteria. Tam et al. examined 34 patients with Pseudomonas aeruginosa bacteremia having elevated MICs to piperacillin‐tazobactam (32 g/mL) that were reported as susceptible.19 In seven of these cases, piperacillin‐tazobactam was prescribed empirically, whereas other agents directed against Gram‐negative bacteria were employed in the other patients (carbapenems, aminoglycosides). Thirty‐day mortality was significantly greater for the patients treated with piperacillin‐tazobactam (85.7% vs 22.2%; P = 0.004), and a multivariate analysis found treatment with piperacillin‐tazobactam to be independently associated with 30‐day mortality. Similarly, Bhat et al. examined 204 episodes of bacteremia caused by Gram‐negative bacteria for which patients received cefepime.20 Patients infected with a Gram‐negative bacteria having an MIC to cefepime greater than, or equal to, 8 g/mL had a significantly greater 28‐day mortality compared to patients infected with isolates having an MIC to cefepime that was less than 8 g/mL (54.8% vs 24.1%; P = 0.001).
Our findings are consistent with earlier studies of patients with serious Gram‐negative infections including bacteremia and nosocomial pneumonia. Micek et al. showed that patients with Pseudomonas aeruginosa bacteremia who received inappropriate initial antimicrobial therapy had a greater risk of hospital mortality compared to patients initially treated with an antimicrobial regimen having activity for the Pseudomonas isolate based on in vitro susceptibility testing.21 Similarly, Trouillet et al.,22 Beardsley et al.,23 and Heyland et al.24 found that combination antimicrobial regimens directed against Gram‐negative bacteria in patients with nosocomial pneumonia were more likely to be appropriate based on the antimicrobial susceptibility patterns of the organisms compared to monotherapy. In a more recent study, Micek et al. demonstrated that combination antimicrobial therapy directed against severe sepsis attributed to Gram‐negative bacteria was associated with improved outcomes compared to monotherapy, especially when the combination agent was an aminoglycoside.25 However, empiric combination therapy that included an aminoglycoside was also associated with increased nephrotoxicity which makes the empiric use of aminoglycosides in all patients with suspected Gram‐negative severe sepsis problematic.25, 26 Nevertheless, the use of combination therapy represents a potential strategy to maximize the administration of appropriate treatment for serious Gram‐negative bacterial infections.
Rapid assessment of antimicrobial susceptibility is another strategy that offers the possibility of identifying the resistance pattern of Gram‐negative pathogens quickly in order to provide more appropriate treatment. Bouza et al. found that use of a rapid E‐test on the respiratory specimens of patients with ventilator‐associated pneumonia was associated with fewer days of fever, fewer days of antibiotic administration until resolution of the episode of ventilator‐associated pneumonia, decreased antibiotic consumption, less Clostridium difficile‐associated diarrhea, lower costs of antimicrobial agents, and fewer days receiving mechanical ventilation.27 Other methods for the rapid identification of resistant bacteria include real‐time polymerase chain reaction assays based on hybridization probes to identify specific resistance mechanisms in bacteria.28 Application of such methods for identification of broad categories of resistance mechanisms in Gram‐negative bacteria offer the possibility of tailoring initial antimicrobial regimens in order to provide appropriate therapy in a more timely manner.
Our study has several important limitations that should be noted. First, the study was performed at a single center and the results may not be generalizable to other institutions. However, the findings from other investigators corroborate the importance of antimicrobial resistance as a predictor of outcome for patients with serious Gram‐negative infections.19, 20 Additionally, a similar association has been observed in patients with methicillin‐resistant Staphylococcus aureus bacteremia, supporting the more general importance of antimicrobial resistance as an outcome predictor.29 Second, the method employed for determining MICs was a literature‐based linear regression method correlating disk diffusion diameters with broth dilution MIC determinations. Therefore, the lack of correlation we observed between MIC values and outcome for susceptible Gram‐negative isolates associated with severe sepsis requires further confirmation. Third, we only examined 3 antibiotics, or antibiotic classes, so our results may not be applicable to other agents. This also applies to doripenem, as we did not have that specific carbapenem available at the time this investigation took place.
Another important limitation of our study is the relatively small number of individuals infected with a pathogen that was resistant to the initial treatment regimen, or only susceptible to the aminoglycoside when combination therapy was prescribed. This limited our ability to detect meaningful associations in these subgroups of patients, to include whether or not combination therapy influenced their clinical outcome. Finally, we did not examine the exact timing of antibiotic therapy relative to the onset of severe sepsis. Instead we used a 12‐hour window from when subsequently positive blood cultures were drawn to the administration of initial antibiotic therapy. Other investigators have shown that delays in initial appropriate therapy of more than one hour for patients with septic shock increases the risk of death.9, 30 Failure to include the exact timing of therapy could have resulted in a final multivariate model that includes prediction variables that would not otherwise have been incorporated.
In summary, we demonstrated that resistance to the initial antibiotic treatment regimen was associated with a greater risk of hospital mortality in patients with severe sepsis attributed to Gram‐negative bacteremia. These findings imply that more rapid assessment of antimicrobial susceptibility could result in improved prescription of antibiotics in order to maximize initial administration of appropriate therapy. Future studies are required to address whether rapid determination of antimicrobial susceptibility can result in more effective administration of appropriate therapy, and if this can result in improved patient outcomes.
Severe sepsis and septic shock are associated with excess mortality when inappropriate initial antimicrobial therapy, defined as an antimicrobial regimen that lacks in vitro activity against the isolated organism(s) responsible for the infection, is administered.14 Unfortunately, bacterial resistance to antibiotics is increasing and creates a therapeutic challenge for clinicians when treating patients with serious infections, such as severe sepsis. Increasing rates of bacterial resistance leads many clinicians to empirically treat critically ill patients with broad‐spectrum antibiotics, which can perpetuate the cycle of increasing resistance.5, 6 Conversely, inappropriate initial antimicrobial therapy can lead to treatment failures and adverse patient outcomes.7 Individuals with severe sepsis appear to be at particularly high risk of excess mortality when inappropriate initial antimicrobial therapy is administered.8, 9
The most recent Surviving Sepsis Guidelines recommend empiric combination therapy targeting Gram‐negative bacteria, particularly for patients with known or suspected Pseudomonas infections, as a means to decrease the likelihood of administering inappropriate initial antimicrobial therapy.10 However, the selection of an antimicrobial regimen that is active against the causative pathogen(s) is problematic, as the treating physician usually does not know the susceptibilities of the pathogen(s) for the selected empiric antibiotics. Therefore, we performed a study with the main goal of determining whether resistance to the initially prescribed antimicrobial regimen was associated with clinical outcome in patients with severe sepsis attributed to Gram‐negative bacteremia.
Materials and Methods
Study Location and Patients
This study was conducted at a university‐affiliated, urban teaching hospital: Barnes‐Jewish Hospital (1200 beds). During a 6‐year period (January 2002 to December 2007), all hospitalized patients with a positive blood culture for Gram‐negative bacteria, with antimicrobial susceptibility testing performed for the blood isolate(s), were eligible for this investigation. This study was approved by the Washington University School of Medicine Human Studies Committee.
Study Design and Data Collection
A retrospective cohort study design was employed. Two investigators (J.A.D., R.M.R.) identified potential study patients by the presence of a positive blood culture for Pseudomonas aeruginosa, Acinetobacter species, or Enterobacteriaceae (Escherichia coli, Klebsiella species, Enterobacter species) combined with primary or secondary International Classification of Diseases (ICD‐9‐CM) codes indicative of acute organ dysfunction, at least two criteria from the systemic inflammatory response syndrome (SIRS),10 and initial antibiotic treatment with either cefepime, piperacillin‐tazobactam, or a carbapenem (imipenem or meropenem). These antimicrobials represent the primary agents employed for the treatment of Gram‐negative infections at Barnes‐Jewish Hospital during the study period, and had to be administered within 12 hours of having the subsequently positive blood cultures drawn. Based on the initial study database construction, 3 investigators (E.C.W., J.K., M.P.) merged patient‐specific data from the automated hospital medical records, microbiology database, and pharmacy database of Barnes‐Jewish Hospital to complete the clinical database under the auspices of the definitions described below.
The baseline characteristics collected by the study investigators included: age, gender, race, the presence of congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, chronic liver disease, underlying malignancy, and end‐stage renal disease requiring renal replacement therapy. All cause hospital mortality was evaluated as the primary outcome variable. Secondary outcomes included acquired organ dysfunction and hospital length of stay. The Acute Physiology and Chronic Health Evaluation (APACHE) II11 and Charlson co‐morbidity scores were also calculated during the 24 hours after the positive blood cultures were drawn. This was done because we included patients with community‐acquired infections who only had clinical data available after blood cultures were drawn.
Definitions
All definitions were selected prospectively as part of the original study design. Cases of Gram‐negative bacteremia were classified into mutually exclusive groups comprised of either community‐acquired or healthcare‐associated infection. Patients with healthcare‐associated bacteremia were categorized as community‐onset or hospital‐onset, as previously described.12 In brief, patients with healthcare‐associated community‐onset bacteremia had the positive culture obtained within the first 48 hours of hospital admission in combination with one or more of the following risk factors: (1) residence in a nursing home, rehabilitation hospital, or other long‐term nursing facility; (2) previous hospitalization within the immediately preceding 12 months; (3) receiving outpatient hemodialysis, peritoneal dialysis, wound care, or infusion therapy necessitating regular visits to a hospital‐based clinic; and (4) having an immune‐compromised state. Patients were classified as having healthcare‐associated hospital‐onset bacteremia when the culture was obtained 48 hours or more after admission. Community‐acquired bacteremia occurred in patients without healthcare risk factors and a positive blood culture within the first 48 hours of admission. Prior antibiotic exposure was defined as having occurred within the previous 30 days from the onset of severe sepsis.
To be included in the analysis, patients had to meet criteria for severe sepsis based on discharge ICD‐9‐CM codes for acute organ dysfunction, as previously described.13 The organs of interest included the heart, lungs, kidneys, bone marrow (hematologic), brain, and liver. Patients were classified as having septic shock if vasopressors (norepinephrine, dopamine, epinephrine, phenylephrine, or vasopressin) were initiated within 24 hours of the blood culture collection date and time. Empiric antimicrobial treatment was classified as being appropriate if the initially prescribed antibiotic regimen was active against the identified pathogen(s) based on in vitro susceptibility testing and administered within 12 hours following blood culture collection. Appropriate antimicrobial treatment also had to be prescribed for at least 24 hours. However, the total duration of antimicrobial therapy was at the discretion of the treating physicians. The Charlson co‐morbidity score was calculated using ICD‐9‐CM codes abstracted from the index hospitalization employing MS‐DRG Grouper version 26.
Antimicrobial Monitoring
From January 2002 through the present, Barnes‐Jewish Hospital utilized an antibiotic control program to help guide antimicrobial therapy. During this time, the use of cefepime and gentamicin was unrestricted. However, initiation of intravenous ciprofloxacin, imipenem/cilastatin, meropenem, or piperacillin/tazobactam was restricted and required preauthorization from either a clinical pharmacist or infectious diseases physician. Each intensive care unit (ICU) had a clinical pharmacist who reviewed all antibiotic orders to insure that dosing and interval of antibiotic administration was adequate for individual patients based on body size, renal function, and the resuscitation status of the patient. After daytime hours, the on‐call clinical pharmacist reviewed and approved the antibiotic orders. The initial antibiotic dosages for the antibiotics employed for the treatment of Gram‐negative infections at Barnes‐Jewish Hospital were as follows: cefepime, 1 to 2 grams every eight hours; pipercillin‐tazobactam, 4.5 grams every six hours; imipenem, 0.5 grams every six hours; meropenem, 1 gram every eight hours; ciprofloxacin, 400 mg every eight hours; gentamicin, 5 mg/kg once daily.
Starting in June 2005, a sepsis order set was implemented in the emergency department, general medical wards, and the intensive care units with the intent of standardizing empiric antibiotic selection for patients with sepsis based on the infection type (ie, community‐acquired pneumonia, healthcare‐associated pneumonia, intra‐abdominal infection, etc) and the hospital's antibiogram.14, 15 However, antimicrobial selection, dosing, and de‐escalation of therapy were still optimized by clinical pharmacists in these clinical areas.
Antimicrobial Susceptibility Testing
The microbiology laboratory performed antimicrobial susceptibility testing of the Gram‐negative blood isolates using the disk diffusion method according to guidelines and breakpoints established by the Clinical Laboratory and Standards Institute (CLSI) and published during the inclusive years of the study.16, 17 Zone diameters obtained by disk diffusion testing were converted to minimum inhibitory concentrations (MICs in mg/L) by linear regression analysis for each antimicrobial agent using the BIOMIC V3 antimicrobial susceptibility system (Giles Scientific, Inc., Santa Barbara, CA). Linear regression algorithms contained in the software of this system were determined by comparative studies correlating microbroth dilution‐determined MIC values with zone sizes obtained by disk diffusion testing.18
Data Analysis
Continuous variables were reported as mean the standard deviation, or median and quartiles. The Student's t test was used when comparing normally distributed data, and the MannWhitney U test was employed to analyze nonnormally distributed data. Categorical data were expressed as frequency distributions and the Chi‐squared test was used to determine if differences existed between groups. We performed multiple logistic regression analysis to identify clinical risk factors that were associated with hospital mortality (SPSS, Inc., Chicago, IL). All risk factors from Table 1, as well as the individual pathogens examined, were included in the corresponding multivariable analysis with the exception of acquired organ dysfunction (considered a secondary outcome). All tests were two‐tailed, and a P value <0.05 was determined to represent statistical significance.
| Variable | Hospital Survivors (n = 302) | Hospital Nonsurvivors (n = 233) | P value |
|---|---|---|---|
| |||
| Age, years | 57.9 16.2 | 60.3 15.8 | 0.091 |
| Male | 156 (51.7) | 132 (56.7) | 0.250 |
| Infection onset source | |||
| Community‐acquired | 31 (10.3) | 15 (6.4) | 0.005 |
| Healthcare‐associated community‐onset | 119 (39.4) | 68 (29.2) | |
| Healthcare‐associated hospital‐onset | 152 (50.3) | 150 (64.4) | |
| Underlying co‐morbidities | |||
| CHF | 43 (14.2) | 53 (22.7) | 0.011 |
| COPD | 42 (13.9) | 56 (24.0) | 0.003 |
| Chronic kidney disease | 31 (10.3) | 41 (17.6) | 0.014 |
| Liver disease | 34 (11.3) | 31 (13.3) | 0.473 |
| Active malignancy | 100 (33.1) | 83 (35.6) | 0.544 |
| Diabetes | 68 (22.5) | 50 (21.5) | 0.770 |
| Charlson co‐morbidity score | 4.5 3.5 | 5.2 3.9 | 0.041 |
| APACHE II score | 21.8 6.1 | 27.1 6.2 | <0.001 |
| ICU admission | 221 (73.2) | 216 (92.7) | <0.001 |
| Vasopressors | 137 (45.4) | 197 (84.5) | <0.001 |
| Mechanical ventilation | 124 (41.1) | 183 (78.5) | <0.001 |
| Drotrecogin alfa (activated) | 6 (2.0) | 21 (9.0) | <0.001 |
| Dysfunctional acquired organ systems | |||
| Cardiovascular | 149 (49.3) | 204 (87.6) | <0.001 |
| Respiratory | 141 (46.7) | 202 (86.7) | <0.001 |
| Renal | 145 (48.0) | 136 (58.4) | 0.017 |
| Hepatic | 13 (4.3) | 27 (11.6) | 0.001 |
| Hematologic | 103 (34.1) | 63 (27.0) | 0.080 |
| Neurologic | 11 (3.6) | 19 (8.2) | 0.024 |
| 2 Dysfunctional acquired organ systems | 164 (54.3) | 213 (91.4) | <0.001 |
| Source of bloodstream infection | |||
| Lungs | 95 (31.5) | 127 (54.5) | <0.001 |
| Urinary tract | 92 (30.5) | 45 (19.3) | |
| Central venous catheter | 30 (9.9) | 16 (6.9) | |
| Intra‐abdominal | 63 (20.9) | 33 (14.2) | |
| Unknown | 22 (7.3) | 12 (5.2) | |
| Prior antibiotics* | 103 (34.1) | 110 (47.2) | 0.002 |
Results
Patient Characteristics
Included in the study were 535 consecutive patients with severe sepsis attributed to Pseudomonas aeruginosa, Acinetobacter species, or Enterobacteriaceae bacteremia, of whom 233 (43.6%) died during their hospitalization. The mean age was 58.9 16.0 years (range, 18 to 96 years) with 288 (53.8%) males and 247 (46.2%) females. The infection sources included community‐acquired (n = 46, 8.6%), healthcare‐associated community‐onset (n = 187, 35.0%), and healthcare‐associated hospital‐onset (n = 302, 56.4%). Hospital nonsurvivors were statistically more likely to have a healthcare‐associated hospital‐onset infection, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, ICU admission, need for mechanical ventilation and/or vasopressors, administration of drotrecogin alfa (activated), prior antibiotic administration, the lungs as the source of infection, acquired dysfunction of the cardiovascular, respiratory, renal, hepatic, and neurologic organ systems, and greater APACHE II and Charlson co‐morbidity scores compared to hospital survivors (Table 1). Hospital nonsurvivors were also statistically less likely to have a healthcare‐associated community‐onset infection and a urinary source of infection compared to hospital survivors (Table 1).
Microbiology
Among the 547 Gram‐negative bacteria isolated from blood, the most common were Enterobacteriaceae (Escherichia coli, Klebsiella species, Enterobacter species) (70.2%) followed by Pseudomonas aeruginosa (20.8%) and Acinetobacter species (9.0%) (Table 2). Nine patients had two different Enterobacteriaceae species isolated from their blood cultures, and three patients had an Enterobacteriaceae species and Pseudomonas aeruginosa isolated from their blood cultures. Hospital nonsurvivors were statistically more likely to be infected with Pseudomonas aeruginosa and less likely to be infected with Enterobacteriaceae. The pathogen‐specific hospital mortality rate was significantly greater for Pseudomonas aeruginosa and Acinetobacter species compared to Enterobacteriaceae (P < 0.001 and P = 0.008, respectively).
| Bacteria | Hospital Survivors (n = 302) | Hospital Nonsurvivors (n = 233) | P value* | Percent Resistant | Pathogen‐ Specific Mortality Rate |
|---|---|---|---|---|---|
| |||||
| Enterobacteriaceae | 241 (79.8) | 143 (61.4) | <0.001 | 9.1 | 37.2 |
| Pseudomonas aeruginosa | 47 (15.6) | 67 (28.8) | <0.001 | 16.7 | 58.8 |
| Acinetobacter species | 22 (7.3) | 27 (11.6) | 0.087 | 71.4 | 55.1 |
Antimicrobial Treatment and Resistance
Among the study patients, 358 (66.9%) received cefepime, 102 (19.1%) received piperacillin‐tazobactam, and 75 (14.0%) received a carbapenem (meropenem or imipenem) as their initial antibiotic treatment. There were 169 (31.6%) patients who received initial combination therapy with either an aminoglycoside (n = 99, 58.6%) or ciprofloxacin (n = 70, 41.4%). Eighty‐two (15.3%) patients were infected with a pathogen that was resistant to the initial antibiotic treatment regimen [cefepime (n = 41; 50.0%), piperacillin‐tazobactam (n = 25; 30.5%), or imipenem/meropenem (n = 16; 19.5%), plus either an aminoglycoside or ciprofloxacin (n = 28; 34.1%)], and were classified as receiving inappropriate initial antibiotic therapy. Among the 453 (84.7%) patients infected with a pathogen that was susceptible to the initial antibiotic regimen, there was no relationship identified between minimum inhibitory concentration values and hospital mortality.
Patients infected with a pathogen resistant to the initial antibiotic regimen had significantly greater risk of hospital mortality (63.4% vs 40.0%; P < 0.001) (Figure 1). For the 82 individuals infected with a pathogen that was resistant to the initial antibiotic regimen, no difference in hospital mortality was observed among those prescribed initial combination treatment with an aminoglycoside (n = 17) (64.7% vs 61.1%; P = 0.790) or ciprofloxacin (n = 11) (72.7% vs 61.1%; P = 0.733) compared to monotherapy (n = 54). Similarly, among the patients infected with a pathogen that was susceptible to the initial antibiotic regimen, there was no difference in hospital mortality among those whose bloodstream isolate was only susceptible to the prescribed aminoglycoside (n = 12) compared to patients with isolates that were susceptible to the prescribed beta‐lactam antibiotic (n = 441) (41.7% vs 39.9%; P = 0.902).
Logistic regression analysis identified infection with a pathogen resistant to the initial antibiotic regimen [adjusted odds ratio (AOR), 2.28; 95% confidence interval (CI), 1.69‐3.08; P = 0.006], increasing APACHE II scores (1‐point increments) (AOR, 1.13; 95% CI, 1.10‐1.15; P < 0.001), the need for vasopressors (AOR, 2.57; 95% CI, 2.15‐3.53; P < 0.001), the need for mechanical ventilation (AOR, 2.54; 95% CI, 2.19‐3.47; P < 0.001), healthcare‐associated hospital‐onset infection (AOR, 1.67; 95% CI, 1.32‐2.10; P =0.027), and infection with Pseudomonas aeruginosa (AOR, 2.21; 95% CI, 1.74‐2.86; P =0.002) as independent risk factors for hospital mortality (Hosmer‐Lemeshow goodness‐of‐fit test = 0.305). The model explained between 29.7% (Cox and Snell R square) and 39.8% (Nagelkerke R squared) of the variance in hospital mortality, and correctly classified 75.3% of cases.
Secondary Outcomes
Two or more acquired organ system derangements occurred significantly more often among patients with a pathogen resistant to the initial antibiotic regimen compared to those infected with susceptible isolates (84.1% vs 68.0%; P = 0.003). Hospital length of stay was significantly longer for patients infected with a pathogen resistant to the initial antibiotic regimen compared to those infected with susceptible isolates [39.9 50.6 days (median 27 days; quartiles 12 days and 45.5 days) vs 21.6 22.0 days (median 15 days; quartiles 7 days and 30 days); P < 0.001].
Discussion
Our study demonstrated that hospital nonsurvivors with severe sepsis attributed to Gram‐negative bacteremia had significantly greater rates of resistance to their initially prescribed antibiotic regimen compared to hospital survivors. This observation was confirmed in a multivariate analysis controlling for severity of illness and other potential confounding variables. Additionally, acquired organ system derangements and hospital length of stay were greater for patients infected with Gram‐negative pathogens resistant to the empiric antibiotic regimen. We also observed no survival advantage with the use of combination antimicrobial therapy for the subgroup of patients whose pathogens were resistant to the initially prescribed antibiotic regimen. Lastly, no difference in mortality was observed for patients with bacterial isolates that were susceptible only to the prescribed aminoglycoside compared to those with isolates susceptible to the prescribed beta‐lactam antibiotic.
Several previous investigators have linked antibiotic resistance and outcome in patients with serious infections attributed to Gram‐negative bacteria. Tam et al. examined 34 patients with Pseudomonas aeruginosa bacteremia having elevated MICs to piperacillin‐tazobactam (32 g/mL) that were reported as susceptible.19 In seven of these cases, piperacillin‐tazobactam was prescribed empirically, whereas other agents directed against Gram‐negative bacteria were employed in the other patients (carbapenems, aminoglycosides). Thirty‐day mortality was significantly greater for the patients treated with piperacillin‐tazobactam (85.7% vs 22.2%; P = 0.004), and a multivariate analysis found treatment with piperacillin‐tazobactam to be independently associated with 30‐day mortality. Similarly, Bhat et al. examined 204 episodes of bacteremia caused by Gram‐negative bacteria for which patients received cefepime.20 Patients infected with a Gram‐negative bacteria having an MIC to cefepime greater than, or equal to, 8 g/mL had a significantly greater 28‐day mortality compared to patients infected with isolates having an MIC to cefepime that was less than 8 g/mL (54.8% vs 24.1%; P = 0.001).
Our findings are consistent with earlier studies of patients with serious Gram‐negative infections including bacteremia and nosocomial pneumonia. Micek et al. showed that patients with Pseudomonas aeruginosa bacteremia who received inappropriate initial antimicrobial therapy had a greater risk of hospital mortality compared to patients initially treated with an antimicrobial regimen having activity for the Pseudomonas isolate based on in vitro susceptibility testing.21 Similarly, Trouillet et al.,22 Beardsley et al.,23 and Heyland et al.24 found that combination antimicrobial regimens directed against Gram‐negative bacteria in patients with nosocomial pneumonia were more likely to be appropriate based on the antimicrobial susceptibility patterns of the organisms compared to monotherapy. In a more recent study, Micek et al. demonstrated that combination antimicrobial therapy directed against severe sepsis attributed to Gram‐negative bacteria was associated with improved outcomes compared to monotherapy, especially when the combination agent was an aminoglycoside.25 However, empiric combination therapy that included an aminoglycoside was also associated with increased nephrotoxicity which makes the empiric use of aminoglycosides in all patients with suspected Gram‐negative severe sepsis problematic.25, 26 Nevertheless, the use of combination therapy represents a potential strategy to maximize the administration of appropriate treatment for serious Gram‐negative bacterial infections.
Rapid assessment of antimicrobial susceptibility is another strategy that offers the possibility of identifying the resistance pattern of Gram‐negative pathogens quickly in order to provide more appropriate treatment. Bouza et al. found that use of a rapid E‐test on the respiratory specimens of patients with ventilator‐associated pneumonia was associated with fewer days of fever, fewer days of antibiotic administration until resolution of the episode of ventilator‐associated pneumonia, decreased antibiotic consumption, less Clostridium difficile‐associated diarrhea, lower costs of antimicrobial agents, and fewer days receiving mechanical ventilation.27 Other methods for the rapid identification of resistant bacteria include real‐time polymerase chain reaction assays based on hybridization probes to identify specific resistance mechanisms in bacteria.28 Application of such methods for identification of broad categories of resistance mechanisms in Gram‐negative bacteria offer the possibility of tailoring initial antimicrobial regimens in order to provide appropriate therapy in a more timely manner.
Our study has several important limitations that should be noted. First, the study was performed at a single center and the results may not be generalizable to other institutions. However, the findings from other investigators corroborate the importance of antimicrobial resistance as a predictor of outcome for patients with serious Gram‐negative infections.19, 20 Additionally, a similar association has been observed in patients with methicillin‐resistant Staphylococcus aureus bacteremia, supporting the more general importance of antimicrobial resistance as an outcome predictor.29 Second, the method employed for determining MICs was a literature‐based linear regression method correlating disk diffusion diameters with broth dilution MIC determinations. Therefore, the lack of correlation we observed between MIC values and outcome for susceptible Gram‐negative isolates associated with severe sepsis requires further confirmation. Third, we only examined 3 antibiotics, or antibiotic classes, so our results may not be applicable to other agents. This also applies to doripenem, as we did not have that specific carbapenem available at the time this investigation took place.
Another important limitation of our study is the relatively small number of individuals infected with a pathogen that was resistant to the initial treatment regimen, or only susceptible to the aminoglycoside when combination therapy was prescribed. This limited our ability to detect meaningful associations in these subgroups of patients, to include whether or not combination therapy influenced their clinical outcome. Finally, we did not examine the exact timing of antibiotic therapy relative to the onset of severe sepsis. Instead we used a 12‐hour window from when subsequently positive blood cultures were drawn to the administration of initial antibiotic therapy. Other investigators have shown that delays in initial appropriate therapy of more than one hour for patients with septic shock increases the risk of death.9, 30 Failure to include the exact timing of therapy could have resulted in a final multivariate model that includes prediction variables that would not otherwise have been incorporated.
In summary, we demonstrated that resistance to the initial antibiotic treatment regimen was associated with a greater risk of hospital mortality in patients with severe sepsis attributed to Gram‐negative bacteremia. These findings imply that more rapid assessment of antimicrobial susceptibility could result in improved prescription of antibiotics in order to maximize initial administration of appropriate therapy. Future studies are required to address whether rapid determination of antimicrobial susceptibility can result in more effective administration of appropriate therapy, and if this can result in improved patient outcomes.
- ,,,.Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.Chest.1999;115:462–474.
- ,,, et al.The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results.Crit Care Med.2003;31:2291–2301.
- ,,,,,.Impact of adequate empical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.Crit Care Med.2003;31:2742–2751.
- ,,,,,.Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.Am J Med.2003;115:529–535.
- ,.Antibiotic‐resistant bugs in the 21st century—a clinical super‐challenge.N Engl J Med.2009;360:439–443.
- ,,, et al.Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.Clin Infect Dis.2009;48:1–12.
- .Broad‐spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front.Clin Infect Dis.2008;47:S3–S13.
- ,,, et al.Bundled care for septic shock: an analysis of clinical trials.Crit Care Med.2010;38:668–678.
- ,,, et al.Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study.Am J Respir Crit Care Med.2009;180:861–866.
- ,,, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Crit Care Med.2008;36:296–327.
- ,,,.APACHE II: a severity of disease classification system.Crit Care Med.1985;13:818–829.
- ,,, et al.Invasive methicillin‐resistant Staphylococcus aureus infections in the United States.JAMA.2007;298:1763–1771.
- ,,,,,.Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.Crit Care Med.2001;29:1303–1310.
- ,,,,,.Hospital‐wide impact of a standardized order set for the management of bacteremic severe sepsis.Crit Care Med.2009;37:819–824.
- ,,, et al.Before‐after study of a standardized hospital order set for the management of septic shock.Crit Care Med.2007;34:2707–2713.
- National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. M100‐S12.Wayne, PA:National Committee for Clinical Laboratory Standards;2002.
- Clinical Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. M100‐S17.Wayne, PA:Clinical Laboratory Standards Institute;2007.
- ,,, et al.Evaluation of the BIOGRAM antimicrobial susceptibility test system.J Clin Microbiol.1985;22:793–798.
- ,,, et al.Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin‐tazobactam: implications on the appropriateness of the resistance breakpoint.Clin Infect Dis.2008;46:862–867.
- ,,, et al.Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by Gram‐negative organisms.Antimicrob Agents Chemother.2007;51:4390–4395.
- ,,,,,.Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.Antimicrob Agents Chemother.2005;49:1306–1311.
- ,,.Ventilator‐associated pneumonia caused by potentially drug‐resistant bacteria.Am J Respir Crit Care Med.1998;157:531–539.
- ,,,,,.Using local microbiologic data to develop institution‐specific guidelines for the treatment of hospital‐acquired pneumonia.Chest.2006;130:787–793.
- ,,, et al.Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator‐associated pneumonia.Crit Care Med.2008;36:737–744.
- ,,, et al.Empiric combination antibiotic therapy is associated with improved outcome in Gram‐negative sepsis: a retrospective analysis.Antimicrob Agents Chemother.2010;54:1742–1748.
- ,,, et al.Monotherapy versus beta‐lactam‐aminoglycoside combination treatment for Gram‐negative bacteremia: a prospective, observational study.Antimicrob Agents Chemother.1997;41:1127–1133.
- ,,, et al.Direct E‐test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator‐associated pneumonia.Clin Infect Dis.2007;44:382–387.
- ,,, et al.Rapid detection of CTX‐M‐producing Enterobacteriaceae in urine samples.J Antimicrob Chemother.2009;64:986–989.
- ,,, et al.Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin‐resistant Staphylococcus aureus bacteremia.Clin Infect Dis.2008;46:193–200.
- ,,, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.Crit Care Med.2006;34:1589–1596.
- ,,,.Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.Chest.1999;115:462–474.
- ,,, et al.The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results.Crit Care Med.2003;31:2291–2301.
- ,,,,,.Impact of adequate empical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.Crit Care Med.2003;31:2742–2751.
- ,,,,,.Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.Am J Med.2003;115:529–535.
- ,.Antibiotic‐resistant bugs in the 21st century—a clinical super‐challenge.N Engl J Med.2009;360:439–443.
- ,,, et al.Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.Clin Infect Dis.2009;48:1–12.
- .Broad‐spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front.Clin Infect Dis.2008;47:S3–S13.
- ,,, et al.Bundled care for septic shock: an analysis of clinical trials.Crit Care Med.2010;38:668–678.
- ,,, et al.Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study.Am J Respir Crit Care Med.2009;180:861–866.
- ,,, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Crit Care Med.2008;36:296–327.
- ,,,.APACHE II: a severity of disease classification system.Crit Care Med.1985;13:818–829.
- ,,, et al.Invasive methicillin‐resistant Staphylococcus aureus infections in the United States.JAMA.2007;298:1763–1771.
- ,,,,,.Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.Crit Care Med.2001;29:1303–1310.
- ,,,,,.Hospital‐wide impact of a standardized order set for the management of bacteremic severe sepsis.Crit Care Med.2009;37:819–824.
- ,,, et al.Before‐after study of a standardized hospital order set for the management of septic shock.Crit Care Med.2007;34:2707–2713.
- National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. M100‐S12.Wayne, PA:National Committee for Clinical Laboratory Standards;2002.
- Clinical Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. M100‐S17.Wayne, PA:Clinical Laboratory Standards Institute;2007.
- ,,, et al.Evaluation of the BIOGRAM antimicrobial susceptibility test system.J Clin Microbiol.1985;22:793–798.
- ,,, et al.Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin‐tazobactam: implications on the appropriateness of the resistance breakpoint.Clin Infect Dis.2008;46:862–867.
- ,,, et al.Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by Gram‐negative organisms.Antimicrob Agents Chemother.2007;51:4390–4395.
- ,,,,,.Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.Antimicrob Agents Chemother.2005;49:1306–1311.
- ,,.Ventilator‐associated pneumonia caused by potentially drug‐resistant bacteria.Am J Respir Crit Care Med.1998;157:531–539.
- ,,,,,.Using local microbiologic data to develop institution‐specific guidelines for the treatment of hospital‐acquired pneumonia.Chest.2006;130:787–793.
- ,,, et al.Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator‐associated pneumonia.Crit Care Med.2008;36:737–744.
- ,,, et al.Empiric combination antibiotic therapy is associated with improved outcome in Gram‐negative sepsis: a retrospective analysis.Antimicrob Agents Chemother.2010;54:1742–1748.
- ,,, et al.Monotherapy versus beta‐lactam‐aminoglycoside combination treatment for Gram‐negative bacteremia: a prospective, observational study.Antimicrob Agents Chemother.1997;41:1127–1133.
- ,,, et al.Direct E‐test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator‐associated pneumonia.Clin Infect Dis.2007;44:382–387.
- ,,, et al.Rapid detection of CTX‐M‐producing Enterobacteriaceae in urine samples.J Antimicrob Chemother.2009;64:986–989.
- ,,, et al.Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin‐resistant Staphylococcus aureus bacteremia.Clin Infect Dis.2008;46:193–200.
- ,,, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.Crit Care Med.2006;34:1589–1596.
Copyright © 2011 Society of Hospital Medicine
Hospitalists Recall 9/11
Flashbulb Memories are memories for the circumstances in which one first learned of a very surprising and consequential (or emotionally arousing) event. Hearing the news that President John Kennedy had been shot is the prototype case. Almost everyone can remember, with an almost perceptual clarity, where he was when he heard, what he was doing at the time, who told him, what was the immediate aftermath, how he felt about it, and also one or more totally idiosyncratic and often trivial concomitants.1
In personal terms, all Americans are connected by recollections of the experience. 97% can remember exactly where they were or what they were doing the moment they heard about the attacks. (Pew Research survey, September 5, 2002)
The classic flashbulb memories of our parents' generation, who were young adults in the 1960s, were the assassinations of Martin Luther King and President John Kennedy. In the same way, the 9/11 attacks seem destined to endure as our generation's flashbulb memory, with the Space Shuttle Challenger explosion a distant second for those of us on the far side of age 40. Few of us are likely to ever forget the grief, anger, and confusion of September 11, 2001 and the days that followed, and it seems appropriate 10 years later to remember those who died that day, and to reflect on the lessons we learnedor should have. As hospitalists, we are at least somewhat familiar with the tragic and senseless loss of life that day, as the terrorist attacks were in a sense a reflection, writ large, of the unexpected and inexplicable deaths we have all been a part of: the healthy young woman exsanguinating from DIC in the immediate postpartum period, the preschool teacher rapidly succumbing to pneumococcal meningitis, the young adult dying of acute leukemia or necrotizing fasciitis.
On September 11, 2001, one of us (B.J.H.) was 2 years out of residency and in private practice near San Francisco.
For most of us on the West coast, 9/11 began while we slept. By the time I had awoken, showered, and coffeed, both planes had already hit the towers, and I only found out in the course of routinely turning on the television for a minute before leaving for work. Sometimes we forget that in those first minutes and hours, the news was contradictory and confused. Television and Internet couldn't keep up with the facts. And then within minutes, the towers fell. My first thought was that I was seeing tens of thousands of people die. Nine years earlier I had worked in the building adjacent to the World Trade Center and I knew the swarms of commuters moving through every morning. That the casualties were so much fewer is still miraculous to me.
I did go to work that morning, to a hospital full of colleagues with identical shocked looks. That dayand for the fog of days afterwardevery television in every room was on, showing planes hitting the towers over and over, different cameras, different angles; long crowds of people walking home to New Jersey out of the smoke; the faces of doomed firefighters in the stairwell, taken by survivors as they came down and the rescuers went up. Several thousand miles away, it was impossible to believe that it was all real and happening. Who could have ever imagined such a thing? I cannot believe that 9/11 didn't transform every American, regardless of background. What landmark would be next? Who in their right mind would work in the Sears Tower or Empire State Building after 9/11? I obsessed about bombings of the Golden Gate Bridge: the deck collapsing, my car plunging into the bay. For 6 months, I changed my commute times to avoid backed‐up, rush‐hour traffic. The events of 9/11 changed my beliefs and how I looked at things around me that I had always trusted.
For the other of us (J.C.P.), the news came in a patient's room during rounds.
My patient and I watched in disbelief while, as a reporter talked about the tragedy of a passenger jet crashing into one of the twin towers moments before, the second attack occurred. We both immediately knew beyond any doubt that this was a terrorist attack, although that fact seemed to take longer to register with the reporter. The rest of that morning is a blur, though I do recall attempting to see patients and teach through a haze of disbelief and disquiet. I eventually made it to my office and sat down, only to have my officemate burst in breathlessly and say, They just bombed the Pentagon! The receipt of that factually altered piece of information caused me to wonder just how horrific the day would prove to be when it was all over, and convinced me that life in the U.S. would never again be the same. The unfolding story over the next several days held my attention as no other public event during my lifetime has, and my wife and I spent evenings glued to the television that week. A benefit concert with an all‐star lineup of pop musicians was organized and held within days of the attacks, and I remember watching Paul Simon perform Bridge Over Troubled Water and thinking that it would have been more honest, though probably too dark, if he had chosen American Tune instead:
And I don't know a soul who's not been battered
I don't know a friend who feels at ease
I don't know a dream that's not been shattered
Or driven to its knees
But it's all right, it's all right
We've lived so well so long .
In a real sense it is surprising, even shocking, that there has not been a major domestic terrorism attack during the intervening decade, particularly given our multicultural, open society, but for me as for many of us, the next occurrence is a matter of when and hownot if. I've flown countless times since, but still never go to or through an airport, particularly in major cities, without thinking about the possibility of a terror strike, and I never walk through my former home of Washington, D.C. without thoughts of what if?
What lessons should we take away from the 9/11 tragedy a decade later, and indeed from our work with our patients? Certainly that mass casualties and disaster preparedness are an unfortunate fact of life in the 21st century, and that hospitalists have a responsibility to engage with our institutions in preparing for these eventualities. Possibly that life is uncertain and, at best, goes by much more quickly than any of us could have imagined when we embarked on our medical training. In the end, that our lives are measured primarily not by the number of years we live, but by how we live them, and the lives that we touch along the way.
Once a year, we pause to remember the nearly 3000 individuals who lost their lives on 9/11. As hospitalists, we practice a profession that demands a great deal from us and encourages workaholism; perhaps the 10th anniversary of those heinous acts should make each of us, as we remember the lives touched most directly by the attacks on the World Trade Center, the Pentagon, and United Flight 93, also pause to consider our work‐life balance, and to ensure that we are reserving sufficient quality time for our families and friends, as well as for activities that renew and enrich us.
- ,.Flashbulb memories.Cognition.1977;5(1):73–99.
Flashbulb Memories are memories for the circumstances in which one first learned of a very surprising and consequential (or emotionally arousing) event. Hearing the news that President John Kennedy had been shot is the prototype case. Almost everyone can remember, with an almost perceptual clarity, where he was when he heard, what he was doing at the time, who told him, what was the immediate aftermath, how he felt about it, and also one or more totally idiosyncratic and often trivial concomitants.1
In personal terms, all Americans are connected by recollections of the experience. 97% can remember exactly where they were or what they were doing the moment they heard about the attacks. (Pew Research survey, September 5, 2002)
The classic flashbulb memories of our parents' generation, who were young adults in the 1960s, were the assassinations of Martin Luther King and President John Kennedy. In the same way, the 9/11 attacks seem destined to endure as our generation's flashbulb memory, with the Space Shuttle Challenger explosion a distant second for those of us on the far side of age 40. Few of us are likely to ever forget the grief, anger, and confusion of September 11, 2001 and the days that followed, and it seems appropriate 10 years later to remember those who died that day, and to reflect on the lessons we learnedor should have. As hospitalists, we are at least somewhat familiar with the tragic and senseless loss of life that day, as the terrorist attacks were in a sense a reflection, writ large, of the unexpected and inexplicable deaths we have all been a part of: the healthy young woman exsanguinating from DIC in the immediate postpartum period, the preschool teacher rapidly succumbing to pneumococcal meningitis, the young adult dying of acute leukemia or necrotizing fasciitis.
On September 11, 2001, one of us (B.J.H.) was 2 years out of residency and in private practice near San Francisco.
For most of us on the West coast, 9/11 began while we slept. By the time I had awoken, showered, and coffeed, both planes had already hit the towers, and I only found out in the course of routinely turning on the television for a minute before leaving for work. Sometimes we forget that in those first minutes and hours, the news was contradictory and confused. Television and Internet couldn't keep up with the facts. And then within minutes, the towers fell. My first thought was that I was seeing tens of thousands of people die. Nine years earlier I had worked in the building adjacent to the World Trade Center and I knew the swarms of commuters moving through every morning. That the casualties were so much fewer is still miraculous to me.
I did go to work that morning, to a hospital full of colleagues with identical shocked looks. That dayand for the fog of days afterwardevery television in every room was on, showing planes hitting the towers over and over, different cameras, different angles; long crowds of people walking home to New Jersey out of the smoke; the faces of doomed firefighters in the stairwell, taken by survivors as they came down and the rescuers went up. Several thousand miles away, it was impossible to believe that it was all real and happening. Who could have ever imagined such a thing? I cannot believe that 9/11 didn't transform every American, regardless of background. What landmark would be next? Who in their right mind would work in the Sears Tower or Empire State Building after 9/11? I obsessed about bombings of the Golden Gate Bridge: the deck collapsing, my car plunging into the bay. For 6 months, I changed my commute times to avoid backed‐up, rush‐hour traffic. The events of 9/11 changed my beliefs and how I looked at things around me that I had always trusted.
For the other of us (J.C.P.), the news came in a patient's room during rounds.
My patient and I watched in disbelief while, as a reporter talked about the tragedy of a passenger jet crashing into one of the twin towers moments before, the second attack occurred. We both immediately knew beyond any doubt that this was a terrorist attack, although that fact seemed to take longer to register with the reporter. The rest of that morning is a blur, though I do recall attempting to see patients and teach through a haze of disbelief and disquiet. I eventually made it to my office and sat down, only to have my officemate burst in breathlessly and say, They just bombed the Pentagon! The receipt of that factually altered piece of information caused me to wonder just how horrific the day would prove to be when it was all over, and convinced me that life in the U.S. would never again be the same. The unfolding story over the next several days held my attention as no other public event during my lifetime has, and my wife and I spent evenings glued to the television that week. A benefit concert with an all‐star lineup of pop musicians was organized and held within days of the attacks, and I remember watching Paul Simon perform Bridge Over Troubled Water and thinking that it would have been more honest, though probably too dark, if he had chosen American Tune instead:
And I don't know a soul who's not been battered
I don't know a friend who feels at ease
I don't know a dream that's not been shattered
Or driven to its knees
But it's all right, it's all right
We've lived so well so long .
In a real sense it is surprising, even shocking, that there has not been a major domestic terrorism attack during the intervening decade, particularly given our multicultural, open society, but for me as for many of us, the next occurrence is a matter of when and hownot if. I've flown countless times since, but still never go to or through an airport, particularly in major cities, without thinking about the possibility of a terror strike, and I never walk through my former home of Washington, D.C. without thoughts of what if?
What lessons should we take away from the 9/11 tragedy a decade later, and indeed from our work with our patients? Certainly that mass casualties and disaster preparedness are an unfortunate fact of life in the 21st century, and that hospitalists have a responsibility to engage with our institutions in preparing for these eventualities. Possibly that life is uncertain and, at best, goes by much more quickly than any of us could have imagined when we embarked on our medical training. In the end, that our lives are measured primarily not by the number of years we live, but by how we live them, and the lives that we touch along the way.
Once a year, we pause to remember the nearly 3000 individuals who lost their lives on 9/11. As hospitalists, we practice a profession that demands a great deal from us and encourages workaholism; perhaps the 10th anniversary of those heinous acts should make each of us, as we remember the lives touched most directly by the attacks on the World Trade Center, the Pentagon, and United Flight 93, also pause to consider our work‐life balance, and to ensure that we are reserving sufficient quality time for our families and friends, as well as for activities that renew and enrich us.
Flashbulb Memories are memories for the circumstances in which one first learned of a very surprising and consequential (or emotionally arousing) event. Hearing the news that President John Kennedy had been shot is the prototype case. Almost everyone can remember, with an almost perceptual clarity, where he was when he heard, what he was doing at the time, who told him, what was the immediate aftermath, how he felt about it, and also one or more totally idiosyncratic and often trivial concomitants.1
In personal terms, all Americans are connected by recollections of the experience. 97% can remember exactly where they were or what they were doing the moment they heard about the attacks. (Pew Research survey, September 5, 2002)
The classic flashbulb memories of our parents' generation, who were young adults in the 1960s, were the assassinations of Martin Luther King and President John Kennedy. In the same way, the 9/11 attacks seem destined to endure as our generation's flashbulb memory, with the Space Shuttle Challenger explosion a distant second for those of us on the far side of age 40. Few of us are likely to ever forget the grief, anger, and confusion of September 11, 2001 and the days that followed, and it seems appropriate 10 years later to remember those who died that day, and to reflect on the lessons we learnedor should have. As hospitalists, we are at least somewhat familiar with the tragic and senseless loss of life that day, as the terrorist attacks were in a sense a reflection, writ large, of the unexpected and inexplicable deaths we have all been a part of: the healthy young woman exsanguinating from DIC in the immediate postpartum period, the preschool teacher rapidly succumbing to pneumococcal meningitis, the young adult dying of acute leukemia or necrotizing fasciitis.
On September 11, 2001, one of us (B.J.H.) was 2 years out of residency and in private practice near San Francisco.
For most of us on the West coast, 9/11 began while we slept. By the time I had awoken, showered, and coffeed, both planes had already hit the towers, and I only found out in the course of routinely turning on the television for a minute before leaving for work. Sometimes we forget that in those first minutes and hours, the news was contradictory and confused. Television and Internet couldn't keep up with the facts. And then within minutes, the towers fell. My first thought was that I was seeing tens of thousands of people die. Nine years earlier I had worked in the building adjacent to the World Trade Center and I knew the swarms of commuters moving through every morning. That the casualties were so much fewer is still miraculous to me.
I did go to work that morning, to a hospital full of colleagues with identical shocked looks. That dayand for the fog of days afterwardevery television in every room was on, showing planes hitting the towers over and over, different cameras, different angles; long crowds of people walking home to New Jersey out of the smoke; the faces of doomed firefighters in the stairwell, taken by survivors as they came down and the rescuers went up. Several thousand miles away, it was impossible to believe that it was all real and happening. Who could have ever imagined such a thing? I cannot believe that 9/11 didn't transform every American, regardless of background. What landmark would be next? Who in their right mind would work in the Sears Tower or Empire State Building after 9/11? I obsessed about bombings of the Golden Gate Bridge: the deck collapsing, my car plunging into the bay. For 6 months, I changed my commute times to avoid backed‐up, rush‐hour traffic. The events of 9/11 changed my beliefs and how I looked at things around me that I had always trusted.
For the other of us (J.C.P.), the news came in a patient's room during rounds.
My patient and I watched in disbelief while, as a reporter talked about the tragedy of a passenger jet crashing into one of the twin towers moments before, the second attack occurred. We both immediately knew beyond any doubt that this was a terrorist attack, although that fact seemed to take longer to register with the reporter. The rest of that morning is a blur, though I do recall attempting to see patients and teach through a haze of disbelief and disquiet. I eventually made it to my office and sat down, only to have my officemate burst in breathlessly and say, They just bombed the Pentagon! The receipt of that factually altered piece of information caused me to wonder just how horrific the day would prove to be when it was all over, and convinced me that life in the U.S. would never again be the same. The unfolding story over the next several days held my attention as no other public event during my lifetime has, and my wife and I spent evenings glued to the television that week. A benefit concert with an all‐star lineup of pop musicians was organized and held within days of the attacks, and I remember watching Paul Simon perform Bridge Over Troubled Water and thinking that it would have been more honest, though probably too dark, if he had chosen American Tune instead:
And I don't know a soul who's not been battered
I don't know a friend who feels at ease
I don't know a dream that's not been shattered
Or driven to its knees
But it's all right, it's all right
We've lived so well so long .
In a real sense it is surprising, even shocking, that there has not been a major domestic terrorism attack during the intervening decade, particularly given our multicultural, open society, but for me as for many of us, the next occurrence is a matter of when and hownot if. I've flown countless times since, but still never go to or through an airport, particularly in major cities, without thinking about the possibility of a terror strike, and I never walk through my former home of Washington, D.C. without thoughts of what if?
What lessons should we take away from the 9/11 tragedy a decade later, and indeed from our work with our patients? Certainly that mass casualties and disaster preparedness are an unfortunate fact of life in the 21st century, and that hospitalists have a responsibility to engage with our institutions in preparing for these eventualities. Possibly that life is uncertain and, at best, goes by much more quickly than any of us could have imagined when we embarked on our medical training. In the end, that our lives are measured primarily not by the number of years we live, but by how we live them, and the lives that we touch along the way.
Once a year, we pause to remember the nearly 3000 individuals who lost their lives on 9/11. As hospitalists, we practice a profession that demands a great deal from us and encourages workaholism; perhaps the 10th anniversary of those heinous acts should make each of us, as we remember the lives touched most directly by the attacks on the World Trade Center, the Pentagon, and United Flight 93, also pause to consider our work‐life balance, and to ensure that we are reserving sufficient quality time for our families and friends, as well as for activities that renew and enrich us.
- ,.Flashbulb memories.Cognition.1977;5(1):73–99.
- ,.Flashbulb memories.Cognition.1977;5(1):73–99.
Causes of Early Readmissions
Hospital readmissions have become a focus of national attention as a potential indicator of poor quality and health care waste.13 Geographic variations in readmission rates, a high rate of unplanned readmissions, and the emergence of promising interventions all suggest that some portion of readmissions are preventable.4, 5 This work adds to the work of the Agency for Healthcare Research and Quality (AHRQ) on reports of preventable hospital admissions, using hospitalization rates for ambulatory‐sensitive conditions as prevention quality indicators.6
The actual proportion of preventable readmissions is unknown. In previous research using physician reviewers, estimates have ranged from 5% to 38%.713 More recently, studies using a methodology based on relationships between diagnoses at the initial and subsequent hospitalizations have flagged as many as 76% of 30‐day readmissions as preventable.14
Understanding the preventability of readmissions is important if we are to gauge the true size of this quality and cost opportunity. Moreover, it is important to assess the beliefs of the front‐line clinicians who will be playing key roles in prevention.
The objective of the current study was to examine readmission preventability from the perspective of hospital medicine experts practicing at a community hospital. Through detailed chart review, we identify patient factors and care processes that affect preventability and describe clinicians' ideas for preventing future readmissions.
METHODS
Setting
The study took place within four community hospitals in Portland, OR, all staffed by a single hospitalist group. The hospitals included two large (483 and 525 bed) tertiary facilities with internal medicine residency programs and two smaller (77 and 40 bed) suburban hospitals, one of which has a family practice residency. The hospitalists are part of an employed medical group owned by the health care system. Each of the hospitalists is assigned as a liaison to a single primary care clinic as a means of fostering collaboration between primary care physicians and their hospital medicine colleagues.
Patients
Eligible patients were those discharged from one of these four hospitals, between January 2009 and May 2010, who had a hospitalist consult during their stay and were cared for in a system primary care clinic. The vast majority of patients were discharged by one of the internal medicine hospitalists (and all had an internal medicine consultation), thus most had medical rather than surgical diagnoses. Acute care and ambulatory care charts were reviewed for all patients readmitted within 21 days after their discharge date. The 21‐day window (rather than the customary 30‐day time period) was chosen to emphasize near‐term returns to the hospital. Hospital transfers and patients discharged to inpatient rehabilitation or inpatient mental health were excluded from the study as not representing a true readmission.
A total of 300 consecutive patient charts meeting these criteria were reviewed. These included patients readmitted multiple times. Each readmission was counted as a separate case.
Reviewers
Hospitalist reviewers came from each of the four participating hospitals. All are board certified internal medicine physicians, who perform both admitting and rounding of patients. None are nocturnists and none have specialist training or experience (in skilled nursing care, geriatrics or palliative care, or fellowship training). There were 11 male reviewers and 6 female; 12 were working full time and 5 part‐time. Two had previous primary care experience. The mean age was 38.1 (range, 3148 years) with an average 7.9 years of experience (119 years).
Six hospitalists accounted for 83% of the reviews. Among these top volume reviewers, the lowest was 17 cases and the highest was 61. There was variability in the number of reviews per hospitalist for two reasons: Some hospitalists joined in the review project earlier than others, and some hospitalists served as liaison for more primary care clinics (or larger ones) and thus had more readmissions to cover. For the purposes of analysis, the six top volume reviewers were compared to each other and to the group of remaining reviewers.
Data Collection
Data were collected via review of both inpatient and ambulatory charts by a hospitalist assigned as liaison to the primary care clinic where the patient had received care prior to hospital admission. In almost all cases (96%), the reviewer was not the discharging hospitalist, in order to provide a fresh perspective on the reasons for readmission.
A structured data collection form was developed in successive iterations by the hospitalists, starting with narrative text to describe the readmission scenario and gradually adding coded fields as themes emerged. A trial form was developed and then modified to final form by consensus discussion, in order to facilitate collection of essential information on patient diagnoses and care process issues (Appendix A). The form includes room for the reviewer to explain in narrative form the circumstances of the initial (index) admission, the readmission, and what happened in the interim. Reviewers were also asked to give their best judgment regarding the relationship between the initial and subsequent admission, whether the readmission was preventable, and potential interventions that could have prevented the readmission. The form went through slight modifications within the study, to eliminate the need for reviewer calculations and to add the more frequent diagnoses and prevention ideas appearing in the Other category.
The 17 physician reviewers were trained by one of the authors (D.K.). For key judgment ratings, definitions were agreed upon by the reviewer group. For ascertaining related admissions, definitions were linked to admitting diagnoses for the readmission and diagnoses listed in the discharge summary of the index admission. For ascertaining preventability, the reviewer decided whether a change in the discharge plan or immediate posthospitalization plan of care would have reduced the likelihood of readmission. Definitions and examples are provided in Appendix B. The two dimensions were intended to be differentthe degree of relatedness of a readmission did not dictate the degree of preventability.
Inter‐rater reliability analyses were not conducted, but data were analyzed by reviewer to determine the importance of reviewer on survey items requiring substantial reviewer judgment. In particular, reviewers were statistically compared on their rating of the relatedness of the initial and subsequent diagnoses using chi‐square. Over the course of the study, additional questions were added to the data collection form, resulting in different numbers of responses for some items.
PASW version 1815 was used for quantitative analyses, to profile readmitted patients and to identify factors important in preventability using the chi‐square and t test statistics. Stata version 1116 was used for hierarchical logistic regression modeling, to gauge the independent effect of various predictors of preventability while controlling for the possible unintended influence of the particular chart reviewer. The study was approved by the local health system institutional review board (IRB).
RESULTS
Two hundred thirteen patients (85%) had a single readmission. Another 33 patients had 2 readmissions, and 5 patients accounted for 21 readmissions for a total sample of 300 cases. Table 1 provides characteristics of readmitted patients. They were likely to be elderly; the mean (SD) age was 75.3 (15.3), and more than 48% were 80 or older. Sixty‐six percent of patients were taking more than ten medications, and a quarter (25%) had more than three new medications prescribed at discharge. Frequent diagnoses at the index admission included renal insufficiency, heart failure, dementia, atrial fibrillation, and chronic obstructive pulmonary disease (COPD). The majority of cases had more than one diagnosis identified at their first admission. These diagnoses are what hospitalists believe are significant patient issues rather than the hospital‐coded principal and secondary diagnoses.
| Characteristics | No. | % |
|---|---|---|
| ||
| Clinical parameter (n = 300 except where noted) | ||
| Age 80 or older | 144 | 48 |
| More than 10 medications at discharge | 197 | 66 |
| More than 3 new medications at discharge | 75 | 25 |
| Diagnoses at index admission* | ||
| Dementia/delirium/altered MS | 86 | 29 |
| Renal insufficiency | 85 | 28 |
| Heart failure | 77 | 26 |
| COPD | 56 | 19 |
| Atrial fibrillation | 51 | 17 |
| Pneumonia | 47 | 16 |
| History of noncompliance | 40 | 13 |
| Respiratory failure | 38 | 13 |
| Urinary tract infection | 30 | 10 |
| Depression/anxiety | 30 | 10 |
| Chemotherapy patient | 17/165 | 10 |
| Anticoagulation medication issues | 22 | 7 |
| Sepsis | 21 | 7 |
| Falls | 12/165 | 7 |
| MI | 18 | 6 |
| CVA | 18 | 6 |
| Readmission culminated in hospice referral | 16 | 5 |
| Sleep apnea | 9/165 | 5 |
| Patient with ongoing substance abuse | 10 | 3 |
Sixty‐four percent readmitted cases had been discharged to home (including those with home services), and 36% were discharged to a care facility (skilled nursing facility [SNF], foster care, assisted living) (Table 2). Fifty‐eight percent of cases were readmitted within seven days of the index admission, and another 29% within the first two weeks. Exactly 75% of the time, the readmission was for the same or related diagnosis as the index admission. Primary care follow‐up did not occur as recommended 69% of the time, and 57% of the time the patient was readmitted prior seeing their primary care physician (PCP).
| Characteristics | No. | % |
|---|---|---|
| ||
| Initial admissions LOS (n = 290) | ||
| 1 day | 33 | 11 |
| 23 days | 112 | 39 |
| 47 days | 108 | 37 |
| 8+ days | 37 | 13 |
| Discharge location (n = 286) | ||
| Home | 130 | 45 |
| SNF or ICF | 76 | 27 |
| Home with HH | 55 | 19 |
| Assisted living facility | 17 | 6 |
| Adult foster care | 8 | 3 |
| Readmit interval in days (n = 296) | ||
| 17 days | 171 | 58 |
| 814 days | 85 | 29 |
| 1521 days | 40 | 14 |
| Related diagnosis? (n = 299) | ||
| Unrelated | 75 | 25 |
| Related | 107 | 36 |
| Same | 117 | 39 |
| Follow‐up appointment did not occur as recommended (n = 166) | 114 | 69 |
| No PCP follow‐up prior to readmission (n = 300) | 172 | 57 |
| No evidence of PCP contact with patient in between hospitalizations (n = 300) | 183 | 61 |
| No evidence of primary care case management prior to readmission (n = 300) | 236 | 79 |
Overall, only 15% of readmissions were termed preventable by the hospital reviewers, although another 46% were deemed possibly preventable. Preventability ratings varied by reviewer, ranging from a high of 27% to a low of 0% among hospitalists rating ten or more cases (Table 3). There was similar variation in the number of recommended interventions. For readmissions deemed preventable or possibly preventable, the number of potential interventions ranged from more than three per patient to less than one per patient.
| Top Volume Reviewers | No. Cases Reviewed | No. (%) Termed Preventable or Possibly Preventable | Total No. Interventions Suggested | Interventions per Preventable Case |
|---|---|---|---|---|
| A | 17 | 3 (18) | 3 | 1.00 |
| B | 41 | 31 (76) | 95 | 3.06 |
| C | 61 | 48 (79) | 111 | 2.31 |
| D | 31 | 12 (39) | 4 | 0.33 |
| E | 34 | 11 (32) | 6 | 0.55 |
| F | 64 | 52 (81) | 120 | 2.31 |
| All others | 50 | 27 (54) | 35 | 1.30 |
| Total | 298 | 184 (62) | 374 | 2.03 |
The most frequently mentioned intervention that could have prevented a readmission was to extend the hospital stay by one to two days (Table 4). An earlier PCP appointment was suggested for another 21% of readmissions. Other interventions received a scattering of mentions. The types of recommended interventions varied with the rater's perception of preventability (Figure 1, available online). Hospitalists were more likely to recommend a longer initial stay, medication changes, or additional education at discharge, and earlier contact from a care facility, for readmissions they thought were preventable. For possibly preventable readmissions, these same recommendations were important, but hospitalists were also likely to recommend case management, disposition to a higher level of care, or a home health visit.
| Interventions | n | % | Total N |
|---|---|---|---|
| |||
| Extend hospital stay by 12 days | 68 | 23 | 300 |
| Earlier PCP follow‐up appointment | 56 | 21 | 269 |
| Primary care case management | 55 | 18 | 300 |
| More end‐of‐life discussion or palliative care consult | 50 | 17 | 300 |
| Different discharge medications/dosage | 48 | 16 | 300 |
| Disposition to a higher level of care | 17 | 13 | 134 |
| Better education re: home management | 17 | 13 | 134 |
| Hospice | 38 | 13 | 300 |
| Home health/home physical therapy visit | 30 | 11 | 269 |
| Nursing home visit by MD or SNF specialist | 24 | 9 | 269 |
| Earlier contact from care facility (SNF, ICF, ALF) | 14 | 5 | 268 |
| Improve medication reconciliation or education | 10 | 4 | 269 |
Table 5 shows the most important characteristics associated with preventability, using a cutoff of 0.2 in statistical significance. Readmissions for the same diagnosis were more likely than others to be rated preventable, as were cases with a short readmission interval, more than three new medications at discharge, and patients with COPD or depression/anxiety. Initial hospital length of stay did not influence preventability, nor did it influence the likelihood of a reviewer recommending a longer initial stay.
| Characteristic | Value | Preventable Portion (%) | P value |
|---|---|---|---|
| |||
| Index vs. readmission diagnosis | Same | 28.2 | <0.001 |
| Related | 8.4 | ||
| Unrelated | 4.1 | ||
| New discharge medications | More than 3 | 25.7 | 0.004 |
| 3 or fewer | 11.8 | ||
| Timing of PCP follow‐up | Readmitted prior to PCP follow‐up | 19.8 | 0.009 |
| Readmitted after PCP follow‐up | 8.7 | ||
| Readmission interval | 1 week or less | 19.3 | 0.012 |
| More than 1 week | 8.8 | ||
| COPD diagnosis | With COPD | 25.5 | 0.018 |
| Without COPD | 12.8 | ||
| Index admission site | Hospital 1 | 14.3 | 0.078 |
| Hospital 2 | 15.1 | ||
| Hospital 3 | 7.1 | ||
| Hospital 4 | 22.7 | ||
| Depression/anxiety diagnosis | With depression | 20.0 | 0.083 |
| Without depression | 9.0 | ||
| Patient on anticoagulation | Anticoagulation | 27.3 | 0.098 |
| No anticoagulation | 14.1 | ||
| Age | Greater than 80 | 12.0 | 0.144 |
| 80 or less | 18.1 | ||
Potential predictors associated with preventability were included in a hierarchical logistic regression model, with hospital site and reviewer included as random effects. In this modeling, preventable readmissions were more likely than nonpreventable readmissions to be influenced by three process factors: having the same index and readmission diagnosis; readmission in the first post‐hospital week; being readmitted prior to a primary care follow‐up; and three patient factors: having more than three new discharge medications, having anticoagulation treatment, and having a COPD diagnosis (data available online). Other chronic diseases, age, discharge location, or previous readmissions were not important in the rating of preventability. When entered as random effects in a hierarchical logistic regression model, the categorical variable representing hospital site did not significantly improve prediction (P = 0.42), but the reviewer variable (categorized by the top six reviewers and others) had marginal significance at P = 0.088.
DISCUSSION
Reported high Medicare 30‐day readmission rates and associate excess costs have created a national climate for eliminating unnecessary hospital readmissions.1 Recently passed healthcare legislation in the USA will put in place diagnosis‐related group (DRG) payment reductions for excess readmission rates by 2013. As the definitions and methodologies for determining the relatedness and preventable nature of readmissions continues to be clarified, this study contributes to the understanding of preventability and specific preventative strategies from a physician perspective. Although potential savings in readmission reduction work is attractive, our study indicates that most front‐line clinicians are not convinced that a large portion of readmissions are preventable.
The proportion of preventable readmissions found in our study is very much in line with previous research.713 Certain predictors of preventable readmissions were also similar. Several researchers have found that preventable readmissions are more likely to be early,8, 10, 12 and have the same or related diagnosis as the initial stay.8 On the other hand, our data did not show an independent effect of age on preventability, as others have suggested.9, 17 Patients with a large number of diagnoses and medications have been shown to be at risk for preventable readmissions,9 but the importance of new discharge medications has not been widely researched and is a factor that deserves further exploration.
One key message from our study was found in the variation in the ratings of preventability by individual physicians. At first blush, it may appear to reflect a lack of inter‐rater reliability or understanding of the underlying concept of preventability. We believe this is unlikely, given the discussions among raters and the clear descriptions offered in writing. Moreover, there was much less variation in other judgments such as the ratings of relatedness of the readmission diagnosis (chi‐square = 21.7, P = .041)
There are a number of possible reasons for variation in reviewer ratings of preventability. Reviewers did vary with regard to age, experience, tenure in the organization, gender, and full/part‐time status. They practiced at different hospitals. None of these factors were related to ratings of preventability. On the other hand, three explanations are worth noting.
First, the hierarchical regression models found that reviewer only slightly improved prediction (P = 0.088), above and beyond the other diagnosis and process factors. This would lead us to reject the factor of reviewer as the most important predictor of preventability; the other case characteristics mentioned above were more important.
Second, the three hospitalists who were more optimistic (rated more cases as preventable) reviewed more charts than others. It is possible that these three were more engaged, not only in the chart review process, but more eager to uncover potential remedies to prevent readmissions. While generating more ideas about how to do that, they rated more readmissions as preventable. We do not believe that actually doing more reviews caused them to rate a greater portion as preventable; none of the reviewers showed progression to more preventable ratings over time (analysis not shown).
Finally, it is worth noting that two of the more optimistic physicians had previous primary care experience. This is an intriguing explanation that would benefit from further research. First‐hand experience with primary care case management, rapid appointment follow‐up, home service referrals, and the like may give the practicing hospitalist reason to believe that actions in the ambulatory setting can prevent readmissions.
Regardless of the source, the variation demonstrates cultural or philosophical biases among clinicians regarding how much influence additional planning, education, and care coordination can have on readmissions. We believe that this variation must be addressed in the implementation of readmission reduction programs. Physician engagement will be more likely if there is optimism about the potential to prevent readmissions. In addition, it will be important to develop more consensus about effective interventions from the perspectives of hospital physicians, primary care physicians, nurses, and patients, as others have alluded.18, 19
The significant rate of related readmissions (75%) has implications for the potential Centers for Medicare and Medicaid Services (CMS) methodology that will be used to reduce DRG payments, given the legislation's current intent to exclude only unrelated and planned readmissions from the calculations. Providing clear definitions on relatedness and a methodology to code this criterion in administrative datasets may need to be developed. The views of hospitalists in the current study suggest that the relatedness methodology may be overly sensitive and not yet specific enough to isolate truly preventable readmissions. Less than a quarter of related readmissions were deemed preventable by these raters.
Hospitalists found both patient and process factors important in assessing the preventability of a readmission. This kind of analysis can point to subgroups with potential for targeted intervention. For example, over a third of patients readmitted within a week for the same diagnosis were rated as preventable, indicating a critical follow‐up period for some patients. Higher ratings of preventability among the readmissions for patients on anticoagulation or who were given more than three new medications at discharge indicates that better medication management may indeed be a fruitful strategy for readmission reduction.
The finding that increasing the length of the initial hospital stay was rated as the most prevalent strategy to mitigate against readmission in our retrospective review was surprising. It emphasizes the tension between efficient hospital throughput which reduces unnecessary hospital days and the necessity for appropriate monitoring to ensure clinical stability prior to discharge. Excess hospital days can prolong the exposure to a multitude of hospital acquired conditions (HAC), and this risk must be weighed against a longer length of stay and the time required delivering the appropriate hospital services.
Exploring alternative strategies to reduce readmissions without increasing the hospital length of stay is a reasonable response to this tension. Better discharge education and attention to discharge medications and dosages were also recommended strategies for preventable readmissions. These are interventions hospitalists are familiar with and can control. Relatively smaller percentages of patients were thought to benefit from case management, hospice, home health, or an MD visit to their nursing home, and hospitalists were more likely to recommend these for the possibly preventable patients. These interventions are not fully implemented within the study health system so there is understandably less confidence in them.
Limitations of this study include its relatively small sample size and the fact that all patients were served by a single medical practice. No extensive inter‐rater reliability checks were performed, although all reviewers were trained in the definitions of the most important judgment items. Other limitations include possible confounding biases which were not controlled, such as the number of charts reviewed, timing of review, and hospital reviewed (ie, each reviewer did not review the same proportion of charts from each hospital).
SUMMARY
We have presented a retrospective chart review study of hospital readmissions in a community hospital setting. This study adds to the increasing literature describing the factors that contribute to hospital readmissions, how preventable they are, and what strategies may reduce the likelihood of readmission. This study is unique in its contribution to the understanding of hospital readmissions by studying front‐line clinician (hospitalist) perceptions of those factors.
Acknowledgements
The authors express their appreciation to the following clinicians for their review of patient charts, revisions to the chart review tool, and contributions to the interpretation of study data: Adam Blomberg, MD; Adam Mizgajski, MD; Alison Ma, MD; Amy Carolan, MD; Amy Johnson, MD; Brian Kearns, MD; Christopher Zaugra, MD; Frank Joerke, MD; Janhavi Meghashyam, MD; Jennifer M. Wilson, MD; Larie Hoover, MD; Patrick J. Gaston, MD; Scott Kemeny, MD; Sean Tushla, MD; Timothy Dygert, MD; and Vinay Siddappa, MD. The authors are also grateful to Eileen O'Reilly‐Hoisington who created the online chart‐review forms and extracted data for the analysis.
- The Library of Congress. Thomas H.R. 3590 Bill Summary 360:1418–1428.
- ,.Preventing the preventable: reducing rehospitalizations through coordinated, patient‐centered discharge processes.Prof Case Manag.2009;14:135–140.
- Agency for Healthcare Research and Quality, Rockville, MD. Preventable Hospitalizations: a Window into Primary and Preventive Care, 2000. Available at: http://www.ahrq.gov/data/hcup/factbk5/. Accessed June 18,2010.
- ,,, et al.Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions.J Gen Intern Med.1996;11:597–607.
- ,,.Early readmissions to the department of medicine as a screening tool for monitoring quality of care problems.Medicine (Baltimore).2008;87:294–300.
- ,,, et al.Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility.Am J Med.1987;83:1031–1036.
- .Are readmissions avoidable?BMJ.1990;301:1136–1138.
- ,,,,.How does managed care manage the frail elderly? The case of hospital readmissions in fee‐for‐service versus HMO systems.Am J Prev Med.1999;16:163–172.
- ,,.Preventability of emergent hospital readmission.Am J Med.1991;90:667–674.
- ,,,.Readmissions to a geriatric medical unit: is prevention possible?Aging Clin Exp Res.1992;4:61–67.
- Medicare Payment Advisory Commission. Payment policy for inpatient readmissions. In: Report to the Congress: Promoting Greater Efficiency in Medicare. Available at: http://www.medpac.gov/chapters/Jun07_Ch05.pdf. Accessed February 9,2010.
- PASW Statistics. Version 18.Chicago, IL:SPSS Inc, an IBM Company;2010.
- Stata Statistical Software: Release 11. Version 18.College Station, TX:StataCorp LP;2009.
- ,,,,,.Measuring potentially avoidable hospital readmissions.J Clin Epidemiol.2002;55(6):573–587.
- ,,,.Unplanned readmission to hospital: a comparison of the views of general practitioners and hospital staff.Age Ageing.2002;31:141–143.
- ,,.Reasons for readmission in heart failure: perspectives of patients, caregivers, cardiologists, and heart failure nurses.Heart Lung.2009;38:427–434.
Hospital readmissions have become a focus of national attention as a potential indicator of poor quality and health care waste.13 Geographic variations in readmission rates, a high rate of unplanned readmissions, and the emergence of promising interventions all suggest that some portion of readmissions are preventable.4, 5 This work adds to the work of the Agency for Healthcare Research and Quality (AHRQ) on reports of preventable hospital admissions, using hospitalization rates for ambulatory‐sensitive conditions as prevention quality indicators.6
The actual proportion of preventable readmissions is unknown. In previous research using physician reviewers, estimates have ranged from 5% to 38%.713 More recently, studies using a methodology based on relationships between diagnoses at the initial and subsequent hospitalizations have flagged as many as 76% of 30‐day readmissions as preventable.14
Understanding the preventability of readmissions is important if we are to gauge the true size of this quality and cost opportunity. Moreover, it is important to assess the beliefs of the front‐line clinicians who will be playing key roles in prevention.
The objective of the current study was to examine readmission preventability from the perspective of hospital medicine experts practicing at a community hospital. Through detailed chart review, we identify patient factors and care processes that affect preventability and describe clinicians' ideas for preventing future readmissions.
METHODS
Setting
The study took place within four community hospitals in Portland, OR, all staffed by a single hospitalist group. The hospitals included two large (483 and 525 bed) tertiary facilities with internal medicine residency programs and two smaller (77 and 40 bed) suburban hospitals, one of which has a family practice residency. The hospitalists are part of an employed medical group owned by the health care system. Each of the hospitalists is assigned as a liaison to a single primary care clinic as a means of fostering collaboration between primary care physicians and their hospital medicine colleagues.
Patients
Eligible patients were those discharged from one of these four hospitals, between January 2009 and May 2010, who had a hospitalist consult during their stay and were cared for in a system primary care clinic. The vast majority of patients were discharged by one of the internal medicine hospitalists (and all had an internal medicine consultation), thus most had medical rather than surgical diagnoses. Acute care and ambulatory care charts were reviewed for all patients readmitted within 21 days after their discharge date. The 21‐day window (rather than the customary 30‐day time period) was chosen to emphasize near‐term returns to the hospital. Hospital transfers and patients discharged to inpatient rehabilitation or inpatient mental health were excluded from the study as not representing a true readmission.
A total of 300 consecutive patient charts meeting these criteria were reviewed. These included patients readmitted multiple times. Each readmission was counted as a separate case.
Reviewers
Hospitalist reviewers came from each of the four participating hospitals. All are board certified internal medicine physicians, who perform both admitting and rounding of patients. None are nocturnists and none have specialist training or experience (in skilled nursing care, geriatrics or palliative care, or fellowship training). There were 11 male reviewers and 6 female; 12 were working full time and 5 part‐time. Two had previous primary care experience. The mean age was 38.1 (range, 3148 years) with an average 7.9 years of experience (119 years).
Six hospitalists accounted for 83% of the reviews. Among these top volume reviewers, the lowest was 17 cases and the highest was 61. There was variability in the number of reviews per hospitalist for two reasons: Some hospitalists joined in the review project earlier than others, and some hospitalists served as liaison for more primary care clinics (or larger ones) and thus had more readmissions to cover. For the purposes of analysis, the six top volume reviewers were compared to each other and to the group of remaining reviewers.
Data Collection
Data were collected via review of both inpatient and ambulatory charts by a hospitalist assigned as liaison to the primary care clinic where the patient had received care prior to hospital admission. In almost all cases (96%), the reviewer was not the discharging hospitalist, in order to provide a fresh perspective on the reasons for readmission.
A structured data collection form was developed in successive iterations by the hospitalists, starting with narrative text to describe the readmission scenario and gradually adding coded fields as themes emerged. A trial form was developed and then modified to final form by consensus discussion, in order to facilitate collection of essential information on patient diagnoses and care process issues (Appendix A). The form includes room for the reviewer to explain in narrative form the circumstances of the initial (index) admission, the readmission, and what happened in the interim. Reviewers were also asked to give their best judgment regarding the relationship between the initial and subsequent admission, whether the readmission was preventable, and potential interventions that could have prevented the readmission. The form went through slight modifications within the study, to eliminate the need for reviewer calculations and to add the more frequent diagnoses and prevention ideas appearing in the Other category.
The 17 physician reviewers were trained by one of the authors (D.K.). For key judgment ratings, definitions were agreed upon by the reviewer group. For ascertaining related admissions, definitions were linked to admitting diagnoses for the readmission and diagnoses listed in the discharge summary of the index admission. For ascertaining preventability, the reviewer decided whether a change in the discharge plan or immediate posthospitalization plan of care would have reduced the likelihood of readmission. Definitions and examples are provided in Appendix B. The two dimensions were intended to be differentthe degree of relatedness of a readmission did not dictate the degree of preventability.
Inter‐rater reliability analyses were not conducted, but data were analyzed by reviewer to determine the importance of reviewer on survey items requiring substantial reviewer judgment. In particular, reviewers were statistically compared on their rating of the relatedness of the initial and subsequent diagnoses using chi‐square. Over the course of the study, additional questions were added to the data collection form, resulting in different numbers of responses for some items.
PASW version 1815 was used for quantitative analyses, to profile readmitted patients and to identify factors important in preventability using the chi‐square and t test statistics. Stata version 1116 was used for hierarchical logistic regression modeling, to gauge the independent effect of various predictors of preventability while controlling for the possible unintended influence of the particular chart reviewer. The study was approved by the local health system institutional review board (IRB).
RESULTS
Two hundred thirteen patients (85%) had a single readmission. Another 33 patients had 2 readmissions, and 5 patients accounted for 21 readmissions for a total sample of 300 cases. Table 1 provides characteristics of readmitted patients. They were likely to be elderly; the mean (SD) age was 75.3 (15.3), and more than 48% were 80 or older. Sixty‐six percent of patients were taking more than ten medications, and a quarter (25%) had more than three new medications prescribed at discharge. Frequent diagnoses at the index admission included renal insufficiency, heart failure, dementia, atrial fibrillation, and chronic obstructive pulmonary disease (COPD). The majority of cases had more than one diagnosis identified at their first admission. These diagnoses are what hospitalists believe are significant patient issues rather than the hospital‐coded principal and secondary diagnoses.
| Characteristics | No. | % |
|---|---|---|
| ||
| Clinical parameter (n = 300 except where noted) | ||
| Age 80 or older | 144 | 48 |
| More than 10 medications at discharge | 197 | 66 |
| More than 3 new medications at discharge | 75 | 25 |
| Diagnoses at index admission* | ||
| Dementia/delirium/altered MS | 86 | 29 |
| Renal insufficiency | 85 | 28 |
| Heart failure | 77 | 26 |
| COPD | 56 | 19 |
| Atrial fibrillation | 51 | 17 |
| Pneumonia | 47 | 16 |
| History of noncompliance | 40 | 13 |
| Respiratory failure | 38 | 13 |
| Urinary tract infection | 30 | 10 |
| Depression/anxiety | 30 | 10 |
| Chemotherapy patient | 17/165 | 10 |
| Anticoagulation medication issues | 22 | 7 |
| Sepsis | 21 | 7 |
| Falls | 12/165 | 7 |
| MI | 18 | 6 |
| CVA | 18 | 6 |
| Readmission culminated in hospice referral | 16 | 5 |
| Sleep apnea | 9/165 | 5 |
| Patient with ongoing substance abuse | 10 | 3 |
Sixty‐four percent readmitted cases had been discharged to home (including those with home services), and 36% were discharged to a care facility (skilled nursing facility [SNF], foster care, assisted living) (Table 2). Fifty‐eight percent of cases were readmitted within seven days of the index admission, and another 29% within the first two weeks. Exactly 75% of the time, the readmission was for the same or related diagnosis as the index admission. Primary care follow‐up did not occur as recommended 69% of the time, and 57% of the time the patient was readmitted prior seeing their primary care physician (PCP).
| Characteristics | No. | % |
|---|---|---|
| ||
| Initial admissions LOS (n = 290) | ||
| 1 day | 33 | 11 |
| 23 days | 112 | 39 |
| 47 days | 108 | 37 |
| 8+ days | 37 | 13 |
| Discharge location (n = 286) | ||
| Home | 130 | 45 |
| SNF or ICF | 76 | 27 |
| Home with HH | 55 | 19 |
| Assisted living facility | 17 | 6 |
| Adult foster care | 8 | 3 |
| Readmit interval in days (n = 296) | ||
| 17 days | 171 | 58 |
| 814 days | 85 | 29 |
| 1521 days | 40 | 14 |
| Related diagnosis? (n = 299) | ||
| Unrelated | 75 | 25 |
| Related | 107 | 36 |
| Same | 117 | 39 |
| Follow‐up appointment did not occur as recommended (n = 166) | 114 | 69 |
| No PCP follow‐up prior to readmission (n = 300) | 172 | 57 |
| No evidence of PCP contact with patient in between hospitalizations (n = 300) | 183 | 61 |
| No evidence of primary care case management prior to readmission (n = 300) | 236 | 79 |
Overall, only 15% of readmissions were termed preventable by the hospital reviewers, although another 46% were deemed possibly preventable. Preventability ratings varied by reviewer, ranging from a high of 27% to a low of 0% among hospitalists rating ten or more cases (Table 3). There was similar variation in the number of recommended interventions. For readmissions deemed preventable or possibly preventable, the number of potential interventions ranged from more than three per patient to less than one per patient.
| Top Volume Reviewers | No. Cases Reviewed | No. (%) Termed Preventable or Possibly Preventable | Total No. Interventions Suggested | Interventions per Preventable Case |
|---|---|---|---|---|
| A | 17 | 3 (18) | 3 | 1.00 |
| B | 41 | 31 (76) | 95 | 3.06 |
| C | 61 | 48 (79) | 111 | 2.31 |
| D | 31 | 12 (39) | 4 | 0.33 |
| E | 34 | 11 (32) | 6 | 0.55 |
| F | 64 | 52 (81) | 120 | 2.31 |
| All others | 50 | 27 (54) | 35 | 1.30 |
| Total | 298 | 184 (62) | 374 | 2.03 |
The most frequently mentioned intervention that could have prevented a readmission was to extend the hospital stay by one to two days (Table 4). An earlier PCP appointment was suggested for another 21% of readmissions. Other interventions received a scattering of mentions. The types of recommended interventions varied with the rater's perception of preventability (Figure 1, available online). Hospitalists were more likely to recommend a longer initial stay, medication changes, or additional education at discharge, and earlier contact from a care facility, for readmissions they thought were preventable. For possibly preventable readmissions, these same recommendations were important, but hospitalists were also likely to recommend case management, disposition to a higher level of care, or a home health visit.
| Interventions | n | % | Total N |
|---|---|---|---|
| |||
| Extend hospital stay by 12 days | 68 | 23 | 300 |
| Earlier PCP follow‐up appointment | 56 | 21 | 269 |
| Primary care case management | 55 | 18 | 300 |
| More end‐of‐life discussion or palliative care consult | 50 | 17 | 300 |
| Different discharge medications/dosage | 48 | 16 | 300 |
| Disposition to a higher level of care | 17 | 13 | 134 |
| Better education re: home management | 17 | 13 | 134 |
| Hospice | 38 | 13 | 300 |
| Home health/home physical therapy visit | 30 | 11 | 269 |
| Nursing home visit by MD or SNF specialist | 24 | 9 | 269 |
| Earlier contact from care facility (SNF, ICF, ALF) | 14 | 5 | 268 |
| Improve medication reconciliation or education | 10 | 4 | 269 |
Table 5 shows the most important characteristics associated with preventability, using a cutoff of 0.2 in statistical significance. Readmissions for the same diagnosis were more likely than others to be rated preventable, as were cases with a short readmission interval, more than three new medications at discharge, and patients with COPD or depression/anxiety. Initial hospital length of stay did not influence preventability, nor did it influence the likelihood of a reviewer recommending a longer initial stay.
| Characteristic | Value | Preventable Portion (%) | P value |
|---|---|---|---|
| |||
| Index vs. readmission diagnosis | Same | 28.2 | <0.001 |
| Related | 8.4 | ||
| Unrelated | 4.1 | ||
| New discharge medications | More than 3 | 25.7 | 0.004 |
| 3 or fewer | 11.8 | ||
| Timing of PCP follow‐up | Readmitted prior to PCP follow‐up | 19.8 | 0.009 |
| Readmitted after PCP follow‐up | 8.7 | ||
| Readmission interval | 1 week or less | 19.3 | 0.012 |
| More than 1 week | 8.8 | ||
| COPD diagnosis | With COPD | 25.5 | 0.018 |
| Without COPD | 12.8 | ||
| Index admission site | Hospital 1 | 14.3 | 0.078 |
| Hospital 2 | 15.1 | ||
| Hospital 3 | 7.1 | ||
| Hospital 4 | 22.7 | ||
| Depression/anxiety diagnosis | With depression | 20.0 | 0.083 |
| Without depression | 9.0 | ||
| Patient on anticoagulation | Anticoagulation | 27.3 | 0.098 |
| No anticoagulation | 14.1 | ||
| Age | Greater than 80 | 12.0 | 0.144 |
| 80 or less | 18.1 | ||
Potential predictors associated with preventability were included in a hierarchical logistic regression model, with hospital site and reviewer included as random effects. In this modeling, preventable readmissions were more likely than nonpreventable readmissions to be influenced by three process factors: having the same index and readmission diagnosis; readmission in the first post‐hospital week; being readmitted prior to a primary care follow‐up; and three patient factors: having more than three new discharge medications, having anticoagulation treatment, and having a COPD diagnosis (data available online). Other chronic diseases, age, discharge location, or previous readmissions were not important in the rating of preventability. When entered as random effects in a hierarchical logistic regression model, the categorical variable representing hospital site did not significantly improve prediction (P = 0.42), but the reviewer variable (categorized by the top six reviewers and others) had marginal significance at P = 0.088.
DISCUSSION
Reported high Medicare 30‐day readmission rates and associate excess costs have created a national climate for eliminating unnecessary hospital readmissions.1 Recently passed healthcare legislation in the USA will put in place diagnosis‐related group (DRG) payment reductions for excess readmission rates by 2013. As the definitions and methodologies for determining the relatedness and preventable nature of readmissions continues to be clarified, this study contributes to the understanding of preventability and specific preventative strategies from a physician perspective. Although potential savings in readmission reduction work is attractive, our study indicates that most front‐line clinicians are not convinced that a large portion of readmissions are preventable.
The proportion of preventable readmissions found in our study is very much in line with previous research.713 Certain predictors of preventable readmissions were also similar. Several researchers have found that preventable readmissions are more likely to be early,8, 10, 12 and have the same or related diagnosis as the initial stay.8 On the other hand, our data did not show an independent effect of age on preventability, as others have suggested.9, 17 Patients with a large number of diagnoses and medications have been shown to be at risk for preventable readmissions,9 but the importance of new discharge medications has not been widely researched and is a factor that deserves further exploration.
One key message from our study was found in the variation in the ratings of preventability by individual physicians. At first blush, it may appear to reflect a lack of inter‐rater reliability or understanding of the underlying concept of preventability. We believe this is unlikely, given the discussions among raters and the clear descriptions offered in writing. Moreover, there was much less variation in other judgments such as the ratings of relatedness of the readmission diagnosis (chi‐square = 21.7, P = .041)
There are a number of possible reasons for variation in reviewer ratings of preventability. Reviewers did vary with regard to age, experience, tenure in the organization, gender, and full/part‐time status. They practiced at different hospitals. None of these factors were related to ratings of preventability. On the other hand, three explanations are worth noting.
First, the hierarchical regression models found that reviewer only slightly improved prediction (P = 0.088), above and beyond the other diagnosis and process factors. This would lead us to reject the factor of reviewer as the most important predictor of preventability; the other case characteristics mentioned above were more important.
Second, the three hospitalists who were more optimistic (rated more cases as preventable) reviewed more charts than others. It is possible that these three were more engaged, not only in the chart review process, but more eager to uncover potential remedies to prevent readmissions. While generating more ideas about how to do that, they rated more readmissions as preventable. We do not believe that actually doing more reviews caused them to rate a greater portion as preventable; none of the reviewers showed progression to more preventable ratings over time (analysis not shown).
Finally, it is worth noting that two of the more optimistic physicians had previous primary care experience. This is an intriguing explanation that would benefit from further research. First‐hand experience with primary care case management, rapid appointment follow‐up, home service referrals, and the like may give the practicing hospitalist reason to believe that actions in the ambulatory setting can prevent readmissions.
Regardless of the source, the variation demonstrates cultural or philosophical biases among clinicians regarding how much influence additional planning, education, and care coordination can have on readmissions. We believe that this variation must be addressed in the implementation of readmission reduction programs. Physician engagement will be more likely if there is optimism about the potential to prevent readmissions. In addition, it will be important to develop more consensus about effective interventions from the perspectives of hospital physicians, primary care physicians, nurses, and patients, as others have alluded.18, 19
The significant rate of related readmissions (75%) has implications for the potential Centers for Medicare and Medicaid Services (CMS) methodology that will be used to reduce DRG payments, given the legislation's current intent to exclude only unrelated and planned readmissions from the calculations. Providing clear definitions on relatedness and a methodology to code this criterion in administrative datasets may need to be developed. The views of hospitalists in the current study suggest that the relatedness methodology may be overly sensitive and not yet specific enough to isolate truly preventable readmissions. Less than a quarter of related readmissions were deemed preventable by these raters.
Hospitalists found both patient and process factors important in assessing the preventability of a readmission. This kind of analysis can point to subgroups with potential for targeted intervention. For example, over a third of patients readmitted within a week for the same diagnosis were rated as preventable, indicating a critical follow‐up period for some patients. Higher ratings of preventability among the readmissions for patients on anticoagulation or who were given more than three new medications at discharge indicates that better medication management may indeed be a fruitful strategy for readmission reduction.
The finding that increasing the length of the initial hospital stay was rated as the most prevalent strategy to mitigate against readmission in our retrospective review was surprising. It emphasizes the tension between efficient hospital throughput which reduces unnecessary hospital days and the necessity for appropriate monitoring to ensure clinical stability prior to discharge. Excess hospital days can prolong the exposure to a multitude of hospital acquired conditions (HAC), and this risk must be weighed against a longer length of stay and the time required delivering the appropriate hospital services.
Exploring alternative strategies to reduce readmissions without increasing the hospital length of stay is a reasonable response to this tension. Better discharge education and attention to discharge medications and dosages were also recommended strategies for preventable readmissions. These are interventions hospitalists are familiar with and can control. Relatively smaller percentages of patients were thought to benefit from case management, hospice, home health, or an MD visit to their nursing home, and hospitalists were more likely to recommend these for the possibly preventable patients. These interventions are not fully implemented within the study health system so there is understandably less confidence in them.
Limitations of this study include its relatively small sample size and the fact that all patients were served by a single medical practice. No extensive inter‐rater reliability checks were performed, although all reviewers were trained in the definitions of the most important judgment items. Other limitations include possible confounding biases which were not controlled, such as the number of charts reviewed, timing of review, and hospital reviewed (ie, each reviewer did not review the same proportion of charts from each hospital).
SUMMARY
We have presented a retrospective chart review study of hospital readmissions in a community hospital setting. This study adds to the increasing literature describing the factors that contribute to hospital readmissions, how preventable they are, and what strategies may reduce the likelihood of readmission. This study is unique in its contribution to the understanding of hospital readmissions by studying front‐line clinician (hospitalist) perceptions of those factors.
Acknowledgements
The authors express their appreciation to the following clinicians for their review of patient charts, revisions to the chart review tool, and contributions to the interpretation of study data: Adam Blomberg, MD; Adam Mizgajski, MD; Alison Ma, MD; Amy Carolan, MD; Amy Johnson, MD; Brian Kearns, MD; Christopher Zaugra, MD; Frank Joerke, MD; Janhavi Meghashyam, MD; Jennifer M. Wilson, MD; Larie Hoover, MD; Patrick J. Gaston, MD; Scott Kemeny, MD; Sean Tushla, MD; Timothy Dygert, MD; and Vinay Siddappa, MD. The authors are also grateful to Eileen O'Reilly‐Hoisington who created the online chart‐review forms and extracted data for the analysis.
Hospital readmissions have become a focus of national attention as a potential indicator of poor quality and health care waste.13 Geographic variations in readmission rates, a high rate of unplanned readmissions, and the emergence of promising interventions all suggest that some portion of readmissions are preventable.4, 5 This work adds to the work of the Agency for Healthcare Research and Quality (AHRQ) on reports of preventable hospital admissions, using hospitalization rates for ambulatory‐sensitive conditions as prevention quality indicators.6
The actual proportion of preventable readmissions is unknown. In previous research using physician reviewers, estimates have ranged from 5% to 38%.713 More recently, studies using a methodology based on relationships between diagnoses at the initial and subsequent hospitalizations have flagged as many as 76% of 30‐day readmissions as preventable.14
Understanding the preventability of readmissions is important if we are to gauge the true size of this quality and cost opportunity. Moreover, it is important to assess the beliefs of the front‐line clinicians who will be playing key roles in prevention.
The objective of the current study was to examine readmission preventability from the perspective of hospital medicine experts practicing at a community hospital. Through detailed chart review, we identify patient factors and care processes that affect preventability and describe clinicians' ideas for preventing future readmissions.
METHODS
Setting
The study took place within four community hospitals in Portland, OR, all staffed by a single hospitalist group. The hospitals included two large (483 and 525 bed) tertiary facilities with internal medicine residency programs and two smaller (77 and 40 bed) suburban hospitals, one of which has a family practice residency. The hospitalists are part of an employed medical group owned by the health care system. Each of the hospitalists is assigned as a liaison to a single primary care clinic as a means of fostering collaboration between primary care physicians and their hospital medicine colleagues.
Patients
Eligible patients were those discharged from one of these four hospitals, between January 2009 and May 2010, who had a hospitalist consult during their stay and were cared for in a system primary care clinic. The vast majority of patients were discharged by one of the internal medicine hospitalists (and all had an internal medicine consultation), thus most had medical rather than surgical diagnoses. Acute care and ambulatory care charts were reviewed for all patients readmitted within 21 days after their discharge date. The 21‐day window (rather than the customary 30‐day time period) was chosen to emphasize near‐term returns to the hospital. Hospital transfers and patients discharged to inpatient rehabilitation or inpatient mental health were excluded from the study as not representing a true readmission.
A total of 300 consecutive patient charts meeting these criteria were reviewed. These included patients readmitted multiple times. Each readmission was counted as a separate case.
Reviewers
Hospitalist reviewers came from each of the four participating hospitals. All are board certified internal medicine physicians, who perform both admitting and rounding of patients. None are nocturnists and none have specialist training or experience (in skilled nursing care, geriatrics or palliative care, or fellowship training). There were 11 male reviewers and 6 female; 12 were working full time and 5 part‐time. Two had previous primary care experience. The mean age was 38.1 (range, 3148 years) with an average 7.9 years of experience (119 years).
Six hospitalists accounted for 83% of the reviews. Among these top volume reviewers, the lowest was 17 cases and the highest was 61. There was variability in the number of reviews per hospitalist for two reasons: Some hospitalists joined in the review project earlier than others, and some hospitalists served as liaison for more primary care clinics (or larger ones) and thus had more readmissions to cover. For the purposes of analysis, the six top volume reviewers were compared to each other and to the group of remaining reviewers.
Data Collection
Data were collected via review of both inpatient and ambulatory charts by a hospitalist assigned as liaison to the primary care clinic where the patient had received care prior to hospital admission. In almost all cases (96%), the reviewer was not the discharging hospitalist, in order to provide a fresh perspective on the reasons for readmission.
A structured data collection form was developed in successive iterations by the hospitalists, starting with narrative text to describe the readmission scenario and gradually adding coded fields as themes emerged. A trial form was developed and then modified to final form by consensus discussion, in order to facilitate collection of essential information on patient diagnoses and care process issues (Appendix A). The form includes room for the reviewer to explain in narrative form the circumstances of the initial (index) admission, the readmission, and what happened in the interim. Reviewers were also asked to give their best judgment regarding the relationship between the initial and subsequent admission, whether the readmission was preventable, and potential interventions that could have prevented the readmission. The form went through slight modifications within the study, to eliminate the need for reviewer calculations and to add the more frequent diagnoses and prevention ideas appearing in the Other category.
The 17 physician reviewers were trained by one of the authors (D.K.). For key judgment ratings, definitions were agreed upon by the reviewer group. For ascertaining related admissions, definitions were linked to admitting diagnoses for the readmission and diagnoses listed in the discharge summary of the index admission. For ascertaining preventability, the reviewer decided whether a change in the discharge plan or immediate posthospitalization plan of care would have reduced the likelihood of readmission. Definitions and examples are provided in Appendix B. The two dimensions were intended to be differentthe degree of relatedness of a readmission did not dictate the degree of preventability.
Inter‐rater reliability analyses were not conducted, but data were analyzed by reviewer to determine the importance of reviewer on survey items requiring substantial reviewer judgment. In particular, reviewers were statistically compared on their rating of the relatedness of the initial and subsequent diagnoses using chi‐square. Over the course of the study, additional questions were added to the data collection form, resulting in different numbers of responses for some items.
PASW version 1815 was used for quantitative analyses, to profile readmitted patients and to identify factors important in preventability using the chi‐square and t test statistics. Stata version 1116 was used for hierarchical logistic regression modeling, to gauge the independent effect of various predictors of preventability while controlling for the possible unintended influence of the particular chart reviewer. The study was approved by the local health system institutional review board (IRB).
RESULTS
Two hundred thirteen patients (85%) had a single readmission. Another 33 patients had 2 readmissions, and 5 patients accounted for 21 readmissions for a total sample of 300 cases. Table 1 provides characteristics of readmitted patients. They were likely to be elderly; the mean (SD) age was 75.3 (15.3), and more than 48% were 80 or older. Sixty‐six percent of patients were taking more than ten medications, and a quarter (25%) had more than three new medications prescribed at discharge. Frequent diagnoses at the index admission included renal insufficiency, heart failure, dementia, atrial fibrillation, and chronic obstructive pulmonary disease (COPD). The majority of cases had more than one diagnosis identified at their first admission. These diagnoses are what hospitalists believe are significant patient issues rather than the hospital‐coded principal and secondary diagnoses.
| Characteristics | No. | % |
|---|---|---|
| ||
| Clinical parameter (n = 300 except where noted) | ||
| Age 80 or older | 144 | 48 |
| More than 10 medications at discharge | 197 | 66 |
| More than 3 new medications at discharge | 75 | 25 |
| Diagnoses at index admission* | ||
| Dementia/delirium/altered MS | 86 | 29 |
| Renal insufficiency | 85 | 28 |
| Heart failure | 77 | 26 |
| COPD | 56 | 19 |
| Atrial fibrillation | 51 | 17 |
| Pneumonia | 47 | 16 |
| History of noncompliance | 40 | 13 |
| Respiratory failure | 38 | 13 |
| Urinary tract infection | 30 | 10 |
| Depression/anxiety | 30 | 10 |
| Chemotherapy patient | 17/165 | 10 |
| Anticoagulation medication issues | 22 | 7 |
| Sepsis | 21 | 7 |
| Falls | 12/165 | 7 |
| MI | 18 | 6 |
| CVA | 18 | 6 |
| Readmission culminated in hospice referral | 16 | 5 |
| Sleep apnea | 9/165 | 5 |
| Patient with ongoing substance abuse | 10 | 3 |
Sixty‐four percent readmitted cases had been discharged to home (including those with home services), and 36% were discharged to a care facility (skilled nursing facility [SNF], foster care, assisted living) (Table 2). Fifty‐eight percent of cases were readmitted within seven days of the index admission, and another 29% within the first two weeks. Exactly 75% of the time, the readmission was for the same or related diagnosis as the index admission. Primary care follow‐up did not occur as recommended 69% of the time, and 57% of the time the patient was readmitted prior seeing their primary care physician (PCP).
| Characteristics | No. | % |
|---|---|---|
| ||
| Initial admissions LOS (n = 290) | ||
| 1 day | 33 | 11 |
| 23 days | 112 | 39 |
| 47 days | 108 | 37 |
| 8+ days | 37 | 13 |
| Discharge location (n = 286) | ||
| Home | 130 | 45 |
| SNF or ICF | 76 | 27 |
| Home with HH | 55 | 19 |
| Assisted living facility | 17 | 6 |
| Adult foster care | 8 | 3 |
| Readmit interval in days (n = 296) | ||
| 17 days | 171 | 58 |
| 814 days | 85 | 29 |
| 1521 days | 40 | 14 |
| Related diagnosis? (n = 299) | ||
| Unrelated | 75 | 25 |
| Related | 107 | 36 |
| Same | 117 | 39 |
| Follow‐up appointment did not occur as recommended (n = 166) | 114 | 69 |
| No PCP follow‐up prior to readmission (n = 300) | 172 | 57 |
| No evidence of PCP contact with patient in between hospitalizations (n = 300) | 183 | 61 |
| No evidence of primary care case management prior to readmission (n = 300) | 236 | 79 |
Overall, only 15% of readmissions were termed preventable by the hospital reviewers, although another 46% were deemed possibly preventable. Preventability ratings varied by reviewer, ranging from a high of 27% to a low of 0% among hospitalists rating ten or more cases (Table 3). There was similar variation in the number of recommended interventions. For readmissions deemed preventable or possibly preventable, the number of potential interventions ranged from more than three per patient to less than one per patient.
| Top Volume Reviewers | No. Cases Reviewed | No. (%) Termed Preventable or Possibly Preventable | Total No. Interventions Suggested | Interventions per Preventable Case |
|---|---|---|---|---|
| A | 17 | 3 (18) | 3 | 1.00 |
| B | 41 | 31 (76) | 95 | 3.06 |
| C | 61 | 48 (79) | 111 | 2.31 |
| D | 31 | 12 (39) | 4 | 0.33 |
| E | 34 | 11 (32) | 6 | 0.55 |
| F | 64 | 52 (81) | 120 | 2.31 |
| All others | 50 | 27 (54) | 35 | 1.30 |
| Total | 298 | 184 (62) | 374 | 2.03 |
The most frequently mentioned intervention that could have prevented a readmission was to extend the hospital stay by one to two days (Table 4). An earlier PCP appointment was suggested for another 21% of readmissions. Other interventions received a scattering of mentions. The types of recommended interventions varied with the rater's perception of preventability (Figure 1, available online). Hospitalists were more likely to recommend a longer initial stay, medication changes, or additional education at discharge, and earlier contact from a care facility, for readmissions they thought were preventable. For possibly preventable readmissions, these same recommendations were important, but hospitalists were also likely to recommend case management, disposition to a higher level of care, or a home health visit.
| Interventions | n | % | Total N |
|---|---|---|---|
| |||
| Extend hospital stay by 12 days | 68 | 23 | 300 |
| Earlier PCP follow‐up appointment | 56 | 21 | 269 |
| Primary care case management | 55 | 18 | 300 |
| More end‐of‐life discussion or palliative care consult | 50 | 17 | 300 |
| Different discharge medications/dosage | 48 | 16 | 300 |
| Disposition to a higher level of care | 17 | 13 | 134 |
| Better education re: home management | 17 | 13 | 134 |
| Hospice | 38 | 13 | 300 |
| Home health/home physical therapy visit | 30 | 11 | 269 |
| Nursing home visit by MD or SNF specialist | 24 | 9 | 269 |
| Earlier contact from care facility (SNF, ICF, ALF) | 14 | 5 | 268 |
| Improve medication reconciliation or education | 10 | 4 | 269 |
Table 5 shows the most important characteristics associated with preventability, using a cutoff of 0.2 in statistical significance. Readmissions for the same diagnosis were more likely than others to be rated preventable, as were cases with a short readmission interval, more than three new medications at discharge, and patients with COPD or depression/anxiety. Initial hospital length of stay did not influence preventability, nor did it influence the likelihood of a reviewer recommending a longer initial stay.
| Characteristic | Value | Preventable Portion (%) | P value |
|---|---|---|---|
| |||
| Index vs. readmission diagnosis | Same | 28.2 | <0.001 |
| Related | 8.4 | ||
| Unrelated | 4.1 | ||
| New discharge medications | More than 3 | 25.7 | 0.004 |
| 3 or fewer | 11.8 | ||
| Timing of PCP follow‐up | Readmitted prior to PCP follow‐up | 19.8 | 0.009 |
| Readmitted after PCP follow‐up | 8.7 | ||
| Readmission interval | 1 week or less | 19.3 | 0.012 |
| More than 1 week | 8.8 | ||
| COPD diagnosis | With COPD | 25.5 | 0.018 |
| Without COPD | 12.8 | ||
| Index admission site | Hospital 1 | 14.3 | 0.078 |
| Hospital 2 | 15.1 | ||
| Hospital 3 | 7.1 | ||
| Hospital 4 | 22.7 | ||
| Depression/anxiety diagnosis | With depression | 20.0 | 0.083 |
| Without depression | 9.0 | ||
| Patient on anticoagulation | Anticoagulation | 27.3 | 0.098 |
| No anticoagulation | 14.1 | ||
| Age | Greater than 80 | 12.0 | 0.144 |
| 80 or less | 18.1 | ||
Potential predictors associated with preventability were included in a hierarchical logistic regression model, with hospital site and reviewer included as random effects. In this modeling, preventable readmissions were more likely than nonpreventable readmissions to be influenced by three process factors: having the same index and readmission diagnosis; readmission in the first post‐hospital week; being readmitted prior to a primary care follow‐up; and three patient factors: having more than three new discharge medications, having anticoagulation treatment, and having a COPD diagnosis (data available online). Other chronic diseases, age, discharge location, or previous readmissions were not important in the rating of preventability. When entered as random effects in a hierarchical logistic regression model, the categorical variable representing hospital site did not significantly improve prediction (P = 0.42), but the reviewer variable (categorized by the top six reviewers and others) had marginal significance at P = 0.088.
DISCUSSION
Reported high Medicare 30‐day readmission rates and associate excess costs have created a national climate for eliminating unnecessary hospital readmissions.1 Recently passed healthcare legislation in the USA will put in place diagnosis‐related group (DRG) payment reductions for excess readmission rates by 2013. As the definitions and methodologies for determining the relatedness and preventable nature of readmissions continues to be clarified, this study contributes to the understanding of preventability and specific preventative strategies from a physician perspective. Although potential savings in readmission reduction work is attractive, our study indicates that most front‐line clinicians are not convinced that a large portion of readmissions are preventable.
The proportion of preventable readmissions found in our study is very much in line with previous research.713 Certain predictors of preventable readmissions were also similar. Several researchers have found that preventable readmissions are more likely to be early,8, 10, 12 and have the same or related diagnosis as the initial stay.8 On the other hand, our data did not show an independent effect of age on preventability, as others have suggested.9, 17 Patients with a large number of diagnoses and medications have been shown to be at risk for preventable readmissions,9 but the importance of new discharge medications has not been widely researched and is a factor that deserves further exploration.
One key message from our study was found in the variation in the ratings of preventability by individual physicians. At first blush, it may appear to reflect a lack of inter‐rater reliability or understanding of the underlying concept of preventability. We believe this is unlikely, given the discussions among raters and the clear descriptions offered in writing. Moreover, there was much less variation in other judgments such as the ratings of relatedness of the readmission diagnosis (chi‐square = 21.7, P = .041)
There are a number of possible reasons for variation in reviewer ratings of preventability. Reviewers did vary with regard to age, experience, tenure in the organization, gender, and full/part‐time status. They practiced at different hospitals. None of these factors were related to ratings of preventability. On the other hand, three explanations are worth noting.
First, the hierarchical regression models found that reviewer only slightly improved prediction (P = 0.088), above and beyond the other diagnosis and process factors. This would lead us to reject the factor of reviewer as the most important predictor of preventability; the other case characteristics mentioned above were more important.
Second, the three hospitalists who were more optimistic (rated more cases as preventable) reviewed more charts than others. It is possible that these three were more engaged, not only in the chart review process, but more eager to uncover potential remedies to prevent readmissions. While generating more ideas about how to do that, they rated more readmissions as preventable. We do not believe that actually doing more reviews caused them to rate a greater portion as preventable; none of the reviewers showed progression to more preventable ratings over time (analysis not shown).
Finally, it is worth noting that two of the more optimistic physicians had previous primary care experience. This is an intriguing explanation that would benefit from further research. First‐hand experience with primary care case management, rapid appointment follow‐up, home service referrals, and the like may give the practicing hospitalist reason to believe that actions in the ambulatory setting can prevent readmissions.
Regardless of the source, the variation demonstrates cultural or philosophical biases among clinicians regarding how much influence additional planning, education, and care coordination can have on readmissions. We believe that this variation must be addressed in the implementation of readmission reduction programs. Physician engagement will be more likely if there is optimism about the potential to prevent readmissions. In addition, it will be important to develop more consensus about effective interventions from the perspectives of hospital physicians, primary care physicians, nurses, and patients, as others have alluded.18, 19
The significant rate of related readmissions (75%) has implications for the potential Centers for Medicare and Medicaid Services (CMS) methodology that will be used to reduce DRG payments, given the legislation's current intent to exclude only unrelated and planned readmissions from the calculations. Providing clear definitions on relatedness and a methodology to code this criterion in administrative datasets may need to be developed. The views of hospitalists in the current study suggest that the relatedness methodology may be overly sensitive and not yet specific enough to isolate truly preventable readmissions. Less than a quarter of related readmissions were deemed preventable by these raters.
Hospitalists found both patient and process factors important in assessing the preventability of a readmission. This kind of analysis can point to subgroups with potential for targeted intervention. For example, over a third of patients readmitted within a week for the same diagnosis were rated as preventable, indicating a critical follow‐up period for some patients. Higher ratings of preventability among the readmissions for patients on anticoagulation or who were given more than three new medications at discharge indicates that better medication management may indeed be a fruitful strategy for readmission reduction.
The finding that increasing the length of the initial hospital stay was rated as the most prevalent strategy to mitigate against readmission in our retrospective review was surprising. It emphasizes the tension between efficient hospital throughput which reduces unnecessary hospital days and the necessity for appropriate monitoring to ensure clinical stability prior to discharge. Excess hospital days can prolong the exposure to a multitude of hospital acquired conditions (HAC), and this risk must be weighed against a longer length of stay and the time required delivering the appropriate hospital services.
Exploring alternative strategies to reduce readmissions without increasing the hospital length of stay is a reasonable response to this tension. Better discharge education and attention to discharge medications and dosages were also recommended strategies for preventable readmissions. These are interventions hospitalists are familiar with and can control. Relatively smaller percentages of patients were thought to benefit from case management, hospice, home health, or an MD visit to their nursing home, and hospitalists were more likely to recommend these for the possibly preventable patients. These interventions are not fully implemented within the study health system so there is understandably less confidence in them.
Limitations of this study include its relatively small sample size and the fact that all patients were served by a single medical practice. No extensive inter‐rater reliability checks were performed, although all reviewers were trained in the definitions of the most important judgment items. Other limitations include possible confounding biases which were not controlled, such as the number of charts reviewed, timing of review, and hospital reviewed (ie, each reviewer did not review the same proportion of charts from each hospital).
SUMMARY
We have presented a retrospective chart review study of hospital readmissions in a community hospital setting. This study adds to the increasing literature describing the factors that contribute to hospital readmissions, how preventable they are, and what strategies may reduce the likelihood of readmission. This study is unique in its contribution to the understanding of hospital readmissions by studying front‐line clinician (hospitalist) perceptions of those factors.
Acknowledgements
The authors express their appreciation to the following clinicians for their review of patient charts, revisions to the chart review tool, and contributions to the interpretation of study data: Adam Blomberg, MD; Adam Mizgajski, MD; Alison Ma, MD; Amy Carolan, MD; Amy Johnson, MD; Brian Kearns, MD; Christopher Zaugra, MD; Frank Joerke, MD; Janhavi Meghashyam, MD; Jennifer M. Wilson, MD; Larie Hoover, MD; Patrick J. Gaston, MD; Scott Kemeny, MD; Sean Tushla, MD; Timothy Dygert, MD; and Vinay Siddappa, MD. The authors are also grateful to Eileen O'Reilly‐Hoisington who created the online chart‐review forms and extracted data for the analysis.
- The Library of Congress. Thomas H.R. 3590 Bill Summary 360:1418–1428.
- ,.Preventing the preventable: reducing rehospitalizations through coordinated, patient‐centered discharge processes.Prof Case Manag.2009;14:135–140.
- Agency for Healthcare Research and Quality, Rockville, MD. Preventable Hospitalizations: a Window into Primary and Preventive Care, 2000. Available at: http://www.ahrq.gov/data/hcup/factbk5/. Accessed June 18,2010.
- ,,, et al.Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions.J Gen Intern Med.1996;11:597–607.
- ,,.Early readmissions to the department of medicine as a screening tool for monitoring quality of care problems.Medicine (Baltimore).2008;87:294–300.
- ,,, et al.Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility.Am J Med.1987;83:1031–1036.
- .Are readmissions avoidable?BMJ.1990;301:1136–1138.
- ,,,,.How does managed care manage the frail elderly? The case of hospital readmissions in fee‐for‐service versus HMO systems.Am J Prev Med.1999;16:163–172.
- ,,.Preventability of emergent hospital readmission.Am J Med.1991;90:667–674.
- ,,,.Readmissions to a geriatric medical unit: is prevention possible?Aging Clin Exp Res.1992;4:61–67.
- Medicare Payment Advisory Commission. Payment policy for inpatient readmissions. In: Report to the Congress: Promoting Greater Efficiency in Medicare. Available at: http://www.medpac.gov/chapters/Jun07_Ch05.pdf. Accessed February 9,2010.
- PASW Statistics. Version 18.Chicago, IL:SPSS Inc, an IBM Company;2010.
- Stata Statistical Software: Release 11. Version 18.College Station, TX:StataCorp LP;2009.
- ,,,,,.Measuring potentially avoidable hospital readmissions.J Clin Epidemiol.2002;55(6):573–587.
- ,,,.Unplanned readmission to hospital: a comparison of the views of general practitioners and hospital staff.Age Ageing.2002;31:141–143.
- ,,.Reasons for readmission in heart failure: perspectives of patients, caregivers, cardiologists, and heart failure nurses.Heart Lung.2009;38:427–434.
- The Library of Congress. Thomas H.R. 3590 Bill Summary 360:1418–1428.
- ,.Preventing the preventable: reducing rehospitalizations through coordinated, patient‐centered discharge processes.Prof Case Manag.2009;14:135–140.
- Agency for Healthcare Research and Quality, Rockville, MD. Preventable Hospitalizations: a Window into Primary and Preventive Care, 2000. Available at: http://www.ahrq.gov/data/hcup/factbk5/. Accessed June 18,2010.
- ,,, et al.Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions.J Gen Intern Med.1996;11:597–607.
- ,,.Early readmissions to the department of medicine as a screening tool for monitoring quality of care problems.Medicine (Baltimore).2008;87:294–300.
- ,,, et al.Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility.Am J Med.1987;83:1031–1036.
- .Are readmissions avoidable?BMJ.1990;301:1136–1138.
- ,,,,.How does managed care manage the frail elderly? The case of hospital readmissions in fee‐for‐service versus HMO systems.Am J Prev Med.1999;16:163–172.
- ,,.Preventability of emergent hospital readmission.Am J Med.1991;90:667–674.
- ,,,.Readmissions to a geriatric medical unit: is prevention possible?Aging Clin Exp Res.1992;4:61–67.
- Medicare Payment Advisory Commission. Payment policy for inpatient readmissions. In: Report to the Congress: Promoting Greater Efficiency in Medicare. Available at: http://www.medpac.gov/chapters/Jun07_Ch05.pdf. Accessed February 9,2010.
- PASW Statistics. Version 18.Chicago, IL:SPSS Inc, an IBM Company;2010.
- Stata Statistical Software: Release 11. Version 18.College Station, TX:StataCorp LP;2009.
- ,,,,,.Measuring potentially avoidable hospital readmissions.J Clin Epidemiol.2002;55(6):573–587.
- ,,,.Unplanned readmission to hospital: a comparison of the views of general practitioners and hospital staff.Age Ageing.2002;31:141–143.
- ,,.Reasons for readmission in heart failure: perspectives of patients, caregivers, cardiologists, and heart failure nurses.Heart Lung.2009;38:427–434.
Copyright © 2011 Society of Hospital Medicine